Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,A1BG,Alpha-1B-glycoprotein,24605,122,3.29 [1.23-8.85],0.018032707584182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AAMDC,Mth938 domain-containing protein,23885,117,0.97 [0.70-1.36],0.8710654407373699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AARSD1,Alanyl-tRNA editing protein Aarsd1,28150,131,1.21 [0.93-1.59],0.1531410152534601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABCA2,ATP-binding cassette sub-family A member 2,23789,116,0.94 [0.57-1.57],0.819047070875041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABHD14B,Protein ABHD14B,27982,127,0.94 [0.72-1.23],0.6654725186616688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABL1,Tyrosine-protein kinase ABL1,28150,131,1.00 [0.80-1.24],0.96610129374009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABO,Histo-blood group ABO system transferase,24594,120,1.02 [0.90-1.14],0.7995587679758437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABRAXAS2,BRISC complex subunit Abraxas 2,23789,116,0.93 [0.71-1.21],0.5793077815165131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27585,127,0.95 [0.78-1.15],0.5835443647862251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24115,121,0.96 [0.74-1.24],0.7501806614687848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24567,122,0.96 [0.79-1.17],0.7155461077097598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACAN,Aggrecan core protein,28021,131,0.86 [0.50-1.48],0.5821819073792165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACE,Angiotensin-converting enzyme,24594,120,1.14 [0.58-2.23],0.7039127288981557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACE2,Angiotensin-converting enzyme 2,27774,125,1.09 [0.81-1.48],0.5623197987732691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACHE,Acetylcholinesterase,24019,120,0.98 [0.58-1.67],0.9450524193460244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACOT13,Acyl-coenzyme A thioesterase 13,24472,121,0.90 [0.78-1.05],0.1788051990375679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,28278,131,1.03 [0.76-1.40],0.8290282521186819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23868,118,1.08 [0.74-1.58],0.692042244028163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACP5,Tartrate-resistant acid phosphatase type 5,28381,129,1.19 [0.74-1.89],0.4755391327788784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACP6,Lysophosphatidic acid phosphatase type 6,28492,133,0.96 [0.76-1.20],0.6909112033874443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACRBP,Acrosin-binding protein,24451,121,0.94 [0.60-1.48],0.7857949579233399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACRV1,Acrosomal protein SP-10,23868,118,1.14 [0.90-1.44],0.2678272449246378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23789,116,1.30 [0.86-1.96],0.216474138191504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACTA2,"Actin, aortic smooth muscle",27774,125,0.79 [0.53-1.18],0.2516825180461827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACTN2,Alpha-actinin-2,23789,116,0.99 [0.73-1.34],0.935088013752252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACTN4,Alpha-actinin-4,27752,127,0.91 [0.54-1.54],0.7245957531085399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACVRL1,Serine/threonine-protein kinase receptor R3,28032,128,0.99 [0.51-1.96],0.986406126822014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACY1,Aminoacylase-1,28278,131,1.11 [0.87-1.41],0.4126974388620703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23789,116,0.94 [0.69-1.29],0.6980043764461249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACYP1,Acylphosphatase-1,23928,120,1.15 [0.89-1.49],0.2977949182538875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADA,Adenosine deaminase,28613,132,1.50 [1.01-2.22],0.0445054442277671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADA2,Adenosine deaminase 2,28092,127,1.35 [0.93-1.95],0.1110999349573596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23868,118,0.87 [0.51-1.50],0.6171713529315395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27774,125,0.72 [0.42-1.21],0.2081528840052623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,28081,128,0.75 [0.48-1.16],0.1972524376237069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28613,132,0.94 [0.61-1.44],0.7637916221648232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28501,133,1.06 [0.62-1.81],0.8388404577877574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24472,121,1.50 [0.87-2.59],0.1469407340626437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23868,118,1.16 [0.70-1.93],0.5628925635691955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28628,130,1.05 [0.54-2.07],0.8812130677304002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,28150,131,1.00 [0.71-1.42],0.9921861810799892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27774,125,0.59 [0.32-1.08],0.0858763448381511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23868,118,0.67 [0.40-1.13],0.131259485619067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28342,129,0.95 [0.68-1.34],0.7861538231633531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTSL2,ADAMTS-like protein 2,24559,122,1.40 [0.83-2.35],0.2044434837292155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTSL4,ADAMTS-like protein 4,23885,117,0.97 [0.46-2.04],0.9373469563846092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTSL5,ADAMTS-like protein 5,24567,122,0.73 [0.47-1.13],0.1618710661437183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27585,127,1.28 [0.92-1.78],0.1402617054152156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADD1,Alpha-adducin,24019,120,0.89 [0.69-1.14],0.358273324059649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRB3,Adhesion G protein-coupled receptor B3,28032,128,1.00 [0.62-1.62],0.9841646176539304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRD1,Adhesion G-protein coupled receptor D1,24019,120,1.46 [0.95-2.25],0.0825579640338289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRE1,Adhesion G protein-coupled receptor E1,24472,121,1.17 [0.86-1.60],0.318702654120453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRE2,Adhesion G protein-coupled receptor E2,28400,130,1.35 [0.79-2.32],0.2754123818544577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRE5,Adhesion G protein-coupled receptor E5,28472,129,1.56 [0.95-2.57],0.0778868320463363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRF5,Adhesion G protein-coupled receptor F5,24567,122,0.61 [0.34-1.11],0.1035641222002787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRG1,Adhesion G-protein coupled receptor G1,28150,131,1.16 [0.92-1.47],0.216743642964587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRG2,Adhesion G-protein coupled receptor G2,28278,131,1.25 [0.71-2.20],0.4472691727939347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRV1,Adhesion G-protein coupled receptor V1,23785,114,0.84 [0.63-1.13],0.2451209538413181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADH1B,All-trans-retinol dehydrogenase,24019,120,1.02 [0.81-1.27],0.8856779150335217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27774,125,1.05 [0.87-1.26],0.6086677043516082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADIPOQ,Adiponectin,24605,122,0.88 [0.68-1.13],0.3162788091892187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADM,Pro-adrenomedullin,28529,133,0.86 [0.50-1.49],0.5912426671185822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADRA2A,Alpha-2A adrenergic receptor,23789,116,1.11 [0.90-1.39],0.3317357407169566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AFAP1,Actin filament-associated protein 1,24019,120,0.95 [0.77-1.17],0.6019280303642851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AFM,Afamin,24605,122,1.45 [0.60-3.53],0.4081518848036506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AFP,Alpha-fetoprotein,27992,127,1.07 [0.85-1.35],0.5688185312574253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGBL2,Cytosolic carboxypeptidase 2,23785,114,1.02 [0.83-1.24],0.8783986656096318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGER,Advanced glycosylation end product-specific receptor,28205,128,0.75 [0.51-1.09],0.1339808101244132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGR2,Anterior gradient protein 2 homolog,27382,125,1.22 [1.04-1.42],0.0123431399585315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGR3,Anterior gradient protein 3,27548,127,0.98 [0.75-1.28],0.8854020031442713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGRN,Agrin,28400,130,0.81 [0.50-1.31],0.3948846118010012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGRP,Agouti-related protein,28613,132,0.89 [0.67-1.18],0.4093729719386659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGT,Angiotensinogen,24594,120,0.53 [0.22-1.27],0.1567087068061856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGXT,Serine--pyruvate aminotransferase,28278,131,1.06 [0.87-1.29],0.5601531782391722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHCY,Adenosylhomocysteinase,28278,131,0.92 [0.73-1.16],0.4793370977909796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHNAK,Neuroblast differentiation-associated protein AHNAK,23885,117,0.82 [0.46-1.44],0.4867541480855849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHNAK2,Protein AHNAK2,23885,117,1.08 [0.59-1.96],0.8114950648177266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24451,121,0.98 [0.76-1.27],0.8936813029698215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHSG,Alpha-2-HS-glycoprotein,24594,120,1.11 [0.58-2.10],0.7565683477243177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHSP,Alpha-hemoglobin-stabilizing protein,28222,129,1.16 [0.97-1.38],0.0996539992914801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AIDA,"Axin interactor, dorsalization-associated protein",23882,119,0.78 [0.60-1.02],0.0660622144386662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AIF1,Allograft inflammatory factor 1,27585,127,0.85 [0.63-1.14],0.2725918892602316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AIF1L,Allograft inflammatory factor 1-like,23885,117,0.97 [0.70-1.33],0.8439350476791463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28099,131,0.95 [0.82-1.10],0.4603554046800423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AK1,Adenylate kinase isoenzyme 1,28278,131,1.15 [0.91-1.45],0.2322295248625655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AK2,"Adenylate kinase 2, mitochondrial",24496,120,0.84 [0.72-0.99],0.0363596068488324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKAP12,A-kinase anchor protein 12,24019,120,1.27 [0.61-2.60],0.5234661631717169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKR1B1,Aldo-keto reductase family 1 member B1,27585,127,0.92 [0.75-1.14],0.4439284370474705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKR1B10,Aldo-keto reductase family 1 member B10,23882,119,0.78 [0.56-1.07],0.1245607110530936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKR1C4,Aldo-keto reductase family 1 member C4,27774,125,0.84 [0.60-1.18],0.3145436696356867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23868,118,0.85 [0.65-1.12],0.2466798908280749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKT1S1,Proline-rich AKT1 substrate 1,27604,125,0.93 [0.74-1.18],0.5587606125300082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKT2,RAC-beta serine/threonine-protein kinase,24531,120,0.91 [0.80-1.04],0.1842880163894726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKT3,RAC-gamma serine/threonine-protein kinase,27442,126,0.88 [0.67-1.16],0.3632283731048955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALCAM,CD166 antigen,28628,130,1.12 [0.50-2.47],0.7858991310916517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALDH1A1,Retinal dehydrogenase 1,28263,129,1.14 [0.86-1.49],0.3605481779591268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24451,121,0.74 [0.48-1.13],0.163329260784979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",28219,133,1.09 [0.88-1.36],0.4346698293202343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24531,120,0.86 [0.58-1.25],0.4233314239467441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALMS1,Alstrom syndrome protein 1,24115,121,0.53 [0.32-0.86],0.0095651346826346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALPI,Intestinal-type alkaline phosphatase,23868,118,1.04 [0.90-1.19],0.632083989436754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALPP,"Alkaline phosphatase, placental type",28150,131,1.15 [1.00-1.33],0.0559869423606126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMBN,Ameloblastin,27752,127,1.23 [0.75-2.01],0.4133431097346989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMBP,Protein AMBP,28492,133,1.51 [0.69-3.28],0.304146623906848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24559,122,1.05 [0.54-2.03],0.8915395884333249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMFR,E3 ubiquitin-protein ligase AMFR,27604,125,0.83 [0.63-1.08],0.1574595161253016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMIGO1,Amphoterin-induced protein 1,23882,119,0.96 [0.67-1.36],0.8125437202583867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMIGO2,Amphoterin-induced protein 2,28150,131,1.89 [0.97-3.67],0.0614096897362741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMN,Protein amnionless,27752,127,0.84 [0.60-1.18],0.3057942090454467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMOT,Angiomotin,24019,120,1.11 [0.73-1.70],0.6306901881284896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMOTL2,Angiomotin-like protein 2,24370,120,0.64 [0.41-1.00],0.0514616661601933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMPD3,AMP deaminase 3,24496,120,1.39 [1.10-1.74],0.0050722390761624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23053,113,0.67 [0.45-0.99],0.0453083729450297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMY2A,Pancreatic alpha-amylase,27214,125,0.65 [0.46-0.91],0.0119001758958965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMY2B,Alpha-amylase 2B,26367,120,0.62 [0.44-0.88],0.0074628123837295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANG,Angiogenin,28177,128,1.33 [0.87-2.06],0.1913292752794856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPT1,Angiopoietin-1,28189,129,0.89 [0.75-1.07],0.2122044061321733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPT2,Angiopoietin-2,28529,133,1.18 [0.79-1.75],0.4196710571813079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL1,Angiopoietin-related protein 1,27853,128,0.93 [0.55-1.60],0.8017345269793175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL2,Angiopoietin-related protein 2,28307,129,1.50 [1.02-2.21],0.0389993962690834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL3,Angiopoietin-related protein 3,28278,128,0.77 [0.50-1.19],0.2434408654780014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL4,Angiopoietin-related protein 4,28357,130,1.11 [0.80-1.56],0.5339614080390205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL7,Angiopoietin-related protein 7,28529,133,1.02 [0.67-1.53],0.9348289474805735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANK2,Ankyrin-2,23789,116,0.91 [0.69-1.20],0.5160743957869989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23868,118,0.89 [0.71-1.11],0.3053733247833964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANKRA2,Ankyrin repeat family A protein 2,23697,117,0.92 [0.66-1.29],0.6322355722367491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANKRD54,Ankyrin repeat domain-containing protein 54,27585,127,1.16 [0.91-1.48],0.2421849537076391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23885,117,0.46 [0.24-0.88],0.0181635262983465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANPEP,Aminopeptidase N,28309,127,0.88 [0.50-1.56],0.6713228680687906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA1,Annexin A1,23881,120,0.89 [0.59-1.34],0.5718526267631205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA10,Annexin A10,27604,125,1.09 [0.90-1.32],0.3518672533862321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA11,Annexin A11,28207,133,0.98 [0.78-1.23],0.8796347744066573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA2,Annexin A2,23538,117,1.04 [0.81-1.34],0.7329676780702978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA3,Annexin A3,28501,133,0.95 [0.77-1.18],0.6594629163975139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA4,Annexin A4,28133,130,0.98 [0.79-1.20],0.8150958567855227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA5,Annexin A5,27509,124,1.31 [0.79-2.16],0.3005874943951866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27752,127,0.91 [0.67-1.23],0.5387665700082509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AOC3,Membrane primary amine oxidase,28359,128,1.21 [0.73-2.00],0.4582388164555645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AP1G2,AP-1 complex subunit gamma-like 2,24451,121,0.91 [0.73-1.13],0.3790885225414013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AP2B1,AP-2 complex subunit beta,23882,119,0.73 [0.50-1.08],0.1212594797470789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AP3B1,AP-3 complex subunit beta-1,24472,121,0.86 [0.68-1.08],0.1890142081522332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AP3S2,AP-3 complex subunit sigma-2,24496,120,0.86 [0.59-1.26],0.4461860517901171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,28150,131,0.98 [0.70-1.37],0.8915457810096022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APCS,Serum amyloid P-component,24400,122,0.95 [0.58-1.55],0.8241257831875014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28452,133,1.02 [0.79-1.33],0.8528291454415926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APLP1,Amyloid-like protein 1,28278,131,0.94 [0.70-1.26],0.6652983619225425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOA1,Apolipoprotein A-I,24605,122,1.11 [0.60-2.04],0.7462511513436396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOA2,Apolipoprotein A-II,24594,120,0.82 [0.57-1.17],0.2752062057120666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOA4,Apolipoprotein A-IV,24605,122,1.69 [1.20-2.39],0.0028466768523049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOB,Apolipoprotein B-100,24594,120,1.12 [0.52-2.42],0.7787019503782067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOBR,Apolipoprotein B receptor,23885,117,1.26 [0.82-1.95],0.2979932167245253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOC1,Apolipoprotein C-I,24554,122,0.94 [0.59-1.50],0.7882111239712792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOD,Apolipoprotein D,23460,120,1.13 [0.79-1.62],0.5020108835555926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOE,Apolipoprotein E,24605,122,1.12 [0.91-1.36],0.2886757527770368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOF,Apolipoprotein F,24594,120,0.74 [0.46-1.19],0.2160189356681379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOH,Beta-2-glycoprotein 1,28263,129,1.21 [0.79-1.83],0.3815200463478777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOL1,Apolipoprotein L1,24594,120,0.90 [0.69-1.19],0.4769571355062781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOM,Apolipoprotein M,28324,128,0.98 [0.55-1.74],0.9478470431828634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APP,Amyloid-beta precursor protein,28212,129,0.80 [0.63-1.02],0.0672143685301594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APPL2,DCC-interacting protein 13-beta,24019,120,0.90 [0.77-1.04],0.1585368725258432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APRT,Adenine phosphoribosyltransferase,28048,128,1.17 [0.85-1.63],0.3355889993156593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARAF,Serine/threonine-protein kinase A-Raf,24115,121,0.84 [0.63-1.11],0.2158264741656067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AREG,Amphiregulin,28150,131,1.10 [0.78-1.53],0.5928985868134447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARF6,ADP-ribosylation factor 6,24472,121,0.92 [0.79-1.08],0.3109575151027725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARFIP1,Arfaptin-1,24531,120,0.97 [0.75-1.24],0.7964996918722438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARG1,Arginase-1,28131,132,1.31 [0.98-1.74],0.0654065616068474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARG2,"Arginase-2, mitochondrial",24451,121,0.80 [0.51-1.26],0.3302901980374733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP1,Rho GTPase-activating protein 1,27585,127,0.80 [0.57-1.11],0.1783488556360055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP25,Rho GTPase-activating protein 25,27585,127,0.86 [0.65-1.13],0.2868878436980333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP30,Rho GTPase-activating protein 30,24115,121,0.61 [0.34-1.10],0.1026696972266889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP45,Rho GTPase-activating protein 45,24019,120,0.83 [0.67-1.03],0.0869618384222107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP5,Rho GTPase-activating protein 5,23697,117,0.92 [0.72-1.18],0.5227473455034033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGEF1,Rho guanine nucleotide exchange factor 1,24496,120,0.96 [0.79-1.16],0.6666233700945126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGEF10,Rho guanine nucleotide exchange factor 10,24531,120,0.88 [0.73-1.06],0.188232794465778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGEF12,Rho guanine nucleotide exchange factor 12,28257,133,0.97 [0.83-1.12],0.6435831618646711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGEF5,Rho guanine nucleotide exchange factor 5,23785,114,1.11 [0.88-1.39],0.3805963025586956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARID3A,AT-rich interactive domain-containing protein 3A,23785,114,0.83 [0.52-1.33],0.4402625245630072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARID4B,AT-rich interactive domain-containing protein 4B,27604,125,1.07 [0.75-1.53],0.6919818604375922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARL13B,ADP-ribosylation factor-like protein 13B,23789,116,0.99 [0.77-1.28],0.9426349493958768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23789,116,0.91 [0.58-1.42],0.6770628539147237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARMCX2,Armadillo repeat-containing X-linked protein 2,23785,114,1.05 [0.79-1.40],0.743061635310674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARNT,Aryl hydrocarbon receptor nuclear translocator,27752,127,0.87 [0.56-1.34],0.5187262675268702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23789,116,0.90 [0.62-1.31],0.5752855674331361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARSA,Arylsulfatase A,28263,129,1.20 [0.87-1.66],0.2642517574509997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARSB,Arylsulfatase B,28150,131,0.98 [0.74-1.29],0.8720481446378046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ART3,Ecto-ADP-ribosyltransferase 3,28359,128,0.74 [0.46-1.18],0.2022582885430807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ART5,Ecto-ADP-ribosyltransferase 5,23785,114,1.05 [0.80-1.38],0.7154737750302529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARTN,Artemin,27752,127,0.77 [0.51-1.16],0.2079920174207837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASAH1,Acid ceramidase,24355,122,1.03 [0.71-1.48],0.884803924913038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASAH2,Neutral ceramidase,28081,128,1.14 [0.84-1.55],0.3922197723301222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASGR1,Asialoglycoprotein receptor 1,28081,128,1.08 [0.64-1.82],0.778954197065531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASGR2,Asialoglycoprotein receptor 2,24594,120,0.69 [0.35-1.36],0.2841437120829497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASPN,Asporin,24567,122,0.92 [0.49-1.74],0.7979158071137828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASPSCR1,Tether containing UBX domain for GLUT4,24531,120,0.95 [0.74-1.23],0.7047616760823971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23885,117,0.88 [0.73-1.04],0.141026136359229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASS1,Argininosuccinate synthase,23789,116,1.04 [0.83-1.30],0.7339637531811918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27604,125,1.16 [0.97-1.39],0.1124916821809024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATF4,Cyclic AMP-dependent transcription factor ATF-4,23697,117,0.84 [0.48-1.47],0.5469577362975282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATG16L1,Autophagy-related protein 16-1,24472,121,0.92 [0.75-1.13],0.4233727269577074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATG4A,Cysteine protease ATG4A,27585,127,1.15 [0.89-1.48],0.2841674836998783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATOX1,Copper transport protein ATOX1,28342,129,0.86 [0.69-1.05],0.1440871179168826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23789,116,0.97 [0.66-1.43],0.8910361180158689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23789,116,1.14 [0.65-1.98],0.6519747077002985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23789,116,0.74 [0.44-1.24],0.2523618329576914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP1B4,Protein ATP1B4,23697,117,1.03 [0.67-1.58],0.8843625950123163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23789,116,0.86 [0.62-1.19],0.3615689667018319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23789,116,0.63 [0.40-0.99],0.0452638736170366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP5IF1,"ATPase inhibitor, mitochondrial",28400,130,0.95 [0.83-1.09],0.4579330591262397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP5PO,"ATP synthase subunit O, mitochondrial",27604,125,1.22 [0.90-1.67],0.2012925847864278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6AP2,Renin receptor,27585,127,0.73 [0.47-1.13],0.1598531641513069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6V1D,V-type proton ATPase subunit D,28150,131,1.37 [0.82-2.27],0.2268998910760098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6V1F,V-type proton ATPase subunit F,27554,124,0.92 [0.72-1.17],0.5036895682602194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6V1G1,V-type proton ATPase subunit G 1,23885,117,0.94 [0.74-1.20],0.6188282703342157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6V1G2,V-type proton ATPase subunit G 2,23789,116,0.89 [0.73-1.08],0.2365257324086371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATRAID,All-trans retinoic acid-induced differentiation factor,24472,121,1.20 [0.77-1.89],0.4234332011455252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATRN,"Attractin, Isoform 2",24605,122,2.53 [0.92-6.96],0.0726395344937666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATXN10,Ataxin-10,27604,125,0.87 [0.70-1.08],0.2027580136108518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATXN2,Ataxin-2,23785,114,0.94 [0.79-1.12],0.4847956010639074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATXN2L,Ataxin-2-like protein,24531,120,1.07 [0.75-1.52],0.700597116758238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATXN3,Ataxin-3,24496,120,1.04 [0.79-1.37],0.7852178579532549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AXIN1,Axin-1,28257,133,0.91 [0.78-1.07],0.2583601235019832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AXL,Tyrosine-protein kinase receptor UFO,28359,128,1.21 [0.69-2.11],0.5016478571119443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AZI2,5-azacytidine-induced protein 2,24531,120,0.73 [0.52-1.01],0.0592846353506304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AZU1,Azurocidin,27426,121,1.00 [0.81-1.23],0.963962436941539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B2M,Beta-2-microglobulin,24605,122,0.97 [0.56-1.68],0.9214243127199312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23789,116,1.92 [0.91-4.04],0.085125828825128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23885,117,2.12 [1.31-3.42],0.0020561870714814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B4GALT1,"Beta-1,4-galactosyltransferase 1",28400,130,0.73 [0.41-1.30],0.2839616320244938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B4GAT1,"Beta-1,4-glucuronyltransferase 1",28263,129,1.03 [0.55-1.96],0.9168651666620214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BABAM1,BRISC and BRCA1-A complex member 1,23868,118,0.97 [0.53-1.78],0.9231791418592492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BACH1,Transcription regulator protein BACH1,28257,133,0.97 [0.78-1.19],0.7406660224382451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAG3,BAG family molecular chaperone regulator 3,28032,128,0.80 [0.55-1.15],0.2309338639636071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAG4,BAG family molecular chaperone regulator 4,23868,118,1.00 [0.70-1.42],0.9850219759432072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAG6,Large proline-rich protein BAG6,27774,125,0.95 [0.61-1.46],0.8038578961750495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27585,127,1.14 [0.90-1.45],0.2809196713010656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAMBI,BMP and activin membrane-bound inhibitor homolog,27585,127,0.99 [0.58-1.68],0.968878030070308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BANK1,B-cell scaffold protein with ankyrin repeats,28257,133,0.94 [0.82-1.09],0.4168491459415643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAP18,Chromatin complexes subunit BAP18,24496,120,1.03 [0.80-1.32],0.8215650645315523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BATF,Basic leucine zipper transcriptional factor ATF-like,23882,119,0.88 [0.69-1.12],0.294847710104926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAX,Apoptosis regulator BAX,27554,125,0.99 [0.83-1.18],0.904671626439448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCAM,Basal cell adhesion molecule,28263,129,0.96 [0.50-1.86],0.9147755146593104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCAN,Brevican core protein,28081,128,0.73 [0.46-1.15],0.17469868071312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24567,122,0.92 [0.52-1.65],0.7859635258694152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23785,114,0.83 [0.56-1.22],0.3357422190556405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCHE,Cholinesterase,24133,118,1.38 [0.73-2.62],0.3245322955688518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL2,Apoptosis regulator Bcl-2,24472,121,1.08 [0.79-1.46],0.638706004205803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL2L1,Bcl-2-like protein 1,24496,120,0.92 [0.78-1.10],0.3579930883810016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",28257,133,1.07 [0.75-1.52],0.7066370106007394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL2L15,Bcl-2-like protein 15,23868,118,1.13 [0.85-1.48],0.4033461309315934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL7A,B-cell CLL/lymphoma 7 protein family member A,23697,117,0.78 [0.57-1.07],0.1278311315077401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24451,121,0.76 [0.49-1.18],0.2288800055503103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCR,Breakpoint cluster region protein,28257,133,0.97 [0.82-1.14],0.6928087385866402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BDNF,Brain-derived neurotrophic factor,24559,122,0.82 [0.67-0.99],0.0434071471166257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BECN1,Beclin-1,23885,117,0.87 [0.65-1.18],0.3787923446258298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BEX3,Protein BEX3,23697,117,1.08 [0.76-1.54],0.6532965448316221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BGLAP,Osteocalcin,24559,122,0.82 [0.69-0.98],0.0329028265418043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BGN,Biglycan,27546,127,1.01 [0.89-1.15],0.8557227297862836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BHLHE40,Class E basic helix-loop-helix protein 40,23785,114,0.88 [0.67-1.16],0.3704000465612864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23789,116,1.08 [0.54-2.16],0.822804881272669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BID,BH3-interacting domain death agonist,28257,133,0.85 [0.67-1.08],0.180881652457229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BIN2,Bridging integrator 2,28263,129,0.90 [0.76-1.07],0.2289632652544506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BIRC2,Baculoviral IAP repeat-containing protein 2,27585,127,0.95 [0.74-1.22],0.6828590886753205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLMH,Bleomycin hydrolase,28628,130,1.14 [0.71-1.84],0.5830269496758116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLNK,B-cell linker protein,23868,118,0.67 [0.40-1.12],0.1263254243210789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23785,114,0.83 [0.63-1.10],0.1913111627428514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24496,120,0.74 [0.47-1.16],0.1842431697553409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLVRB,Flavin reductase,28263,129,1.29 [1.04-1.59],0.0193498652357366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BMP10,Bone morphogenetic protein 10,24019,120,1.47 [0.78-2.76],0.2306199071131132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BMP4,Bone morphogenetic protein 4,28032,128,0.85 [0.60-1.20],0.3565330524836224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BMP6,Bone morphogenetic protein 6,27722,124,0.92 [0.63-1.34],0.6683445046006056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BMPER,BMP-binding endothelial regulator protein,24019,120,1.29 [0.61-2.72],0.507591083584947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24567,122,0.89 [0.53-1.48],0.6527559364775757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23868,118,1.03 [0.70-1.51],0.8943807342785906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BOC,Brother of CDO,27774,125,0.89 [0.45-1.76],0.7438439037910947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BOLA1,BolA-like protein 1,23785,114,1.10 [0.80-1.50],0.5622027887395911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BOLA2_BOLA2B,BolA-like protein 2,23885,117,1.18 [0.86-1.62],0.3168731497599586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BPIFA2,BPI fold-containing family A member 2,23031,113,1.03 [0.87-1.21],0.7499733250704329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BPIFB1,BPI fold-containing family B member 1,28226,129,1.02 [0.80-1.30],0.8625210545371375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BPIFB2,BPI fold-containing family B member 2,24527,122,1.23 [0.96-1.58],0.0960095521119193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRAP,BRCA1-associated protein,24239,121,0.92 [0.79-1.08],0.3112555293629471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRD1,Bromodomain-containing protein 1,24115,121,1.21 [0.71-2.06],0.4870905642898243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRD2,Bromodomain-containing protein 2,23785,114,1.01 [0.59-1.72],0.9695983696641992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRD3,Bromodomain-containing protein 3,23789,116,0.91 [0.61-1.36],0.6496349581842986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRDT,Bromodomain testis-specific protein,23789,116,0.73 [0.44-1.21],0.2224059478449641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRK1,Protein BRICK1,27604,125,0.78 [0.55-1.12],0.1813512705235583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRME1,Break repair meiotic recombinase recruitment factor 1,23785,114,1.01 [0.65-1.57],0.965876159404784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRSK2,Serine/threonine-protein kinase BRSK2,24531,120,0.64 [0.39-1.05],0.0800546817215593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BSG,Basigin,28562,132,1.05 [0.48-2.29],0.9100901568818582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BSND,Barttin,23697,117,1.12 [0.68-1.82],0.6594541145043629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28543,133,0.77 [0.59-1.01],0.0580536216070447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BST2,Bone marrow stromal antigen 2,28543,133,1.02 [0.76-1.35],0.916023181526961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTC,Probetacellulin,27585,127,0.91 [0.73-1.13],0.3918360677711354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTD,Biotinidase,24605,122,1.20 [0.52-2.75],0.6736813517123146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTLA,B- and T-lymphocyte attenuator,23697,117,0.97 [0.79-1.20],0.7996383061006167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTN1A1,Butyrophilin subfamily 1 member A1,24407,121,1.09 [0.72-1.64],0.6917956696507683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTN2A1,Butyrophilin subfamily 2 member A1,28400,130,0.89 [0.48-1.64],0.7058416503427763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTN3A2,Butyrophilin subfamily 3 member A2,28257,133,0.80 [0.53-1.21],0.2924884835027096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTNL10,Butyrophilin-like protein 10,23697,117,0.80 [0.47-1.34],0.3898536617905936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C19orf12,Protein C19orf12,27604,125,0.90 [0.70-1.17],0.4424227940460545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1GALT1C1,C1GALT1-specific chaperone 1,23789,116,0.70 [0.38-1.27],0.2374388960907422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QA,Complement C1q subcomponent subunit A,28465,132,1.12 [0.57-2.19],0.7368160770258476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24531,120,0.98 [0.74-1.29],0.8811002010511787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QL2,Complement C1q-like protein 2,23868,118,0.97 [0.64-1.46],0.8712874648028734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28359,128,1.60 [1.15-2.22],0.0053316866941018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24019,120,0.97 [0.61-1.53],0.8913662957866296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24531,120,0.66 [0.36-1.23],0.1908375393073282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23976,120,0.83 [0.59-1.16],0.2807052602025995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1R,Complement C1r subcomponent,24605,122,1.46 [0.72-2.98],0.2922265915052088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1RL,Complement C1r subcomponent-like protein,24566,122,0.85 [0.35-2.03],0.7120382677305758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1S,Complement C1s subcomponent,24605,122,1.15 [0.51-2.56],0.7388767994770635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C2,Complement C2,28324,128,1.08 [0.54-2.15],0.8203878307979887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C2CD2L,Phospholipid transfer protein C2CD2L,27554,124,0.66 [0.45-0.99],0.0426760930020337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C2orf69,UPF0565 protein C2orf69,23882,119,0.72 [0.50-1.04],0.0801968187520403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C3,Complement C3,23361,116,1.00 [0.69-1.47],0.9811217410351272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C4BPB,C4b-binding protein beta chain,28342,129,1.04 [0.71-1.53],0.8317551392139024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C5,Complement C5,24605,122,2.53 [1.10-5.87],0.0297714546850327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C7,Complement component C7,24031,122,1.63 [0.94-2.83],0.0804306832145188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C7orf50,Uncharacterized protein C7orf50,24496,120,0.91 [0.42-1.97],0.8137693024445697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C8B,Complement component C8 beta chain,24605,122,1.28 [0.73-2.24],0.3873007189859833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C9,Complement component C9,24594,120,0.84 [0.62-1.16],0.2962483151694804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C9orf40,Uncharacterized protein C9orf40,24472,121,1.22 [1.00-1.49],0.0528087512919161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA1,Carbonic anhydrase 1,27627,125,1.25 [0.97-1.62],0.0832026394468752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA11,Carbonic anhydrase-related protein 11,27585,127,1.03 [0.62-1.69],0.9197866017645336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA12,Carbonic anhydrase 12,28150,131,1.58 [1.04-2.39],0.0321645685592903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA13,Carbonic anhydrase 13,27946,129,0.94 [0.81-1.09],0.4019986724217306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA14,Carbonic anhydrase 14,28529,133,0.71 [0.46-1.09],0.1174036714261768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA2,Carbonic anhydrase 2,28183,129,1.21 [0.97-1.49],0.0845018225624423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA3,Carbonic anhydrase 3,28581,130,1.21 [0.95-1.53],0.1163250027120282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA4,Carbonic anhydrase 4,28628,130,1.09 [0.57-2.09],0.804146017318557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA5A,"Carbonic anhydrase 5A, mitochondrial",27774,125,1.02 [0.86-1.21],0.8532988124923754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA6,Carbonic anhydrase 6,28171,128,1.02 [0.80-1.30],0.8773469368041412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA7,Carbonic anhydrase 7,24115,121,1.00 [0.60-1.66],0.994467082184022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA8,Carbonic anhydrase-related protein,23868,118,0.67 [0.30-1.52],0.3372920351476922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA9,Carbonic anhydrase 9,28529,133,1.54 [1.14-2.08],0.0053139973044353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CABP2,Calcium-binding protein 2,23882,119,0.83 [0.62-1.11],0.2083613805123457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23785,114,1.18 [0.70-1.99],0.5249493109961227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23789,116,0.76 [0.51-1.13],0.171531384470544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23785,114,0.78 [0.56-1.10],0.1561413809108144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24531,120,0.87 [0.71-1.07],0.1899214987551955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACYBP,Calcyclin-binding protein,23967,120,0.91 [0.77-1.08],0.2852702068491236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CADPS,Calcium-dependent secretion activator 1,23882,119,0.53 [0.31-0.92],0.0251726365408324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALB1,Calbindin,28150,131,0.93 [0.65-1.33],0.6723535636719512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALB2,Calretinin,27604,125,1.37 [0.85-2.21],0.1973527081836403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALCA,Calcitonin,28031,127,1.24 [0.98-1.57],0.0788870210941028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALCB,Calcitonin gene-related peptide 2,24496,120,1.26 [0.85-1.87],0.2573970511529835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28447,133,0.90 [0.78-1.04],0.1636404418918704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23885,117,0.82 [0.65-1.04],0.1056989992310499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALY,Neuron-specific vesicular protein calcyon,23789,116,0.99 [0.61-1.61],0.9570115979081044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27585,127,0.77 [0.54-1.11],0.1677385140072103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23882,119,0.55 [0.37-0.82],0.003346799023402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24531,120,0.88 [0.74-1.03],0.1148824231884322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CANT1,Soluble calcium-activated nucleotidase 1,28203,131,0.74 [0.34-1.58],0.43197533916911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAPG,Macrophage-capping protein,28096,132,1.08 [0.84-1.39],0.5621166705064399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAPN3,Calpain-3,24451,121,0.94 [0.58-1.52],0.8020268455887645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAPS,Calcyphosin,24496,120,0.91 [0.73-1.15],0.4292485638133293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CARHSP1,Calcium-regulated heat-stable protein 1,27604,125,1.06 [0.78-1.44],0.6987454075907646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASC3,Protein CASC3,23882,119,0.68 [0.44-1.06],0.0864496233042785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP1,Caspase-1,27604,125,0.96 [0.76-1.22],0.748781816295687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP10,Caspase-10,27604,125,0.87 [0.70-1.09],0.2305059875805167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP2,Caspase-2,28257,133,0.90 [0.72-1.13],0.3750508301733398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP3,Caspase-3,28628,130,0.95 [0.80-1.13],0.5851006910331671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP4,Caspase-4,24115,121,1.01 [0.91-1.12],0.8275633496363818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP7,Caspase-7,24496,120,0.86 [0.70-1.06],0.1469007526420674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP8,Caspase-8,28455,133,0.97 [0.76-1.24],0.8316191703903675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP9,Caspase-9,23868,118,0.94 [0.70-1.24],0.6518993925933438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASQ2,Calsequestrin-2,23789,116,0.54 [0.33-0.91],0.0207655921587024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAT,Catalase,24218,119,1.21 [0.90-1.64],0.2111047267299871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBLIF,Cobalamin binding intrinsic factor,28245,131,1.13 [0.90-1.41],0.2840765876923362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBLN1,Cerebellin-1,23785,114,0.78 [0.61-1.00],0.0532732377720732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBLN4,Cerebellin-4,28529,133,1.14 [0.72-1.81],0.5649000279291464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBS,Cystathionine beta-synthase,23885,117,0.96 [0.68-1.36],0.8258756246277017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBX2,Chromobox protein homolog 2,23789,116,0.72 [0.41-1.25],0.2393299143534224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,28081,128,0.99 [0.81-1.23],0.9524370887594116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCAR2,Cell cycle and apoptosis regulator protein 2,24496,120,0.83 [0.58-1.21],0.3391784256474416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCDC134,Coiled-coil domain-containing protein 134,24451,121,0.88 [0.61-1.26],0.488991085125999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCDC28A,Coiled-coil domain-containing protein 28A,23882,119,0.48 [0.27-0.88],0.0165932938107867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCDC50,Coiled-coil domain-containing protein 50,24531,120,0.98 [0.78-1.23],0.8567293943230121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCDC80,Coiled-coil domain-containing protein 80,28278,131,0.80 [0.50-1.29],0.3674557888968502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23885,117,0.78 [0.58-1.05],0.0959811190040411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL11,Eotaxin,28613,132,1.00 [0.67-1.48],0.9804203899718752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL13,C-C motif chemokine 13,28564,132,0.95 [0.76-1.19],0.6659897041181189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL14,C-C motif chemokine 14,28177,128,0.85 [0.57-1.28],0.4351584333689505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL15,C-C motif chemokine 15,28628,130,1.33 [0.96-1.83],0.0872046959265804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL16,C-C motif chemokine 16,28628,130,1.09 [0.82-1.44],0.5516183771635768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL17,C-C motif chemokine 17,28205,130,1.05 [0.89-1.24],0.583356465249106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL18,C-C motif chemokine 18,27876,128,1.03 [0.83-1.28],0.7922711953008885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL19,C-C motif chemokine 19,28543,133,1.00 [0.88-1.13],0.992974808292554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL2,C-C motif chemokine 2,28032,128,0.94 [0.70-1.26],0.662437024615578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL20,C-C motif chemokine 20,28613,132,1.00 [0.83-1.19],0.975546491744216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL21,C-C motif chemokine 21,28400,130,1.02 [0.70-1.49],0.9177902547911012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL22,C-C motif chemokine 22,27955,128,0.98 [0.72-1.33],0.8757520360365094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL23,C-C motif chemokine 23,28400,130,0.96 [0.66-1.38],0.8216154292888991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL24,C-C motif chemokine 24,28357,130,1.17 [0.98-1.41],0.0898127849008989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL25,C-C motif chemokine 25,28613,132,0.95 [0.70-1.30],0.7488532073236154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL26,C-C motif chemokine 26,28257,133,0.80 [0.66-0.97],0.0242547745565031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL27,C-C motif chemokine 27,28278,131,0.95 [0.74-1.22],0.6956842352362294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL28,C-C motif chemokine 28,28173,133,0.80 [0.61-1.05],0.1004078147983091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL3,C-C motif chemokine 3,28257,133,1.10 [0.93-1.31],0.2706384073822696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL4,C-C motif chemokine 4,28300,130,1.00 [0.79-1.27],0.9973128671474424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL5,C-C motif chemokine 5,28359,128,0.97 [0.83-1.13],0.7106439277328114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL7,C-C motif chemokine 7,28257,133,0.99 [0.76-1.29],0.9490974635098044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL8,C-C motif chemokine 8,28492,133,1.00 [0.78-1.28],0.984602449079776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN1,CCN family member 1,28110,131,0.92 [0.76-1.13],0.4364394593791108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN2,CCN family member 2,28279,130,0.80 [0.61-1.05],0.1033089990873781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN3,CCN family member 3,28582,129,0.78 [0.48-1.26],0.307989028697944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN4,CCN family member 4,28529,133,0.76 [0.51-1.12],0.1585800576138985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN5,CCN family member 5,28263,129,1.00 [0.67-1.49],0.9983693048861876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCND2,G1/S-specific cyclin-D2,24115,121,0.96 [0.61-1.52],0.8659889371356884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCNE1,G1/S-specific cyclin-E1,23868,118,1.03 [0.86-1.22],0.7658830218523947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCS,Copper chaperone for superoxide dismutase,28081,128,1.17 [0.86-1.61],0.32081602293216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCT5,T-complex protein 1 subunit epsilon,27585,127,0.82 [0.57-1.19],0.3076526414875412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD101,Immunoglobulin superfamily member 2,24472,121,0.88 [0.58-1.33],0.5463215538335211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD109,CD109 antigen,28263,129,1.26 [0.79-2.02],0.3350611506018815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD14,Monocyte differentiation antigen CD14,27652,124,1.13 [0.77-1.66],0.5212384820791421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD160,CD160 antigen,28613,132,1.00 [0.71-1.40],0.9779279521815688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28359,128,0.91 [0.63-1.30],0.6039683263846081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD164,Sialomucin core protein 24,28263,129,0.93 [0.50-1.72],0.8224985911876274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD164L2,CD164 sialomucin-like 2 protein,23882,119,0.84 [0.51-1.38],0.4929404552633762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD177,CD177 antigen,28216,129,0.99 [0.88-1.13],0.925770777751572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD1C,T-cell surface glycoprotein CD1c,28342,129,0.59 [0.33-1.07],0.0811452477020398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD2,T-cell surface antigen CD2,23789,116,0.77 [0.45-1.33],0.3480235785752312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD200,OX-2 membrane glycoprotein,28257,133,1.19 [0.67-2.14],0.5513722141541095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD200R1,Cell surface glycoprotein CD200 receptor 1,28156,133,0.90 [0.58-1.40],0.6506501521789925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD207,C-type lectin domain family 4 member K,27676,131,1.44 [0.96-2.15],0.0772551242683848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD209,CD209 antigen,28338,128,0.98 [0.67-1.45],0.9317550731154908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD22,B-cell receptor CD22,28613,132,1.06 [0.73-1.55],0.7551432943034253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD226,CD226 antigen,23868,118,0.71 [0.47-1.09],0.1183218284502804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD244,Natural killer cell receptor 2B4,28613,132,0.60 [0.34-1.07],0.0835414994550363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD248,Endosialin,24559,122,0.84 [0.55-1.30],0.4369279869944583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD27,CD27 antigen,28342,129,1.07 [0.72-1.58],0.7342713599567037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD274,Programmed cell death 1 ligand 1,28081,128,0.74 [0.45-1.20],0.2239563443527383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD276,CD276 antigen,28255,128,0.86 [0.56-1.31],0.4828341894447945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD28,T-cell-specific surface glycoprotein CD28,27585,127,0.80 [0.50-1.26],0.331570754273678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD2AP,CD2-associated protein,28278,131,1.08 [0.85-1.36],0.545306804267075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300A,CMRF35-like molecule 8,24019,120,1.39 [0.77-2.50],0.2705955964821117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300C,CMRF35-like molecule 6,28543,133,0.88 [0.57-1.37],0.5757003146762556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300E,CMRF35-like molecule 2,28439,132,0.81 [0.54-1.21],0.3005674850468944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300LF,CMRF35-like molecule 1,28529,133,0.92 [0.73-1.15],0.448446387899157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300LG,CMRF35-like molecule 9,28263,129,1.04 [0.68-1.59],0.8573923729775951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD302,CD302 antigen,28150,131,1.06 [0.63-1.77],0.833585513208233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD33,Myeloid cell surface antigen CD33,28342,129,0.93 [0.77-1.13],0.4888226936757042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD34,Hematopoietic progenitor cell antigen CD34,28444,132,1.29 [0.69-2.42],0.4233476232264536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD36,Platelet glycoprotein 4,23868,118,0.72 [0.49-1.06],0.0913106116980093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,28150,131,0.82 [0.49-1.36],0.4402976165352046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD3D,T-cell surface glycoprotein CD3 delta chain,23785,114,1.18 [0.76-1.84],0.4662072764364621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24115,121,1.06 [0.66-1.69],0.8120321457109593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD3G,T-cell surface glycoprotein CD3 gamma chain,23868,118,0.95 [0.77-1.17],0.6181841203287617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD4,T-cell surface glycoprotein CD4,28211,133,1.03 [0.61-1.72],0.9233763587946456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD40,Tumor necrosis factor receptor superfamily member 5,28257,130,0.88 [0.64-1.20],0.4179088616674952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD40LG,CD40 ligand,28613,132,0.91 [0.75-1.10],0.3289128936010985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD46,Membrane cofactor protein,28083,126,0.80 [0.45-1.40],0.4267949152154421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD48,CD48 antigen,28357,130,0.88 [0.51-1.49],0.625390645601078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD5,T-cell surface glycoprotein CD5,28492,133,0.70 [0.44-1.12],0.1346526083264309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD55,Complement decay-accelerating factor,27264,121,0.94 [0.49-1.78],0.842658653842373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD58,Lymphocyte function-associated antigen 3,28200,128,0.71 [0.30-1.70],0.4384657457904057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD59,CD59 glycoprotein,27219,123,0.52 [0.23-1.19],0.1228114495974147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD5L,CD5 antigen-like,24473,122,1.42 [1.00-2.03],0.0495841304223666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD6,T-cell differentiation antigen CD6,28562,132,0.75 [0.57-1.01],0.0547655462424971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD63,CD63 antigen,28032,128,0.97 [0.71-1.31],0.8175870348221446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD69,Early activation antigen CD69,28122,129,0.89 [0.75-1.05],0.1689690125886901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD7,T-cell antigen CD7,23831,118,1.19 [0.80-1.77],0.3848297116317796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD70,CD70 antigen,28257,133,1.08 [0.75-1.55],0.6787623471642401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD72,B-cell differentiation antigen CD72,24019,120,0.91 [0.59-1.40],0.6640049251230598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD74,HLA class II histocompatibility antigen gamma chain,28543,133,1.00 [0.64-1.57],0.9888764821589572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD79B,B-cell antigen receptor complex-associated protein beta chain,28613,132,1.07 [0.75-1.53],0.7106174278351194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD80,T-lymphocyte activation antigen CD80,24567,122,1.03 [0.62-1.72],0.8985760153225676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD82,CD82 antigen,24115,121,1.11 [0.76-1.64],0.5835235056070582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD83,CD83 antigen,28257,133,0.82 [0.51-1.32],0.4057829825851108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD84,SLAM family member 5,28257,133,0.72 [0.44-1.15],0.1702956780287833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD86,T-lymphocyte activation antigen CD86,24472,121,0.77 [0.44-1.33],0.3417407833398234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD8A,T-cell surface glycoprotein CD8 alpha chain,28543,133,1.08 [0.79-1.48],0.6234606706307536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD93,Complement component C1q receptor,27177,123,0.85 [0.50-1.43],0.5400006403457187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD99,CD99 antigen,28263,129,0.62 [0.27-1.40],0.2499828993722237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD99L2,CD99 antigen-like protein 2,28263,129,0.67 [0.36-1.27],0.2201875614438166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDA,Cytidine deaminase,24527,122,1.00 [0.70-1.44],0.9796110087593684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDAN1,Codanin-1,24496,120,0.67 [0.29-1.54],0.3432922659004269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC123,Cell division cycle protein 123 homolog,23697,117,0.86 [0.63-1.18],0.3567675054338686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC25A,M-phase inducer phosphatase 1,23697,117,0.78 [0.48-1.26],0.3124723016336278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC26,Anaphase-promoting complex subunit CDC26,24432,120,0.83 [0.65-1.07],0.1565319847577138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC27,Cell division cycle protein 27 homolog,27585,127,1.08 [0.84-1.38],0.5635172850691739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC37,Hsp90 co-chaperone Cdc37,28342,129,0.96 [0.80-1.15],0.660044277505286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24472,121,0.87 [0.73-1.03],0.1105195677389955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDCP1,CUB domain-containing protein 1,28081,128,0.90 [0.66-1.23],0.5208219360893986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH1,Cadherin-1,27306,122,1.13 [0.78-1.64],0.5102158663341196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH15,Cadherin-15,28493,132,0.89 [0.67-1.19],0.4462412479985093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH17,Cadherin-17,28278,131,1.25 [1.01-1.54],0.0360407707667827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH2,Cadherin-2,28278,131,1.49 [0.97-2.28],0.0690098349019905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH22,Cadherin-22,24115,121,0.88 [0.47-1.68],0.7061532153577535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH23,Cadherin-23,24496,120,1.11 [0.59-2.09],0.7546162685329196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH3,Cadherin-3,28543,133,0.97 [0.63-1.51],0.9067859215743038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH4,Cadherin-4,23785,114,1.10 [0.76-1.59],0.6158224665944381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH5,Cadherin-5,28628,130,0.88 [0.53-1.46],0.6233168939572227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH6,Cadherin-6,28278,131,0.91 [0.61-1.36],0.6468167264884691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDHR1,Cadherin-related family member 1,27604,125,1.13 [0.79-1.59],0.5059523295663451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDHR2,Cadherin-related family member 2,28150,131,1.00 [0.81-1.23],0.996786575127014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDHR5,Cadherin-related family member 5,28278,131,0.83 [0.56-1.21],0.3293693254682086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDK1,Cyclin-dependent kinase 1,23697,117,1.27 [0.78-2.05],0.3395905748628105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24531,120,0.79 [0.58-1.09],0.1467061558417166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDKL5,Cyclin-dependent kinase-like 5,23785,114,1.09 [0.79-1.50],0.5908302484065335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDKN1A,Cyclin-dependent kinase inhibitor 1,28150,131,0.98 [0.85-1.14],0.8325669931951822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,28150,131,0.96 [0.82-1.12],0.5933259792526003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDNF,Cerebral dopamine neurotrophic factor,28150,131,0.66 [0.40-1.09],0.1028302149291622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,28305,130,1.07 [0.60-1.90],0.8213372621630799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDSN,Corneodesmosin,28521,132,0.69 [0.48-0.98],0.039345155983951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,28301,129,0.90 [0.53-1.52],0.6853994931381765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24472,121,1.23 [1.00-1.52],0.052670144925129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24115,121,0.97 [0.75-1.26],0.8462992713485682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24472,121,1.04 [0.67-1.61],0.8702311167756485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24115,121,1.17 [0.82-1.66],0.3966256528600985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,28257,133,1.04 [0.87-1.24],0.6922848166618304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27585,127,0.94 [0.68-1.31],0.7323246519437308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,27208,124,1.03 [0.80-1.34],0.7981948656699478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24559,122,1.03 [0.66-1.60],0.8948618285486736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27774,125,0.82 [0.60-1.13],0.2317423962378074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEBPA,CCAAT/enhancer-binding protein alpha,23868,118,0.76 [0.43-1.34],0.3502030369812682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEBPB,CCAAT/enhancer-binding protein beta,27774,125,0.94 [0.62-1.45],0.7900016396704608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CELA2A,Chymotrypsin-like elastase family member 2A,24559,122,0.86 [0.65-1.14],0.2949207003068633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CELA3A,Chymotrypsin-like elastase family member 3A,28578,129,0.84 [0.64-1.11],0.2212621485773217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24019,120,0.99 [0.53-1.85],0.9869300838579396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEMIP2,Cell surface hyaluronidase,23868,118,1.01 [0.60-1.73],0.9582754032905244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEND1,Cell cycle exit and neuronal differentiation protein 1,23785,114,0.76 [0.52-1.12],0.1650432549265875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CENPF,Centromere protein F,24115,121,1.29 [0.97-1.70],0.0756972387388772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CENPJ,Centromere protein J,24115,121,0.98 [0.76-1.26],0.8743142662683581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP112,Centrosomal protein of 112 kDa,23789,116,0.78 [0.48-1.27],0.3163808236157886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP152,Centrosomal protein of 152 kDa,23697,117,0.72 [0.45-1.15],0.1732789571454741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP164,Centrosomal protein of 164 kDa,27752,127,0.88 [0.66-1.18],0.3971222439991915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP170,Centrosomal protein of 170 kDa,23885,117,0.95 [0.76-1.20],0.6859947618003583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP20,Centrosomal protein 20,27585,127,0.93 [0.75-1.16],0.529239031058553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP290,Centrosomal protein of 290 kDa,24115,121,0.63 [0.41-0.95],0.0265802809717271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP350,Centrosome-associated protein 350,23697,117,1.11 [0.70-1.76],0.6685976435926807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP43,Centrosomal protein 43,27554,125,1.13 [0.90-1.41],0.2935719953944675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP85,Centrosomal protein of 85 kDa,27585,127,0.95 [0.74-1.22],0.7030315501800933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CERT,Ceramide transfer protein,27604,125,0.80 [0.61-1.03],0.0858919282965294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CES1,Liver carboxylesterase 1,28328,126,1.06 [0.88-1.28],0.532229975866072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CES2,Cocaine esterase,28150,131,1.04 [0.79-1.38],0.7799548892134966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CES3,Carboxylesterase 3,28150,131,0.92 [0.73-1.15],0.4674743837022114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CETN2,Centrin-2,27604,125,0.82 [0.64-1.05],0.1122139110958682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CETN3,Centrin-3,24472,121,0.82 [0.66-1.03],0.0922048677886458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFB,Complement factor B,24151,121,1.09 [0.64-1.84],0.7503941996422527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFC1,Cryptic protein,27585,127,0.86 [0.61-1.23],0.4191497119703257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFD,Complement factor D,24605,122,0.91 [0.37-2.24],0.8377799823332552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFH,Complement factor H,23184,114,1.33 [0.62-2.83],0.4603529231086036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFHR2,Complement factor H-related protein 2,24429,121,1.71 [1.21-2.43],0.0025787701011782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFHR4,Complement factor H-related protein 4,24557,122,0.98 [0.77-1.24],0.8675466330586522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFHR5,Complement factor H-related protein 5,24279,117,1.61 [1.04-2.50],0.0329921441884037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFI,Complement factor I,24605,122,1.56 [0.67-3.63],0.2991807678722146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFP,Properdin,24605,122,0.94 [0.45-1.98],0.8718865266760639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CGA,Glycoprotein hormones alpha chain,28263,129,1.00 [0.83-1.22],0.9605938346854098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24594,120,1.11 [0.77-1.59],0.5801069817113795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CGN,Cingulin,23882,119,0.76 [0.45-1.27],0.2884913207448101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CGREF1,Cell growth regulator with EF hand domain protein 1,28278,131,0.84 [0.58-1.21],0.3526509527158263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27585,127,0.98 [0.75-1.28],0.8915450028209566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHAD,Chondroadherin,24019,120,0.61 [0.44-0.85],0.0029991215708034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24496,120,1.06 [0.68-1.63],0.8055161294373359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHCHD6,MICOS complex subunit MIC25,24451,121,1.10 [0.62-1.95],0.7512006774536475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHEK2,Serine/threonine-protein kinase Chk2,27774,125,1.20 [0.76-1.89],0.4411557018792458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHGA,Chromogranin-A,24559,122,1.25 [1.04-1.49],0.0167529009469752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHGB,Secretogranin-1,28443,132,0.86 [0.58-1.27],0.4539643017483552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHI3L1,Chitinase-3-like protein 1,27607,124,0.92 [0.74-1.14],0.430417104285536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHIT1,Chitotriosidase-1,28388,129,1.01 [0.91-1.12],0.8818724394856491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHL1,Neural cell adhesion molecule L1-like protein,28314,128,0.91 [0.55-1.51],0.724346342199213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHM,Rab proteins geranylgeranyltransferase component A 1,23882,119,0.68 [0.50-0.93],0.0147766625347594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHMP1A,Charged multivesicular body protein 1a,28081,128,0.99 [0.81-1.20],0.901168839568891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHMP6,Charged multivesicular body protein 6,24567,122,0.85 [0.63-1.15],0.2970486977837028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHP1,Calcineurin B homologous protein 1,23785,114,0.84 [0.64-1.10],0.2109914889049544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHRDL1,Chordin-like protein 1,28357,130,0.84 [0.51-1.39],0.5027564113193109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHRDL2,Chordin-like protein 2,28278,131,0.87 [0.66-1.15],0.3420907653967437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHRM1,Muscarinic acetylcholine receptor M1,23882,119,0.61 [0.34-1.07],0.086717207402547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CIAPIN1,Anamorsin,28342,129,0.93 [0.73-1.19],0.5869740501712526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CILP,Cartilage intermediate layer protein 1,24559,122,1.32 [0.95-1.83],0.093136568070538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CINP,Cyclin-dependent kinase 2-interacting protein,24115,121,0.76 [0.48-1.19],0.2328002398585969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CIRBP,Cold-inducible RNA-binding protein,24472,121,0.90 [0.76-1.08],0.2662881374087273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CIT,Citron Rho-interacting kinase,23882,119,0.96 [0.65-1.40],0.8135041903847515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CKAP4,Cytoskeleton-associated protein 4,28462,131,0.46 [0.24-0.89],0.0203947423019884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CKB,Creatine kinase B-type,24559,122,1.04 [0.78-1.39],0.8084512797703483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",28152,128,1.28 [1.00-1.64],0.049402338688943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLASP1,CLIP-associating protein 1,23697,117,0.81 [0.61-1.07],0.1427611044697596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLC,Galectin-10,28239,131,1.02 [0.81-1.28],0.8666260317429241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC10A,C-type lectin domain family 10 member A,28081,128,1.09 [0.71-1.67],0.6937528653087637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC11A,C-type lectin domain family 11 member A,28213,128,1.15 [0.83-1.60],0.3913885010412282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC12A,C-type lectin domain family 12 member A,23868,118,0.49 [0.19-1.24],0.1302852455111706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC14A,C-type lectin domain family 14 member A,28263,129,1.25 [0.76-2.07],0.3819836972990973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC1A,C-type lectin domain family 1 member A,27774,125,0.69 [0.42-1.14],0.1508658412800603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC1B,C-type lectin domain family 1 member B,28543,133,0.92 [0.79-1.08],0.312623421450199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC2L,C-type lectin domain family 2 member L,23882,119,0.74 [0.48-1.13],0.1635407322216138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC3B,Tetranectin,24038,121,0.90 [0.40-2.00],0.7894660088004594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4A,C-type lectin domain family 4 member A,28257,133,1.06 [0.69-1.63],0.7971612548183147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4C,C-type lectin domain family 4 member C,28257,133,0.73 [0.53-1.01],0.0592580050833537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4D,C-type lectin domain family 4 member D,28257,133,0.92 [0.72-1.18],0.5220528565456184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4G,C-type lectin domain family 4 member G,28257,133,0.97 [0.61-1.53],0.884947047643654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4M,C-type lectin domain family 4 member M,24518,122,1.01 [0.71-1.44],0.9507003630924176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC5A,C-type lectin domain family 5 member A,28176,130,1.01 [0.59-1.73],0.9678039486289116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC6A,C-type lectin domain family 6 member A,27585,127,0.92 [0.66-1.29],0.6336142425965549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC7A,C-type lectin domain family 7 member A,28613,132,0.82 [0.67-1.01],0.0647645680143628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLGN,Calmegin,23882,119,0.89 [0.59-1.35],0.5974408372597545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLIC5,Chloride intracellular channel protein 5,23882,119,0.77 [0.42-1.40],0.3866465009628147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLINT1,Clathrin interactor 1,23697,117,1.04 [0.72-1.49],0.8488832936999224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLIP2,CAP-Gly domain-containing linker protein 2,28257,133,0.93 [0.81-1.06],0.2784250631379014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLMP,CXADR-like membrane protein,28529,133,0.84 [0.40-1.75],0.642315089646518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLNS1A,Methylosome subunit pICln,23882,119,1.04 [0.63-1.72],0.8673898965239925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",28031,127,1.03 [0.88-1.21],0.7123008368800531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLPS,Colipase,28222,129,0.85 [0.68-1.07],0.166841954059894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLSPN,Claspin,27554,124,0.56 [0.31-1.00],0.049498169619876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLSTN1,Calsyntenin-1,27604,125,1.15 [0.86-1.52],0.3458920311833052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLSTN2,Calsyntenin-2,28613,132,1.12 [0.76-1.64],0.5778429383870911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLSTN3,Calsyntenin-3,24496,120,1.20 [0.69-2.09],0.5158124650243585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLTA,Clathrin light chain A,27774,125,1.04 [0.75-1.45],0.8244266075857625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLU,Clusterin,24605,122,1.43 [1.02-2.03],0.040338531837177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLUL1,Clusterin-like protein 1,28231,131,0.86 [0.61-1.20],0.375599867089754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CMC1,COX assembly mitochondrial protein homolog,24567,122,0.89 [0.73-1.07],0.2143376754270496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CMIP,C-Maf-inducing protein,24451,121,0.85 [0.69-1.05],0.1317842290415701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNDP1,Beta-Ala-His dipeptidase,28359,128,1.12 [0.79-1.58],0.5250518825989212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23785,114,1.09 [0.81-1.46],0.5699864471851341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23842,117,0.98 [0.78-1.22],0.8422495812884455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNPY2,Protein canopy homolog 2,27774,125,0.87 [0.64-1.18],0.3613305173925912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNPY4,Protein canopy homolog 4,28150,131,0.92 [0.75-1.12],0.3987386850583176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNST,Consortin,28278,131,0.92 [0.80-1.06],0.2583907527400257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTF,Ciliary neurotrophic factor,23785,114,1.13 [0.67-1.89],0.6556052144958426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN1,Contactin-1,28628,130,0.95 [0.54-1.69],0.8731149629224128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN2,Contactin-2,28529,133,1.14 [0.82-1.60],0.4407907041024191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN3,Contactin-3,28263,129,0.87 [0.55-1.37],0.5494487027764967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN4,Contactin-4,28263,129,1.61 [0.83-3.09],0.1559301126333654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN5,Contactin-5,28358,132,0.76 [0.49-1.17],0.2079460549221048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTNAP2,Contactin-associated protein-like 2,28257,133,0.86 [0.59-1.25],0.4294161403438529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTNAP4,Contactin-associated protein-like 4,23882,119,0.90 [0.74-1.09],0.2888087217971541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COCH,Cochlin,24567,122,0.71 [0.48-1.04],0.0776467197227857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL15A1,Collagen alpha-1(XV) chain,24559,122,0.71 [0.37-1.36],0.2981478908351117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL18A1,Collagen alpha-1(XVIII) chain,28375,128,1.25 [0.64-2.45],0.5157914268232642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL1A1,Collagen alpha-1(I) chain,28628,130,0.38 [0.20-0.70],0.0019320192314513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL24A1,Collagen alpha-1(XXIV) chain,24472,121,1.00 [0.75-1.35],0.9933855428337696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL28A1,Collagen alpha-1(XXVIII) chain,23882,119,1.08 [0.87-1.34],0.5097680212433997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL2A1,Collagen alpha-1(II) chain,23885,117,1.17 [0.95-1.45],0.1451624102543376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL3A1,Collagen alpha-1(III) chain,24559,122,0.89 [0.42-1.87],0.7582683596982278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL4A1,Collagen alpha-1(IV) chain,28278,131,1.05 [0.71-1.55],0.8105305573580204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL4A4,Collagen alpha-4(IV) chain,24074,119,1.29 [0.91-1.83],0.1596565600398664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL5A1,Collagen alpha-1(V) chain,24019,120,1.02 [0.65-1.58],0.9355836161218728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL6A3,Collagen alpha-3(VI) chain,28628,130,0.82 [0.50-1.33],0.4186871206980866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL9A1,Collagen alpha-1(IX) chain,28257,133,0.91 [0.64-1.29],0.5980785397928268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL9A2,Collagen alpha-2(IX) chain,24115,121,1.11 [0.78-1.56],0.5664047234800285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COLEC12,Collectin-12,28255,128,1.18 [0.64-2.20],0.5943029721947739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COMMD1,COMM domain-containing protein 1,23885,117,0.76 [0.57-1.03],0.0743148476006811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COMMD9,COMM domain-containing protein 9,24451,121,0.82 [0.51-1.32],0.418016480245562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COMP,Cartilage oligomeric matrix protein,27961,128,0.85 [0.53-1.36],0.4938038781336652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COMT,Catechol O-methyltransferase,27465,123,0.95 [0.79-1.15],0.5855242710673416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COPB2,Coatomer subunit beta',23789,116,0.88 [0.57-1.36],0.5653137946563178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COPE,Coatomer subunit epsilon,27604,125,1.24 [0.94-1.64],0.1207550052975907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23885,117,0.99 [0.67-1.48],0.9772060518716982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CORO1A,Coronin-1A,27717,124,0.93 [0.77-1.11],0.4216713990844714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CORO6,Coronin-6,23785,114,1.27 [0.83-1.94],0.2678740524901081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",28150,131,0.98 [0.79-1.22],0.8824186628543781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COX6B1,Cytochrome c oxidase subunit 6B1,24567,122,0.81 [0.47-1.40],0.4520647688499792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPA1,Carboxypeptidase A1,28628,130,0.69 [0.53-0.89],0.0040310737608835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPA2,Carboxypeptidase A2,28440,132,0.84 [0.66-1.07],0.157063860530783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPA4,Carboxypeptidase A4,23539,120,0.81 [0.55-1.21],0.309164011016916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPB1,Carboxypeptidase B,28628,130,0.71 [0.54-0.93],0.012664951804719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPB2,Carboxypeptidase B2,24554,122,0.85 [0.40-1.81],0.6802661282793376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPE,Carboxypeptidase E,28327,133,0.62 [0.45-0.87],0.0057188332844601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPLX2,Complexin-2,23697,117,1.03 [0.58-1.85],0.9116466216386496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPM,Carboxypeptidase M,28416,133,1.33 [0.88-2.02],0.1738909623825275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23868,118,1.22 [0.67-2.23],0.5227301675811284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPPED1,Serine/threonine-protein phosphatase CPPED1,28543,133,1.20 [0.96-1.50],0.1078563764938369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPQ,Carboxypeptidase Q,24518,122,1.22 [0.77-1.92],0.4057673194774018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPTP,Ceramide-1-phosphate transfer protein,23789,116,0.98 [0.63-1.53],0.9261255305783482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPVL,Probable serine carboxypeptidase CPVL,28476,133,1.34 [0.91-1.97],0.1451079415249222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPXM1,Probable carboxypeptidase X1,28342,129,0.91 [0.73-1.14],0.4137514899880146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPXM2,Inactive carboxypeptidase-like protein X2,24567,122,0.70 [0.34-1.43],0.3300818836817366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CR1,Complement receptor type 1,24500,120,0.97 [0.60-1.58],0.907944900847565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CR2,Complement receptor type 2,28359,128,1.31 [0.94-1.83],0.1153089146750005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27585,127,0.87 [0.72-1.06],0.160023649015601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRADD,Death domain-containing protein CRADD,28031,127,0.98 [0.80-1.21],0.8828802843964517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CREB3,Cyclic AMP-responsive element-binding protein 3,23697,117,0.90 [0.64-1.27],0.5528755973677173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CREBZF,CREB/ATF bZIP transcription factor,23697,117,0.83 [0.41-1.67],0.6016158894987442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CREG1,Protein CREG1,27882,129,0.73 [0.48-1.12],0.15240325167243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRELD1,Protein disulfide isomerase CRELD1,24019,120,1.77 [1.12-2.80],0.0151324101821589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRELD2,Protein disulfide isomerase CRELD2,28357,130,0.99 [0.74-1.33],0.94714619786635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRH,Corticoliberin,27540,127,0.89 [0.74-1.07],0.222983029578877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRHBP,Corticotropin-releasing factor-binding protein,28255,128,0.94 [0.54-1.61],0.8102622265461896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRHR1,Corticotropin-releasing factor receptor 1,27774,125,0.90 [0.68-1.18],0.4443289700131102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRIM1,Cysteine-rich motor neuron 1 protein,28400,130,0.87 [0.40-1.90],0.7222179671874196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRIP2,Cysteine-rich protein 2,28081,128,1.54 [1.05-2.27],0.0286977118200277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRISP2,Cysteine-rich secretory protein 2,28529,133,1.03 [0.79-1.35],0.8115576188667672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRISP3,Cysteine-rich secretory protein 3,24353,120,0.49 [0.26-0.93],0.0280911003051202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRKL,Crk-like protein,28302,130,0.96 [0.83-1.10],0.549084892091507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRLF1,Cytokine receptor-like factor 1,28400,130,1.19 [0.65-2.17],0.5721373673943909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRNN,Cornulin,27439,129,0.91 [0.72-1.16],0.4539248040637459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRTAC1,Cartilage acidic protein 1,28628,130,0.67 [0.40-1.10],0.1099155245010039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRTAM,Cytotoxic and regulatory T-cell molecule,28081,128,0.92 [0.67-1.27],0.6136609090470281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRTAP,Cartilage-associated protein,23882,119,0.54 [0.33-0.87],0.0107193634718895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRX,Cone-rod homeobox protein,27774,125,1.05 [0.92-1.21],0.4572628120941215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYBB1,Beta-crystallin B1,24567,122,0.89 [0.68-1.15],0.3632226283342467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYBB2,Beta-crystallin B2,24496,120,1.50 [1.30-1.72],1.158937087486984e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYGD,Gamma-crystallin D,24496,120,1.03 [0.86-1.23],0.7735561786782829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYM,Ketimine reductase mu-crystallin,23785,114,0.94 [0.74-1.20],0.6310157262786462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYZL1,Quinone oxidoreductase-like protein 1,23885,117,0.95 [0.78-1.15],0.5958675054013681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSDE1,Cold shock domain-containing protein E1,23789,116,0.87 [0.73-1.03],0.1119145362175064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF1,Macrophage colony-stimulating factor 1,28400,130,0.99 [0.55-1.78],0.9842820165667328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF1R,Macrophage colony-stimulating factor 1 receptor,24594,120,0.99 [0.63-1.54],0.9472514027353716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF2,Granulocyte-macrophage colony-stimulating factor,23789,116,1.04 [0.64-1.71],0.8656884459171207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,28081,128,1.12 [0.88-1.44],0.3580391833415607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF2RB,Cytokine receptor common subunit beta,23868,118,1.32 [0.88-2.00],0.1784626652974109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF3,Granulocyte colony-stimulating factor,27752,127,0.97 [0.70-1.35],0.8538096505383197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF3R,Granulocyte colony-stimulating factor receptor,23868,118,0.92 [0.53-1.60],0.760160428426018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSH1,Chorionic somatomammotropin hormone 1,24594,120,1.22 [0.81-1.82],0.3398323769340036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSNK1D,Casein kinase I isoform delta,23868,118,1.05 [0.80-1.37],0.744351044765129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSNK2A1,Casein kinase II subunit alpha,24531,120,1.09 [0.74-1.59],0.6616647303447254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSPG4,Chondroitin sulfate proteoglycan 4,24559,122,0.94 [0.56-1.58],0.8187853923684438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSPG5,Chondroitin sulfate proteoglycan 5,23785,114,0.89 [0.60-1.32],0.5556627170936947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSRP3,Cysteine and glycine-rich protein 3,23789,116,1.13 [0.96-1.34],0.1519275455326119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST1,Cystatin-SN,21293,104,0.80 [0.66-0.98],0.0274651337578426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST3,Cystatin-C,28311,128,0.86 [0.48-1.54],0.615252222016337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST5,Cystatin-D,27753,127,0.95 [0.72-1.26],0.7196669284250748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST6,Cystatin-M,27552,124,0.73 [0.52-1.02],0.063333534251357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST7,Cystatin-F,28300,130,1.06 [0.91-1.23],0.4603705495579896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSTB,Cystatin-B,27889,127,1.30 [0.92-1.85],0.140539208749001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTAG1A_CTAG1B,Cancer/testis antigen 1,24063,121,1.09 [0.77-1.53],0.6331914149777289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTBS,Di-N-acetylchitobiase,24255,118,0.95 [0.51-1.78],0.8804457106058777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTF1,Cardiotrophin-1,27774,125,0.94 [0.78-1.14],0.5178425765439021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTHRC1,Collagen triple helix repeat-containing protein 1,24559,122,1.35 [0.73-2.51],0.3378406447560982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTLA4,Cytotoxic T-lymphocyte protein 4,24559,122,0.92 [0.51-1.64],0.7716023857307167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTNNA1,Catenin alpha-1,23785,114,0.69 [0.37-1.29],0.2478418788451747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTRB1,Chymotrypsinogen B,28263,129,0.74 [0.55-0.99],0.0392437423953722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTRC,Chymotrypsin-C,28256,129,0.71 [0.56-0.90],0.0042403154420134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTRL,Chymotrypsin-like protease CTRL-1,24496,120,0.81 [0.63-1.05],0.1106001255339678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSB,Cathepsin B,28279,129,0.89 [0.66-1.21],0.4625132109989803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSC,Dipeptidyl peptidase 1,28210,130,1.29 [0.92-1.82],0.1413918200425422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSD,Cathepsin D,26370,120,1.19 [0.81-1.76],0.3828588426075767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSE,Cathepsin E,24019,120,1.52 [1.11-2.09],0.0091286407614516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSF,Cathepsin F,28342,129,1.18 [0.81-1.74],0.3905236276664497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSH,Pro-cathepsin H,27689,125,0.99 [0.80-1.23],0.9304050650879814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSL,Cathepsin L1,28278,131,1.10 [0.58-2.08],0.7789225409377398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSO,Cathepsin O,28613,132,1.59 [0.98-2.58],0.0606663563382148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSS,Cathepsin S,22305,104,1.65 [0.76-3.58],0.2079906062877982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSV,Cathepsin L2,28436,133,0.98 [0.68-1.40],0.8964696635492018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSZ,Cathepsin Z,28255,127,1.48 [0.91-2.43],0.1154401132998176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23882,119,1.03 [0.67-1.58],0.8882299061733354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CWC15,Spliceosome-associated protein CWC15 homolog,24344,121,0.80 [0.57-1.12],0.1946477269605231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CX3CL1,Fractalkine,28081,128,1.23 [0.78-1.94],0.3772951691562528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXADR,Coxsackievirus and adenovirus receptor,28257,133,0.82 [0.60-1.12],0.2128651618119911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL1,Growth-regulated alpha protein,28211,130,0.83 [0.70-0.98],0.0316404513763189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL10,C-X-C motif chemokine 10,28400,130,0.84 [0.65-1.08],0.1739749131277392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL11,C-X-C motif chemokine 11,28543,133,0.80 [0.65-0.98],0.0340763187593196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL12,Stromal cell-derived factor 1,27752,127,0.87 [0.59-1.29],0.4921361895396169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL13,C-X-C motif chemokine 13,28543,133,0.93 [0.71-1.21],0.5777606669523496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL14,C-X-C motif chemokine 14,27752,127,0.91 [0.69-1.21],0.523388789474263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL16,C-X-C motif chemokine 16,28573,129,1.02 [0.53-1.99],0.9440721581975292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL17,C-X-C motif chemokine 17,28613,132,0.92 [0.64-1.33],0.6697297927510093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL3,C-X-C motif chemokine 3,28257,130,0.95 [0.81-1.12],0.5424144918621374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL5,C-X-C motif chemokine 5,28181,131,1.00 [0.88-1.14],0.9784274284921086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL6,C-X-C motif chemokine 6,28613,132,0.95 [0.78-1.16],0.6178198073424358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL8,Interleukin-8,28051,131,1.01 [0.81-1.27],0.9048237001601546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL9,C-X-C motif chemokine 9,28400,130,0.80 [0.61-1.03],0.0840984810707473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYB5A,Cytochrome b5,23697,117,1.07 [0.85-1.34],0.5695399524833477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYB5R2,NADH-cytochrome b5 reductase 2,24179,121,0.86 [0.63-1.17],0.3398087453275621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23789,116,0.85 [0.66-1.08],0.1861557732177047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYTH3,Cytohesin-3,23697,117,0.90 [0.69-1.17],0.4216906334483087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYTL1,Cytokine-like protein 1,24559,122,0.69 [0.33-1.44],0.3223517137279156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAAM1,Disheveled-associated activator of morphogenesis 1,24019,120,0.88 [0.71-1.09],0.2493890161187888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAB2,Disabled homolog 2,28529,133,0.97 [0.85-1.11],0.621751388326804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAG1,Dystroglycan,28400,130,1.00 [0.73-1.37],0.9965573665578272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAND5,DAN domain family member 5,23868,118,1.12 [0.85-1.48],0.4206570877092241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAPK2,Death-associated protein kinase 2,23868,118,0.88 [0.63-1.24],0.474477215409674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,28257,133,0.96 [0.85-1.09],0.5605225176734572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DARS1,"Aspartate--tRNA ligase, cytoplasmic",28031,127,0.98 [0.79-1.22],0.8743691195281982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DBH,Dopamine beta-hydroxylase,24554,120,0.98 [0.84-1.13],0.7444515349186283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DBI,Acyl-CoA-binding protein,28121,128,0.90 [0.74-1.10],0.305997058957469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DBN1,Drebrin,23868,118,0.71 [0.49-1.02],0.0631687793674695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DBNL,Drebrin-like protein,28400,130,0.93 [0.79-1.09],0.3558663182423405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28342,129,1.29 [0.83-2.01],0.2570273963884803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCC,Netrin receptor DCC,23882,119,0.63 [0.26-1.57],0.3263223659692153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCDC2C,Doublecortin domain-containing protein 2C,23697,117,0.93 [0.69-1.25],0.6217721172783679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCLRE1C,Protein artemis,23697,117,0.90 [0.50-1.60],0.70988431794449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCN,Decorin,27774,125,0.64 [0.31-1.35],0.2419720808954763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTD,Deoxycytidylate deaminase,24019,120,0.89 [0.74-1.07],0.2039986601980702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTN1,Dynactin subunit 1,28529,133,0.97 [0.77-1.22],0.7708018187133052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTN2,Dynactin subunit 2,28150,131,1.00 [0.85-1.18],0.966150456889681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTN6,Dynactin subunit 6,27604,125,0.93 [0.73-1.18],0.5427198494890066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTPP1,dCTP pyrophosphatase 1,28278,131,0.83 [0.51-1.35],0.4593501709072697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCUN1D1,DCN1-like protein 1,23785,114,0.76 [0.56-1.02],0.0686051869499883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCUN1D2,DCN1-like protein 2,23697,117,1.06 [0.86-1.31],0.6038977100636302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCXR,L-xylulose reductase,28342,129,1.14 [0.86-1.51],0.3572588955586512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDA1,DET1- and DDB1-associated protein 1,23789,116,0.76 [0.46-1.25],0.2822728389034696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",28150,131,0.95 [0.67-1.34],0.7653164886402786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDC,Aromatic-L-amino-acid decarboxylase,28245,131,1.07 [0.78-1.46],0.6698751650334032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDHD2,Phospholipase DDHD2,24531,120,0.92 [0.71-1.20],0.5372677815871987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDI2,Protein DDI1 homolog 2,24019,120,1.23 [0.99-1.52],0.0626796600668301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDR1,Epithelial discoidin domain-containing receptor 1,28543,133,1.09 [0.55-2.15],0.7991079361209713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDT,D-dopachrome decarboxylase,24559,122,1.31 [0.89-1.92],0.1748783813015211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX1,ATP-dependent RNA helicase DDX1,24472,121,1.06 [0.76-1.47],0.7476275258737786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX25,ATP-dependent RNA helicase DDX25,23882,119,0.49 [0.27-0.90],0.021282027368874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX39A,ATP-dependent RNA helicase DDX39A,23868,118,0.85 [0.37-1.93],0.6970265135270939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX4,Probable ATP-dependent RNA helicase DDX4,23868,118,0.93 [0.66-1.30],0.6711751022648891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX53,Probable ATP-dependent RNA helicase DDX53,23882,119,0.75 [0.45-1.25],0.2676647276059766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX58,Antiviral innate immune response receptor RIG-I,27585,127,0.82 [0.61-1.10],0.1900989505781311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",28257,133,0.99 [0.84-1.15],0.8570318204821848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFA1_DEFA1B,Neutrophil defensin 1,27682,126,0.90 [0.65-1.24],0.5207058569467797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB103A_DEFB103B,Beta-defensin 103,23701,117,1.04 [0.69-1.57],0.856611095024895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB104A_DEFB104B,Beta-defensin 104,23785,114,0.94 [0.68-1.31],0.7220523659560414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB116,Beta-defensin 116,23785,114,1.09 [0.88-1.35],0.4178186284530206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB118,Beta-defensin 118,23785,114,1.18 [0.92-1.51],0.1936363747062626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB4A_DEFB4B,Beta-defensin 4A,27855,129,1.00 [0.89-1.11],0.928396283627132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DENND2B,DENN domain-containing protein 2B,23789,116,1.05 [0.75-1.49],0.7675361827154021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DENR,Density-regulated protein,23868,118,0.97 [0.71-1.32],0.8426098876054499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DFFA,DNA fragmentation factor subunit alpha,28613,132,0.96 [0.77-1.21],0.756498861473879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DGCR6,Protein DGCR6,23785,114,0.85 [0.54-1.34],0.4846888409835926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DGKA,Diacylglycerol kinase alpha,23868,118,1.00 [0.72-1.38],0.9810142374571088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DGKZ,Diacylglycerol kinase zeta,27752,127,0.74 [0.47-1.16],0.1894050377495606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DHODH,Dihydroorotate dehydrogenase,23789,116,0.84 [0.55-1.28],0.4134814303300343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DHPS,Deoxyhypusine synthase,24451,121,1.04 [0.69-1.58],0.8376512724315764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24496,120,0.71 [0.47-1.07],0.1048850709642779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DIABLO,"Diablo homolog, mitochondrial",28176,130,0.91 [0.79-1.05],0.2024235576968387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DIPK1C,Divergent protein kinase domain 1C,23882,119,0.62 [0.38-1.02],0.0588964681377368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DIPK2B,Divergent protein kinase domain 2B,24019,120,0.67 [0.37-1.24],0.2036857790574197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DKK1,Dickkopf-related protein 1,28543,133,0.84 [0.66-1.08],0.1776296198138126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DKK3,Dickkopf-related protein 3,28628,130,1.10 [0.65-1.85],0.7297602291302812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DKK4,Dickkopf-related protein 4,28030,128,1.18 [0.85-1.64],0.3165381244473726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DKKL1,Dickkopf-like protein 1,28150,131,0.90 [0.76-1.06],0.2013556813810991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLG4,Disks large homolog 4,24496,120,0.78 [0.60-1.00],0.0546051656693616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLGAP5,Disks large-associated protein 5,24531,120,1.03 [0.75-1.41],0.8682120576829101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLK1,Protein delta homolog 1,28628,130,1.06 [0.80-1.39],0.6937416505920739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLL1,Delta-like protein 1,28342,129,1.13 [0.66-1.94],0.6507826278953673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLL4,Delta-like protein 4,23885,117,0.98 [0.79-1.22],0.8695107687111643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DMD,Dystrophin,23885,117,0.88 [0.61-1.26],0.4781614789214468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DMP1,Dentin matrix acidic phosphoprotein 1,23885,117,0.90 [0.68-1.18],0.4344597109810719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJA1,DnaJ homolog subfamily A member 1,23697,117,0.90 [0.60-1.36],0.6255900520526261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJA2,DnaJ homolog subfamily A member 2,28513,131,0.95 [0.79-1.14],0.5715594118864259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJA4,DnaJ homolog subfamily A member 4,24496,120,1.21 [0.96-1.52],0.1082955218873318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB1,DnaJ homolog subfamily B member 1,28150,131,1.08 [0.91-1.29],0.3867304671792341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB14,DnaJ homolog subfamily B member 14,24472,121,0.82 [0.63-1.08],0.1649346425930391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB2,DnaJ homolog subfamily B member 2,24019,120,1.16 [0.85-1.59],0.3430240339556403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB6,DnaJ homolog subfamily B member 6,23795,119,0.93 [0.75-1.14],0.4626318633721393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB8,DnaJ homolog subfamily B member 8,27774,125,0.97 [0.73-1.29],0.8179631212698806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJC21,DnaJ homolog subfamily C member 21,24496,120,0.86 [0.54-1.36],0.5169745240338112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23885,117,0.97 [0.79-1.20],0.8055516628995816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJC9,DnaJ homolog subfamily C member 9,24472,121,1.17 [0.94-1.45],0.1685465606353362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNER,Delta and Notch-like epidermal growth factor-related receptor,28214,129,0.81 [0.44-1.47],0.4807963249137894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNLZ,DNL-type zinc finger protein,23785,114,0.98 [0.79-1.21],0.821941780114452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNM1,Dynamin-1,24472,121,0.93 [0.80-1.08],0.3169784964580885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNM3,Dynamin-3,24531,120,1.01 [0.73-1.38],0.9734552217193956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNMBP,Dynamin-binding protein,28081,128,0.82 [0.63-1.07],0.1413652207077156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNPEP,Aspartyl aminopeptidase,24496,120,0.88 [0.67-1.17],0.3948339903678178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28345,130,1.18 [0.88-1.58],0.2678627675242785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DOC2B,Double C2-like domain-containing protein beta,23882,119,0.99 [0.61-1.61],0.9774690935345944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DOCK9,Dedicator of cytokinesis protein 9,23785,114,1.14 [1.00-1.29],0.0548067530119528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DOK1,Docking protein 1,24496,120,0.91 [0.81-1.03],0.1298160405867762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DOK2,Docking protein 2,28278,131,0.94 [0.83-1.06],0.3221449421433129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPEP1,Dipeptidase 1,28031,127,0.74 [0.54-1.01],0.0583516128726823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPEP2,Dipeptidase 2,28150,131,1.01 [0.60-1.70],0.9704905490732058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPP10,Inactive dipeptidyl peptidase 10,28257,133,1.12 [0.73-1.74],0.5994681390952805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPP4,Dipeptidyl peptidase 4,27709,125,0.96 [0.57-1.64],0.8952929293879685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPP6,Dipeptidyl aminopeptidase-like protein 6,28150,131,1.93 [1.24-3.03],0.0039229852489909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPP7,Dipeptidyl peptidase 2,28036,130,1.05 [0.81-1.35],0.7145567483351059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPT,Dermatopontin,28628,130,1.21 [0.67-2.18],0.5211807641238491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPY30,Protein dpy-30 homolog,28452,133,0.91 [0.70-1.18],0.4760138850094939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DRAXIN,Draxin,28081,128,1.01 [0.70-1.46],0.9426017186439376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DRG2,Developmentally-regulated GTP-binding protein 2,28150,131,0.89 [0.68-1.18],0.4205587942666169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSC2,Desmocollin-2,27923,128,1.20 [0.76-1.90],0.4428150417789188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSCAM,Down syndrome cell adhesion molecule,24531,120,1.08 [0.67-1.75],0.7567265046506078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSG2,Desmoglein-2,28263,129,1.56 [0.88-2.75],0.1269139820832735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSG3,Desmoglein-3,28444,133,0.95 [0.61-1.49],0.8250717245616519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSG4,Desmoglein-4,28054,131,0.69 [0.52-0.93],0.014819860854714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTD1,D-aminoacyl-tRNA deacylase 1,24019,120,0.91 [0.74-1.11],0.3305476652633258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTNB,Dystrobrevin beta,24411,120,0.93 [0.62-1.38],0.7037524241566903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23882,119,0.70 [0.49-0.98],0.0406727647274198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTX3,Probable E3 ubiquitin-protein ligase DTX3,28150,131,0.76 [0.39-1.49],0.4251761203214719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTYMK,Thymidylate kinase,24567,122,1.05 [0.82-1.35],0.6727554645481796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUOX2,Dual oxidase 2,27774,125,1.13 [0.94-1.38],0.1995459855843547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUSP13,Dual specificity protein phosphatase 13 isoform A,24451,121,0.97 [0.64-1.48],0.8973016873835536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUSP29,Dual specificity phosphatase 29,23882,119,0.99 [0.76-1.29],0.9470456002442166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUSP3,Dual specificity protein phosphatase 3,27604,125,0.94 [0.77-1.14],0.5073523384295067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24472,121,0.96 [0.81-1.13],0.5990438963061528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DXO,Decapping and exoribonuclease protein,24496,120,0.96 [0.66-1.41],0.8334907985069907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24451,121,0.77 [0.50-1.18],0.2328344814789925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DYNLT1,Dynein light chain Tctex-type 1,23882,119,0.85 [0.67-1.08],0.1842086169307431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DYNLT3,Dynein light chain Tctex-type 3,24451,121,0.87 [0.58-1.29],0.4812160391622345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,28081,128,0.97 [0.82-1.15],0.7287129701622417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EBI3_IL27,Interleukin-27,28492,133,1.15 [0.70-1.89],0.5730405894578248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECE1,Endothelin-converting enzyme 1,27604,125,1.03 [0.66-1.62],0.8920229143239978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24567,122,1.01 [0.81-1.27],0.9249672624796492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23885,117,0.99 [0.82-1.18],0.8722351406199893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECI2,Enoyl-CoA delta isomerase 2,23789,116,0.90 [0.66-1.21],0.4730808091661013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECM1,Extracellular matrix protein 1,23912,122,0.97 [0.61-1.55],0.902920485624517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECSCR,Endothelial cell-specific chemotaxis regulator,23785,114,0.87 [0.59-1.29],0.4996725855488052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDA2R,Tumor necrosis factor receptor superfamily member 27,28529,133,0.98 [0.64-1.52],0.9421829804492328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDAR,Tumor necrosis factor receptor superfamily member EDAR,28257,133,0.92 [0.78-1.09],0.3536521109116572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDDM3B,Epididymal secretory protein E3-beta,24451,121,1.26 [0.91-1.73],0.1630257745397209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23789,116,1.10 [0.70-1.74],0.6703141478334238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDF1,Endothelial differentiation-related factor 1,24531,120,0.79 [0.60-1.06],0.1161212010673348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27774,125,1.06 [0.68-1.66],0.7875567496504677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDN1,Endothelin-1,23885,117,1.59 [0.87-2.89],0.1315581987128319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDNRB,Endothelin receptor type B,23868,118,0.98 [0.66-1.46],0.9297656902441556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EEF1D,Elongation factor 1-delta,24567,122,0.91 [0.75-1.10],0.3152389702660934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24472,121,1.19 [0.64-2.20],0.5860591295146518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFCAB2,Dynein regulatory complex protein 8,24115,121,1.01 [0.61-1.65],0.9790495936154106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,28305,128,0.87 [0.52-1.46],0.6058579583381681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFHD1,EF-hand domain-containing protein D1,24531,120,1.13 [0.70-1.83],0.6097106878941096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFNA1,Ephrin-A1,28212,129,0.73 [0.40-1.34],0.3112754223657653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFNA4,Ephrin-A4,28032,128,1.13 [0.65-1.99],0.6608282547396735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFNB2,Ephrin-B2,23882,119,1.21 [0.97-1.52],0.0942862420629769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGF,Pro-epidermal growth factor,28208,128,0.93 [0.80-1.08],0.3226606429670707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGFL7,Epidermal growth factor-like protein 7,27585,127,0.97 [0.66-1.44],0.8908741673113487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGFLAM,Pikachurin,24472,121,1.22 [0.71-2.09],0.4633160660946226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGFR,Epidermal growth factor receptor,28628,130,0.58 [0.23-1.50],0.2646181543574564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGLN1,Egl nine homolog 1,28257,133,1.13 [0.89-1.45],0.3140935388018527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EHBP1,EH domain-binding protein 1,24567,122,0.82 [0.65-1.03],0.0940538430712667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EHD3,EH domain-containing protein 3,23885,117,0.91 [0.78-1.05],0.1943590884605534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24496,120,0.91 [0.65-1.27],0.5849016202597555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24395,121,0.92 [0.78-1.08],0.293575530004611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23789,116,0.84 [0.63-1.12],0.2353870684327079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23885,117,0.88 [0.57-1.36],0.5628110320111803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4B,Eukaryotic translation initiation factor 4B,28081,128,1.02 [0.78-1.33],0.908794340591011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4E,Eukaryotic translation initiation factor 4E,23868,118,0.97 [0.80-1.18],0.7446794331831259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,28278,131,1.14 [0.91-1.43],0.2493461517614932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28613,132,0.94 [0.81-1.10],0.4490130964927316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24531,120,0.72 [0.55-0.96],0.0257862359682329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF5,Eukaryotic translation initiation factor 5,23789,116,1.24 [0.89-1.73],0.2045754560714175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF5A,Eukaryotic translation initiation factor 5A-1,27752,127,0.84 [0.49-1.44],0.5201459413292865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELAC1,Zinc phosphodiesterase ELAC protein 1,24531,120,0.93 [0.76-1.13],0.4659443950638845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELAVL4,ELAV-like protein 4,23785,114,0.91 [0.73-1.14],0.4246743317464492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELN,Elastin,24567,122,1.13 [0.69-1.86],0.6279492562779744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELOA,Elongin-A,28150,131,0.98 [0.73-1.30],0.8707274872007078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELOB,Elongin-B,23789,116,1.13 [0.74-1.73],0.5767706419719458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENAH,Protein enabled homolog,27752,127,0.95 [0.69-1.33],0.7833241739728092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENDOU,Poly(U)-specific endoribonuclease,22684,118,0.81 [0.57-1.15],0.2388413909352568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENG,Endoglin,28628,130,0.72 [0.29-1.79],0.4827002672413846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENO1,Alpha-enolase,28244,131,0.94 [0.77-1.14],0.5047175957652081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENO2,Gamma-enolase,28543,133,1.03 [0.82-1.29],0.8065906131978714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENO3,Beta-enolase,23885,117,0.82 [0.60-1.13],0.2252470398511547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENOPH1,Enolase-phosphatase E1,24451,121,0.73 [0.52-1.02],0.0641113951733724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23789,116,1.13 [0.61-2.08],0.7051130596179422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPEP,Glutamyl aminopeptidase,23789,116,1.10 [0.75-1.62],0.6293235371903952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28628,130,0.88 [0.50-1.57],0.6704986075428745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28400,130,0.77 [0.57-1.04],0.0846004160350382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23885,117,1.36 [0.84-2.21],0.215238653432955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27457,126,1.11 [0.93-1.34],0.2496190073848445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENSA,Alpha-endosulfine,24451,121,0.80 [0.57-1.13],0.2102152207818845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27585,127,1.05 [0.73-1.52],0.7842940619023656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27774,125,0.64 [0.31-1.32],0.2304713093477494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27774,125,0.78 [0.45-1.37],0.392961353507953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENTR1,Endosome-associated-trafficking regulator 1,23885,117,0.88 [0.65-1.20],0.4314575015493513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EP300,Histone acetyltransferase p300,23868,118,1.13 [0.65-1.95],0.6703893144592339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPB41L5,Band 4.1-like protein 5,23882,119,0.84 [0.61-1.14],0.2659164578770123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPCAM,Epithelial cell adhesion molecule,28264,130,1.12 [0.96-1.31],0.154790863615399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPGN,Epigen,24451,121,1.07 [0.77-1.49],0.6821336044506099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHA1,Ephrin type-A receptor 1,28345,130,0.80 [0.51-1.25],0.3216665713113037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHA10,Ephrin type-A receptor 10,27604,125,1.18 [0.96-1.45],0.1197555395178976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHA2,Ephrin type-A receptor 2,27263,129,1.14 [0.67-1.94],0.6230339031811265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHA4,Ephrin type-A receptor 4,24019,120,1.44 [0.78-2.65],0.2474730062639732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHB4,Ephrin type-B receptor 4,28628,130,0.76 [0.39-1.48],0.4219276613316349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHB6,Ephrin type-B receptor 6,28031,127,0.70 [0.42-1.18],0.1787167267338091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHX2,Bifunctional epoxide hydrolase 2,27774,125,0.91 [0.69-1.20],0.5004079427826651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPN1,Epsin-1,24115,121,0.83 [0.53-1.32],0.4323915600033199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPO,Erythropoietin,28257,133,1.12 [0.93-1.35],0.243692596837926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPPK1,Epiplakin,23885,117,0.82 [0.64-1.04],0.0977067156532427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28489,133,0.84 [0.50-1.40],0.5055184714570224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERBB2,Receptor tyrosine-protein kinase erbB-2,28342,129,1.09 [0.59-2.04],0.7768675758037535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERBB3,Receptor tyrosine-protein kinase erbB-3,28150,130,1.26 [0.56-2.82],0.5714747641412028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERBB4,Receptor tyrosine-protein kinase erbB-4,28342,129,2.13 [1.13-4.02],0.0193707988668022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERBIN,Erbin,28150,131,0.94 [0.81-1.09],0.3951715151487521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERC2,ERC protein 2,23882,119,0.86 [0.66-1.12],0.2676892616126942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERCC1,DNA excision repair protein ERCC-1,23697,117,0.83 [0.46-1.50],0.5473820561708214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EREG,Proepiregulin,28031,127,0.92 [0.75-1.12],0.3890860074959347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERI1,3'-5' exoribonuclease 1,24115,121,0.69 [0.40-1.20],0.189106769161608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERMAP,Erythroid membrane-associated protein,23868,118,1.09 [0.74-1.61],0.6554037788077449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24451,121,0.85 [0.54-1.35],0.4950141341998312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERP29,Endoplasmic reticulum resident protein 29,24019,120,0.91 [0.79-1.06],0.2250305521782712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERP44,Endoplasmic reticulum resident protein 44,28110,131,0.89 [0.50-1.61],0.709316690528415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23789,116,1.12 [0.79-1.60],0.516753198475179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESAM,Endothelial cell-selective adhesion molecule,28628,130,0.83 [0.51-1.36],0.4678682788228776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESM1,Endothelial cell-specific molecule 1,28255,128,0.94 [0.60-1.49],0.7980884720274737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESPL1,Separin,23697,117,1.19 [0.91-1.55],0.2000456416604199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESR1,Estrogen receptor,23868,118,0.84 [0.60-1.19],0.3219584345757686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESYT2,Extended synaptotagmin-2,24496,120,0.88 [0.71-1.09],0.236163917141182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EVI2B,Protein EVI2B,23697,117,1.16 [0.81-1.67],0.4123057313930541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EVI5,Ecotropic viral integration site 5 protein homolog,23868,118,0.86 [0.71-1.05],0.1309369969120185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EVPL,Envoplakin,24115,121,0.96 [0.56-1.65],0.8733612941222711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EXOSC10,Exosome component 10,23789,116,0.82 [0.58-1.16],0.2599153789798948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EXTL1,Exostosin-like 1,23789,116,0.71 [0.46-1.11],0.134496450161707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EZR,Ezrin,28543,133,1.08 [0.58-2.01],0.8134213109189938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F10,Coagulation factor X,24594,120,1.53 [0.92-2.54],0.0995936186253715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F11,Coagulation factor XI,24242,122,1.45 [1.09-1.92],0.0102660214550137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F11R,Junctional adhesion molecule A,28263,129,0.80 [0.60-1.05],0.1075396421265803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F12,Coagulation factor XII,24605,122,0.78 [0.53-1.16],0.2179895808307127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F13B,Coagulation factor XIII B chain,24473,122,1.22 [0.64-2.34],0.5496335346256271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F2,Prothrombin,24605,122,1.55 [0.49-4.91],0.4576953834253076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F2R,Proteinase-activated receptor 1,28357,130,0.97 [0.75-1.26],0.8353780122151515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F3,Tissue factor,28351,133,1.06 [0.61-1.82],0.8432161596510928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F7,Coagulation factor VII,28312,128,1.30 [0.77-2.19],0.3292722914904867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F9,Coagulation factor IX,28324,128,2.80 [1.21-6.49],0.0160271142423009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP1,"Fatty acid-binding protein, liver",28255,128,0.97 [0.82-1.15],0.7234107728858417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP2,"Fatty acid-binding protein, intestinal",28278,131,0.92 [0.76-1.13],0.443631537199858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP3,"Fatty acid-binding protein, heart",24567,122,1.30 [0.95-1.77],0.0999575118461253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP4,"Fatty acid-binding protein, adipocyte",28628,130,1.20 [0.88-1.63],0.2473865962488093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP5,Fatty acid-binding protein 5,28462,132,1.04 [0.83-1.29],0.7543402476911227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP6,Gastrotropin,27738,125,0.79 [0.58-1.07],0.1244744088279485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP9,Fatty acid-binding protein 9,28257,133,0.83 [0.63-1.09],0.1706418761286564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FADD,FAS-associated death domain protein,28278,131,0.93 [0.76-1.14],0.4907080947013699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM13A,Protein FAM13A,24472,121,0.88 [0.68-1.14],0.3229393814323791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM171A2,Protein FAM171A2,24531,120,1.01 [0.91-1.13],0.7930306432843233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM171B,Protein FAM171B,24451,121,1.22 [0.68-2.17],0.500699957670654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM172A,Cotranscriptional regulator FAM172A,23885,117,0.80 [0.60-1.07],0.1260074891398415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM20A,Pseudokinase FAM20A,24567,122,1.04 [0.57-1.90],0.901886929258222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM3B,Protein FAM3B,28150,131,1.08 [0.71-1.63],0.7221345274443041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM3C,Protein FAM3C,28245,131,1.07 [0.63-1.82],0.7901641341534633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM3D,Protein FAM3D,24472,121,1.14 [0.93-1.40],0.2146318588411006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAP,Prolyl endopeptidase FAP,28628,130,0.71 [0.41-1.24],0.2297484290800305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FARSA,Phenylalanine--tRNA ligase alpha subunit,23882,119,0.84 [0.63-1.11],0.2092767940277491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAS,Tumor necrosis factor receptor superfamily member 6,28526,129,0.83 [0.50-1.39],0.4842887053027587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FASLG,Tumor necrosis factor ligand superfamily member 6,28613,132,0.58 [0.39-0.86],0.0064875989907212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FBLN2,Fibulin-2,24559,122,0.88 [0.51-1.50],0.6309793414207935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FBN2,Fibrillin-2,23882,119,1.06 [0.79-1.42],0.6915513329516119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FBP1,"Fructose-1,6-bisphosphatase 1",28278,131,0.99 [0.80-1.22],0.938806067942492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24567,122,1.11 [0.88-1.41],0.3840372047464335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCAR,Immunoglobulin alpha Fc receptor,28257,133,1.02 [0.74-1.41],0.9119968452084573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24531,120,1.42 [0.71-2.84],0.3253516616201929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCER2,Low affinity immunoglobulin epsilon Fc receptor,28263,129,0.83 [0.60-1.16],0.2716661129695616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,28135,128,0.91 [0.72-1.16],0.4586663939833167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27585,127,1.04 [0.80-1.37],0.7505561763455781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,28269,128,0.93 [0.69-1.26],0.6370357346044327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCN1,Ficolin-1,24554,120,1.07 [0.78-1.47],0.6621003901380287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCN2,Ficolin-2,28136,127,0.80 [0.57-1.13],0.2075542143512233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL1,Fc receptor-like protein 1,28278,131,0.84 [0.59-1.19],0.3284351567335891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL2,Fc receptor-like protein 2,28488,132,1.11 [0.81-1.53],0.5221909142366683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL3,Fc receptor-like protein 3,27752,127,0.91 [0.68-1.23],0.5369476968705755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL5,Fc receptor-like protein 5,28263,129,0.91 [0.69-1.20],0.4972320005279005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL6,Fc receptor-like protein 6,28257,133,0.84 [0.67-1.05],0.1247404111975423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRLB,Fc receptor-like B,27585,127,0.98 [0.74-1.29],0.8823533466046712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FDX1,"Adrenodoxin, mitochondrial",23789,116,0.99 [0.74-1.32],0.9548136716052984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FDX2,"Ferredoxin-2, mitochondrial",23789,116,0.94 [0.68-1.31],0.7274860018681046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FEN1,Flap endonuclease 1,27585,127,1.01 [0.80-1.29],0.9159435143942244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FES,Tyrosine-protein kinase Fes/Fps,27585,127,0.80 [0.56-1.14],0.2118300859935664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FETUB,Fetuin-B,28324,128,1.01 [0.63-1.61],0.9758542167105422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGA,Fibrinogen alpha chain,24017,119,1.43 [0.82-2.51],0.2058939819284401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24531,120,0.88 [0.71-1.10],0.2685828481779094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF12,Fibroblast growth factor 12,23868,118,1.13 [0.82-1.55],0.458977832876547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF16,Fibroblast growth factor 16,23868,118,0.97 [0.66-1.42],0.8750133657672513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF19,Fibroblast growth factor 19,28400,130,1.17 [0.96-1.43],0.1169313453861591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF2,Fibroblast growth factor 2,28257,133,0.89 [0.71-1.12],0.3204614530661762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF20,Fibroblast growth factor 20,23868,118,1.14 [0.78-1.66],0.489017863258375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF21,Fibroblast growth factor 21,28492,133,0.93 [0.82-1.06],0.2904942545462504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF23,Fibroblast growth factor 23,28478,133,1.09 [0.85-1.40],0.4982027078914308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF3,Fibroblast growth factor 3,23868,118,0.82 [0.43-1.54],0.5288010127091518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF5,Fibroblast growth factor 5,27752,127,1.03 [0.65-1.64],0.8989081876919697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF6,Fibroblast growth factor 6,23868,118,0.97 [0.64-1.48],0.8883524134427154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF7,Fibroblast growth factor 7,23697,117,1.03 [0.83-1.27],0.8082486910631244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF9,Fibroblast growth factor 9,23649,117,0.77 [0.50-1.19],0.244411876210506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFBP1,Fibroblast growth factor-binding protein 1,28342,129,0.55 [0.36-0.85],0.0074069827811055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFBP2,Fibroblast growth factor-binding protein 2,24559,122,0.85 [0.61-1.21],0.3710039129129925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFBP3,Fibroblast growth factor-binding protein 3,24496,120,0.64 [0.40-1.03],0.0641950000404286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFR2,Fibroblast growth factor receptor 2,28342,129,1.63 [0.81-3.27],0.167157800170875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFR4,Fibroblast growth factor receptor 4,24019,120,0.93 [0.67-1.28],0.6410798229946411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGL1,Fibrinogen-like protein 1,24594,120,1.38 [1.05-1.83],0.0213750058951233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGR,Tyrosine-protein kinase Fgr,27604,125,1.08 [0.84-1.39],0.5533558271527563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FH,"Fumarate hydratase, mitochondrial",23785,114,0.90 [0.70-1.15],0.3950335433916963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23789,116,0.88 [0.60-1.31],0.5403786552062657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FHIT,Bis(5'-adenosyl)-triphosphatase,27604,125,0.90 [0.73-1.12],0.3449509858354858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FIS1,Mitochondrial fission 1 protein,28245,130,0.91 [0.74-1.11],0.3511682338021666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24531,120,0.91 [0.77-1.08],0.2871603867192038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28387,130,0.93 [0.81-1.06],0.2708175300518018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,28081,128,1.08 [0.76-1.53],0.6796115397061882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,28081,128,0.98 [0.83-1.16],0.8169506613378085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27554,124,0.79 [0.54-1.16],0.2276082730885048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBPL,FK506-binding protein-like,24472,121,0.97 [0.73-1.30],0.860989860672614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLI1,Friend leukemia integration 1 transcription factor,27585,127,0.98 [0.85-1.13],0.7424363009289244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,28081,128,0.81 [0.46-1.41],0.4512612742756635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLT1,Vascular endothelial growth factor receptor 1,28104,131,0.81 [0.39-1.69],0.5764572307824185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLT3,Receptor-type tyrosine-protein kinase FLT3,27585,127,0.85 [0.50-1.46],0.5592011052221415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLT3LG,Fms-related tyrosine kinase 3 ligand,28613,132,0.74 [0.47-1.17],0.2031219115275136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLT4,Vascular endothelial growth factor receptor 3,28342,129,0.96 [0.61-1.52],0.8763649563453243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FMNL1,Formin-like protein 1,27604,125,0.84 [0.63-1.12],0.2426211618934185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FMR1,Synaptic functional regulator FMR1,27585,127,1.26 [0.82-1.94],0.2917549949321517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FN1,Fibronectin,24605,122,1.13 [0.60-2.14],0.7066892427957823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FNDC1,Fibronectin type III domain-containing protein 1,24496,120,0.85 [0.59-1.23],0.3935796569424706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24451,121,1.22 [0.80-1.87],0.3593203854672232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOLH1,Glutamate carboxypeptidase 2,23868,118,0.99 [0.84-1.16],0.8848384827210061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOLR1,Folate receptor alpha,28205,128,0.94 [0.53-1.66],0.840550239273198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOLR2,Folate receptor beta,28543,133,0.65 [0.39-1.09],0.1046246889771511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOLR3,Folate receptor gamma,28252,128,1.06 [0.99-1.14],0.0933452000350015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOS,Proto-oncogene c-Fos,23649,117,1.27 [0.78-2.07],0.3300906480787525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOSB,Protein fosB,27604,125,0.79 [0.50-1.26],0.3235861522064091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOXJ3,Forkhead box protein J3,23868,118,0.67 [0.43-1.04],0.074009927754588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOXO1,Forkhead box protein O1,28257,133,0.93 [0.78-1.11],0.4039407842249795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOXO3,Forkhead box protein O3,27585,127,1.06 [0.91-1.24],0.460961410865823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FRMD4B,FERM domain-containing protein 4B,23789,116,0.86 [0.66-1.12],0.2621301532674706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FRMD7,FERM domain-containing protein 7,23882,119,1.06 [0.63-1.77],0.8224763079521574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FRZB,Secreted frizzled-related protein 3,27984,128,0.84 [0.48-1.46],0.538063717761208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FSHB,Follitropin subunit beta,23885,117,1.17 [0.89-1.54],0.2503309916210147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FST,Follistatin,28357,130,0.91 [0.67-1.24],0.5418591577010974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FSTL1,Follistatin-related protein 1,23885,117,1.16 [0.54-2.50],0.7015348884915673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FSTL3,Follistatin-related protein 3,28213,129,0.50 [0.29-0.86],0.0120321444492679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FTCD,Formimidoyltransferase-cyclodeaminase,24456,119,0.98 [0.80-1.20],0.8322244716786782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUCA1,Tissue alpha-L-fucosidase,28431,130,0.95 [0.79-1.15],0.6030719036767626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUOM,Fucose mutarotase,24019,120,0.94 [0.71-1.24],0.6588086879270418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FURIN,Furin,28342,129,0.88 [0.56-1.38],0.576134718210664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUS,RNA-binding protein FUS,27534,127,0.97 [0.65-1.45],0.8818181762062786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24073,120,1.00 [0.76-1.30],0.9903055035534716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28543,133,0.91 [0.65-1.27],0.5810354396532329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUT8,"Alpha-(1,6)-fucosyltransferase",28081,128,0.91 [0.70-1.19],0.4958128578388843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FXN,"Frataxin, mitochondrial",28529,133,0.99 [0.81-1.22],0.9602407444251878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FXYD5,FXYD domain-containing ion transport regulator 5,27752,127,0.93 [0.72-1.18],0.5399780181111932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FYB1,FYN-binding protein 1,28222,129,0.87 [0.73-1.02],0.0899192576973231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FZD10,Frizzled-10,23882,119,0.82 [0.57-1.17],0.2688700443975583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FZD8,Frizzled-8,23785,114,1.02 [0.67-1.55],0.9238544282003576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24451,121,1.00 [0.70-1.42],0.9923108774478616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24115,121,0.87 [0.65-1.17],0.3665001764544274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23785,114,1.19 [0.95-1.49],0.1289208556180375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAD1,Glutamate decarboxylase 1,23697,117,1.14 [0.58-2.24],0.7115889688545095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAD2,Glutamate decarboxylase 2,23868,118,1.06 [0.74-1.52],0.7570327572782014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24115,121,0.79 [0.51-1.23],0.2962085821701814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23885,117,0.84 [0.60-1.19],0.3224242484645309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAGE2A,G antigen 2A,23697,117,1.03 [0.78-1.37],0.8243648805199766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAL,Galanin peptides,28400,130,0.80 [0.63-1.02],0.0692067448457519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,28150,131,1.32 [0.77-2.26],0.3059368765343299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28529,133,0.61 [0.34-1.09],0.0952696789172994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27752,127,1.05 [0.72-1.52],0.8041036214220952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24567,122,0.51 [0.28-0.96],0.0357021050121875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT7,N-acetylgalactosaminyltransferase 7,28150,131,1.31 [0.62-2.75],0.4824268106409275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAMT,Guanidinoacetate N-methyltransferase,23789,116,0.98 [0.60-1.59],0.9317039561973832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23510,118,1.24 [0.70-2.19],0.4554393217645848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GART,Trifunctional purine biosynthetic protein adenosine-3,24531,120,0.84 [0.42-1.70],0.6359350796997318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAS2,Growth arrest-specific protein 2,24115,121,0.66 [0.43-1.00],0.0515023262280189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAS6,Growth arrest-specific protein 6,28425,128,0.76 [0.41-1.38],0.3624697958393748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GASK1A,Golgi-associated kinase 1A,23789,116,0.79 [0.52-1.20],0.2671480671267612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAST,Gastrin,24496,120,1.11 [0.98-1.27],0.1017430849487584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23697,117,1.03 [0.52-2.01],0.9408863045040085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23885,117,0.84 [0.67-1.06],0.1429212551703068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBA,Lysosomal acid glucosylceramidase,23882,119,0.85 [0.61-1.19],0.3447231848423894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBP1,Guanylate-binding protein 1,24450,120,0.91 [0.69-1.19],0.4837169591920444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBP2,Guanylate-binding protein 2,27752,127,1.14 [0.89-1.46],0.2970225062477386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBP4,Guanylate-binding protein 4,27604,125,0.93 [0.67-1.30],0.6842360754239436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBP6,Guanylate-binding protein 6,23789,116,1.27 [0.93-1.73],0.1291288097491145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GC,Vitamin D-binding protein,24605,122,1.07 [0.55-2.07],0.8462403723321916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCC1,GRIP and coiled-coil domain-containing protein 1,24496,120,0.87 [0.74-1.01],0.0717264223571418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCG,Pro-glucagon,27585,127,1.05 [0.93-1.20],0.4171974264269096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23427,118,1.18 [0.85-1.64],0.3124738223779262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCLM,Glutamate--cysteine ligase regulatory subunit,23789,116,1.32 [0.96-1.81],0.0873680246600071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",28150,131,1.14 [0.73-1.79],0.5547964735570987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GDF15,Growth/differentiation factor 15,28628,130,1.33 [0.96-1.83],0.0839400122819716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GDF2,Growth/differentiation factor 2,28278,131,1.02 [0.66-1.57],0.9329202186951288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GDNF,Glial cell line-derived neurotrophic factor,27604,125,0.99 [0.65-1.50],0.9465195829445764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GET3,ATPase GET3,24567,122,1.25 [0.96-1.63],0.1039609293685872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFAP,Glial fibrillary acidic protein,27543,127,0.67 [0.46-0.96],0.0294270092960754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFER,FAD-linked sulfhydryl oxidase ALR,27585,127,0.96 [0.75-1.22],0.7222396717764792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27585,127,1.02 [0.90-1.15],0.797760368525468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFRA1,GDNF family receptor alpha-1,28492,133,1.22 [0.70-2.12],0.4883976459921382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFRA2,GDNF family receptor alpha-2,28150,131,1.01 [0.49-2.12],0.9721110005395356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFRA3,GDNF family receptor alpha-3,27988,127,1.11 [0.63-1.95],0.7220309944915284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFRAL,GDNF family receptor alpha-like,23782,119,0.97 [0.73-1.29],0.8351364976814598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGA1,ADP-ribosylation factor-binding protein GGA1,27604,125,0.97 [0.77-1.22],0.7857885187033128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGACT,Gamma-glutamylaminecyclotransferase,24567,122,0.93 [0.73-1.18],0.538451376823132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGCT,Gamma-glutamylcyclotransferase,24525,122,1.09 [0.77-1.54],0.6402459304413675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGH,Gamma-glutamyl hydrolase,27753,125,1.12 [0.71-1.76],0.6219321420743699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGT1,Glutathione hydrolase 1 proenzyme,28212,129,1.07 [0.78-1.45],0.6848172678578657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGT5,Glutathione hydrolase 5 proenzyme,28081,128,0.58 [0.30-1.12],0.1048038815347404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GH1,Somatotropin,28245,131,1.06 [0.98-1.15],0.1559190009853857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GH2,Growth hormone variant,27585,127,1.03 [0.94-1.13],0.5532867542420457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GHR,Growth hormone receptor,24019,120,1.20 [0.66-2.21],0.549200195292751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GHRHR,Growth hormone-releasing hormone receptor,27604,125,0.75 [0.52-1.06],0.1050344175350813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GHRL,Appetite-regulating hormone,28278,131,0.96 [0.79-1.17],0.6859604762603793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GID8,Glucose-induced degradation protein 8 homolog,24531,120,0.96 [0.56-1.65],0.8897925437401943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIGYF2,GRB10-interacting GYF protein 2,24531,120,0.86 [0.68-1.08],0.2039319629258307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIMAP7,GTPase IMAP family member 7,24019,120,0.87 [0.50-1.54],0.6400400258556351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIMAP8,GTPase IMAP family member 8,23697,117,0.99 [0.69-1.41],0.9384059474330236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIP,Gastric inhibitory polypeptide,23885,117,1.01 [0.68-1.49],0.973917803731138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIPC2,PDZ domain-containing protein GIPC2,24496,120,1.70 [0.99-2.92],0.0552213615533841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIPC3,PDZ domain-containing protein GIPC3,24472,121,0.89 [0.75-1.05],0.1789169441444078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIPR,Gastric inhibitory polypeptide receptor,23868,118,1.14 [0.83-1.56],0.4133718839044622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIT1,ARF GTPase-activating protein GIT1,23868,118,0.92 [0.77-1.10],0.3662311391240095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GJA8,Gap junction alpha-8 protein,23697,117,1.09 [0.83-1.43],0.5509064954034496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GKN1,Gastrokine-1,27068,121,1.07 [0.60-1.91],0.8212249727550376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLA,Alpha-galactosidase A,23967,120,1.47 [0.95-2.29],0.0849049646671752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLB1,Beta-galactosidase,28081,128,1.05 [0.72-1.51],0.8052625788901847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLI2,Zinc finger protein GLI2,23868,118,1.06 [0.65-1.72],0.8235343006460448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLO1,Lactoylglutathione lyase,27774,125,1.38 [1.06-1.79],0.0173174456134843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLOD4,Glyoxalase domain-containing protein 4,28202,130,1.02 [0.66-1.56],0.9431405238583104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLP1R,Glucagon-like peptide 1 receptor,23785,114,0.67 [0.38-1.18],0.1622429165820278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLRX,Glutaredoxin-1,28103,130,1.17 [0.90-1.51],0.2500408745060825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24019,120,0.89 [0.73-1.08],0.245350259298186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27604,125,0.87 [0.60-1.26],0.4690732975240843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLYR1,Putative oxidoreductase GLYR1,24451,121,1.02 [0.77-1.35],0.8783567537825233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GM2A,Ganglioside GM2 activator,23985,121,0.93 [0.57-1.52],0.784284978624539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GMFG,Glia maturation factor gamma,24567,122,0.95 [0.75-1.21],0.6996309692128764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GMPR,GMP reductase 1,28613,132,1.01 [0.75-1.37],0.93835711683004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GMPR2,GMP reductase 2,24019,120,0.94 [0.72-1.22],0.6480960346739161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNAS,Neuroendocrine secretory protein 55,24531,120,1.00 [0.83-1.22],0.9649902062903868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27585,127,0.86 [0.67-1.10],0.2307645659052684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23882,119,0.85 [0.57-1.26],0.4115543526227629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNLY,Granulysin,28263,129,0.84 [0.63-1.11],0.2205222337507497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNPDA1,Glucosamine-6-phosphate isomerase 1,23885,117,0.85 [0.47-1.53],0.5869656267072011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNPDA2,Glucosamine-6-phosphate isomerase 2,24019,120,0.83 [0.51-1.34],0.4461131271480736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GOLGA3,Golgin subfamily A member 3,24531,120,0.92 [0.73-1.16],0.484087143717811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GOLM2,Protein GOLM2,28543,133,0.79 [0.40-1.57],0.5018710006122695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,28257,133,0.92 [0.79-1.06],0.2483558896939763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GORASP2,Golgi reassembly-stacking protein 2,24472,121,0.70 [0.48-1.03],0.0691888626707621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GOT1,"Aspartate aminotransferase, cytoplasmic",24559,122,1.01 [0.67-1.52],0.9750259369117884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP1BA,Platelet glycoprotein Ib alpha chain,28139,128,0.83 [0.51-1.33],0.437296748898343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP1BB,Platelet glycoprotein Ib beta chain,23789,116,0.99 [0.77-1.29],0.96633314953955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27413,121,0.89 [0.73-1.08],0.2372226342287999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP5,Platelet glycoprotein V,24019,120,0.73 [0.47-1.16],0.1832078909944376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP6,Platelet glycoprotein VI,28222,129,0.89 [0.75-1.06],0.2014957114145027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPA33,Cell surface A33 antigen,28150,131,1.05 [0.93-1.18],0.4144838999381846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPC1,Glypican-1,28529,133,0.98 [0.58-1.66],0.9487653440772732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPC5,Glypican-5,28081,128,0.91 [0.69-1.21],0.5184261876265082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPD1,Glycerol-3-phosphate dehydrogenase,24451,121,1.10 [0.80-1.51],0.5573121617717312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPHA2,Glycoprotein hormone alpha-2,24472,121,0.78 [0.50-1.22],0.2742862242849242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPI,Glucose-6-phosphate isomerase,24594,120,0.88 [0.61-1.28],0.5096678198584883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24472,121,1.02 [0.80-1.30],0.8881458239785291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPKOW,G-patch domain and KOW motifs-containing protein,27604,125,0.50 [0.25-0.98],0.0450698187081875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPNMB,Transmembrane glycoprotein NMB,27512,127,1.14 [0.65-1.99],0.6534371268684656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPR101,Probable G-protein coupled receptor 101,23785,114,0.83 [0.58-1.18],0.290396955983018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPR158,Probable G-protein coupled receptor 158,24531,120,0.84 [0.50-1.42],0.5145655361685808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPR15L,Protein GPR15L,24472,121,1.02 [0.78-1.34],0.8864275493394603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPR37,Prosaposin receptor GPR37,27774,125,1.06 [0.83-1.36],0.6434145380877714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPRC5C,G-protein coupled receptor family C group 5 member C,24451,121,1.23 [0.96-1.58],0.1066276198439299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRAP2,GRB2-related adapter protein 2,28278,131,0.96 [0.85-1.08],0.4904961818667032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24567,122,1.03 [0.79-1.34],0.8500053745444842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRIK2,"Glutamate receptor ionotropic, kainate 2",24531,120,0.86 [0.54-1.38],0.5359995850652076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23785,114,0.85 [0.59-1.24],0.4060793246936132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRK5,G protein-coupled receptor kinase 5,27774,125,1.13 [0.86-1.49],0.3863208622439416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRN,Progranulin,28121,129,0.91 [0.48-1.72],0.7650683842676863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRP,Gastrin-releasing peptide,23885,117,0.79 [0.57-1.10],0.1557425391164041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRPEL1,"GrpE protein homolog 1, mitochondrial",28150,131,1.13 [0.89-1.44],0.3153086781871543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRSF1,G-rich sequence factor 1,23562,117,0.80 [0.63-1.01],0.0650093222303805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSAP,Gamma-secretase-activating protein,27585,127,1.01 [0.84-1.21],0.8949492244216405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSN,Gelsolin,24492,120,0.51 [0.21-1.23],0.1347142379556367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSR,"Glutathione reductase, mitochondrial",24460,120,0.64 [0.29-1.39],0.2605101704014491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTA1,Glutathione S-transferase A1,28239,131,1.05 [0.88-1.26],0.5590066589271445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTA3,Glutathione S-transferase A3,27585,127,1.01 [0.82-1.23],0.9593068294542324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTM4,Glutathione S-transferase Mu 4,23789,116,0.98 [0.76-1.27],0.8890270650616563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTP1,Glutathione S-transferase P,27427,125,0.96 [0.76-1.21],0.7529200316665563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTT2B,Glutathione S-transferase theta-2B,24496,120,0.98 [0.91-1.05],0.5595579787089068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24115,121,1.18 [0.98-1.43],0.083976859194837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GTPBP2,GTP-binding protein 2,23882,119,0.86 [0.69-1.08],0.1912563806135074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GUCA2A,Guanylin,28128,129,1.36 [0.84-2.19],0.2110567898604044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GUCY2C,Heat-stable enterotoxin receptor,24115,121,1.09 [0.90-1.32],0.3785927286754993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GUK1,Guanylate kinase,23789,116,1.23 [0.87-1.75],0.234301959231197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GUSB,Beta-glucuronidase,28381,129,1.16 [0.90-1.49],0.2591750825627871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GYS1,"Glycogen [starch] synthase, muscle",27774,125,0.92 [0.77-1.09],0.3119327090572383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GZMA,Granzyme A,28613,132,0.79 [0.50-1.24],0.2967514786574481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GZMB,Granzyme B,28257,133,0.89 [0.70-1.14],0.365340227269066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GZMH,Granzyme H,27774,125,1.03 [0.84-1.26],0.7969453430920062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,H2AP,Huntingtin-interacting protein M,23697,117,0.76 [0.48-1.20],0.2413009396680885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23789,116,1.11 [0.88-1.41],0.3755217811438672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28455,133,1.17 [0.96-1.43],0.1246834148785349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HAO1,Hydroxyacid oxidase 1,28529,133,1.05 [0.93-1.18],0.4227009050029435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HARS1,"Histidine--tRNA ligase, cytoplasmic",28263,129,0.93 [0.77-1.14],0.4965380740319033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HAVCR1,Hepatitis A virus cellular receptor 1,28492,133,1.57 [1.26-1.96],4.836516029817073e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HAVCR2,Hepatitis A virus cellular receptor 2,28263,129,0.86 [0.54-1.36],0.5163590248892294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HBEGF,Proheparin-binding EGF-like growth factor,28455,133,0.88 [0.71-1.08],0.2122034622182567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HBQ1,Hemoglobin subunit theta-1,28529,133,1.19 [0.95-1.50],0.1314320212963642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HBZ,Hemoglobin subunit zeta,24567,122,1.11 [0.95-1.29],0.1957694436421578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HCG22,Protein PBMUCL2,23789,116,1.05 [0.78-1.41],0.755053475520491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HCLS1,Hematopoietic lineage cell-specific protein,28613,132,0.90 [0.69-1.18],0.4432241762787683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDAC8,Histone deacetylase 8,23868,118,1.03 [0.78-1.34],0.8493534967579314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDAC9,Histone deacetylase 9,23785,114,0.89 [0.64-1.22],0.4579278934528704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDDC2,5'-deoxynucleotidase HDDC2,24472,121,1.11 [0.76-1.62],0.5848875255803909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDGF,Hepatoma-derived growth factor,28497,133,1.02 [0.87-1.20],0.8174231982863797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDGFL2,Hepatoma-derived growth factor-related protein 2,24496,120,0.94 [0.72-1.24],0.6811031363635999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEBP1,Heme-binding protein 1,27774,125,1.31 [1.07-1.60],0.0090258370048481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEG1,Protein HEG homolog 1,24019,120,1.99 [1.05-3.75],0.0337136124087553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEPACAM2,HEPACAM family member 2,24496,120,0.99 [0.66-1.50],0.9653931819784464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEPH,Hephaestin,24567,122,1.93 [0.99-3.77],0.0538838322743717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEXIM1,Protein HEXIM1,28257,133,0.94 [0.78-1.13],0.5034680441712643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HGF,Hepatocyte growth factor,28613,132,1.16 [0.75-1.80],0.5052845364868185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HGFAC,Hepatocyte growth factor activator,24363,118,0.87 [0.47-1.61],0.6508350836432417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27585,127,0.99 [0.81-1.21],0.9212669640272884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HHEX,Hematopoietically-expressed homeobox protein HHEX,24496,120,0.87 [0.70-1.09],0.2339813364993567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HIF1A,Hypoxia-inducible factor 1-alpha,23868,118,0.86 [0.64-1.17],0.3424902789606814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HIP1,Huntingtin-interacting protein 1,23789,116,0.82 [0.46-1.46],0.5075158399064963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HIP1R,Huntingtin-interacting protein 1-related protein,24459,119,0.99 [0.66-1.48],0.9571217363564736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HJV,Hemojuvelin,24531,120,0.81 [0.53-1.25],0.3409786964865921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HK2,Hexokinase-2,27774,125,1.01 [0.57-1.79],0.980542863280394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24531,120,1.26 [0.74-2.16],0.3977006345135814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",28165,133,0.84 [0.54-1.29],0.4208273189852749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",28257,133,0.99 [0.56-1.72],0.9588229047728684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMBS,Porphobilinogen deaminase,28529,133,1.39 [0.98-1.97],0.0611503632224616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMCN2,Hemicentin-2,23972,120,1.05 [0.78-1.43],0.7375071702580207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23885,117,0.79 [0.55-1.15],0.218894198038485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23789,116,0.86 [0.56-1.32],0.4783764043651206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMMR,Hyaluronan mediated motility receptor,23657,116,0.78 [0.51-1.19],0.2468855267892085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMOX1,Heme oxygenase 1,27958,129,1.21 [0.88-1.67],0.2439538218130816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMOX2,Heme oxygenase 2,27604,125,0.88 [0.62-1.26],0.485200426004341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HNF1A,Hepatocyte nuclear factor 1-alpha,23882,119,0.84 [0.63-1.14],0.2637989732755369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HNMT,Histamine N-methyltransferase,27945,127,0.89 [0.63-1.25],0.5018919331113576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27674,124,1.05 [0.86-1.29],0.6021037965605718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24531,120,1.16 [0.84-1.60],0.3626099806793182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HPCAL1,Hippocalcin-like protein 1,28613,132,0.89 [0.73-1.08],0.2335436032105253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HPGDS,Hematopoietic prostaglandin D synthase,27585,127,0.62 [0.40-0.96],0.0307328218525781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HPSE,Heparanase,24243,122,0.88 [0.74-1.05],0.159971812293081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HRAS,GTPase Hras,24081,121,1.00 [0.84-1.20],0.9748400928904012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23885,117,0.73 [0.41-1.28],0.269223027714877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HRG,Histidine-rich glycoprotein,24473,122,1.37 [0.81-2.31],0.2422033434504786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HS1BP3,HCLS1-binding protein 3,23885,117,0.87 [0.71-1.06],0.1624445660763357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,28150,131,1.01 [0.67-1.51],0.9624044482280296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28529,133,0.98 [0.63-1.53],0.9277391295930264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23868,118,1.17 [0.69-1.99],0.5559453752652102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSBP1,Heat shock factor-binding protein 1,23885,117,1.01 [0.84-1.22],0.8977846189916456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,28257,133,0.56 [0.38-0.81],0.0022536502716425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24496,120,1.07 [0.81-1.41],0.6380796298812947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23789,116,0.99 [0.69-1.44],0.9778724719282146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23885,117,0.77 [0.53-1.13],0.1893130106343042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSP90B1,Endoplasmin,27475,124,1.01 [0.80-1.27],0.9505342683772025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPA1A,Heat shock 70 kDa protein 1A,28345,130,0.94 [0.75-1.16],0.5459591105770533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPA2,Heat shock-related 70 kDa protein 2,24451,121,0.96 [0.57-1.61],0.8760801248981198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPB1,Heat shock protein beta-1,27805,125,0.95 [0.76-1.19],0.6412792161579246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPB6,Heat shock protein beta-6,28529,133,1.18 [0.80-1.75],0.4012521263465456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28043,127,0.75 [0.39-1.44],0.386936658463279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HTR1A,5-hydroxytryptamine receptor 1A,23785,114,0.90 [0.70-1.17],0.4467082046432101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HTR1B,5-hydroxytryptamine receptor 1B,23785,114,0.77 [0.48-1.24],0.2894705707124967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HTRA2,"Serine protease HTRA2, mitochondrial",28342,129,0.95 [0.74-1.22],0.6730844112472778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HYAL1,Hyaluronidase-1,28087,127,0.90 [0.45-1.78],0.7579619012362917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HYOU1,Hypoxia up-regulated protein 1,28628,130,0.68 [0.34-1.38],0.2906693413484742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICA1,Islet cell autoantigen 1,27752,127,0.96 [0.78-1.17],0.6627078123844534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM1,Intercellular adhesion molecule 1,28142,128,0.93 [0.53-1.60],0.7810954796638089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM2,Intercellular adhesion molecule 2,28628,130,0.92 [0.56-1.50],0.7437736508579598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM3,Intercellular adhesion molecule 3,28628,130,1.01 [0.55-1.83],0.9855917948747822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM4,Intercellular adhesion molecule 4,28257,133,1.02 [0.77-1.37],0.8791492828761445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM5,Intercellular adhesion molecule 5,28278,131,0.94 [0.67-1.31],0.701605335334029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICOSLG,ICOS ligand,28150,131,0.60 [0.27-1.34],0.2129249124974408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ID4,DNA-binding protein inhibitor ID-4,24115,121,1.09 [0.76-1.56],0.6324211571689966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27604,125,0.78 [0.54-1.12],0.1763089863411841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IDO1,"Indoleamine 2,3-dioxygenase 1",23885,117,0.85 [0.64-1.12],0.2499680333925542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IDS,Iduronate 2-sulfatase,28613,132,1.17 [0.20-6.78],0.8588314387421281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IDUA,Alpha-L-iduronidase,28529,133,1.35 [0.97-1.89],0.0757192032003503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23897,120,1.17 [0.75-1.83],0.480082840062432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24115,121,0.97 [0.69-1.37],0.8752676387812659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24115,121,0.91 [0.57-1.45],0.6873100766582138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNAR1,Interferon alpha/beta receptor 1,24472,121,1.26 [0.67-2.37],0.4813900232165177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNG,Interferon gamma,27752,127,0.91 [0.80-1.04],0.1736128805009588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNGR1,Interferon gamma receptor 1,28400,130,0.72 [0.33-1.56],0.4041474809678622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNGR2,Interferon gamma receptor 2,28081,128,1.07 [0.80-1.42],0.6676184655132678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNL1,Interferon lambda-1,27604,125,0.81 [0.56-1.16],0.2471045600206587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNL2,Interferon lambda-2,23785,114,1.01 [0.76-1.34],0.9415521318525886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNLR1,Interferon lambda receptor 1,28257,133,0.99 [0.65-1.50],0.9583397725114492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNW1,Interferon omega-1,23789,116,0.73 [0.41-1.32],0.3027452981443008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFT20,Intraflagellar transport protein 20 homolog,23882,119,0.58 [0.37-0.91],0.0177074520526138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGBP1,Immunoglobulin-binding protein 1,24531,120,1.11 [0.84-1.47],0.4578321013525777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23785,114,0.97 [0.66-1.42],0.878950085434371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24559,122,0.79 [0.41-1.52],0.4778360325606953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGF1R,Insulin-like growth factor 1 receptor,28150,131,1.38 [0.74-2.56],0.3118465056449723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23789,116,0.85 [0.55-1.29],0.4414353306472265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGF2R,Cation-independent mannose-6-phosphate receptor,28263,129,1.56 [0.81-3.02],0.182240838059251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP1,Insulin-like growth factor-binding protein 1,28581,130,0.89 [0.79-1.01],0.0769569346845792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP2,Insulin-like growth factor-binding protein 2,28574,130,1.01 [0.79-1.29],0.9217046627895208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP3,Insulin-like growth factor-binding protein 3,28359,128,1.26 [0.72-2.22],0.4211470211347951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP4,Insulin-like growth factor-binding protein 4,27903,123,1.22 [0.82-1.81],0.332455039214422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP6,Insulin-like growth factor-binding protein 6,28145,128,1.05 [0.60-1.82],0.8678578175614962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP7,Insulin-like growth factor-binding protein 7,28628,130,0.75 [0.43-1.31],0.3138715456777677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBPL1,Insulin-like growth factor-binding protein-like 1,28278,131,0.94 [0.58-1.50],0.7843111741377093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFL4,Insulin growth factor-like family member 4,23868,118,0.99 [0.78-1.26],0.9407461387319576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGHMBP2,DNA-binding protein SMUBP-2,23789,116,0.88 [0.63-1.22],0.4341437057388208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGLC2,Immunoglobulin lambda constant 2,24567,122,1.68 [1.18-2.40],0.0041644197967586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGLON5,IgLON family member 5,23697,117,0.84 [0.66-1.08],0.175588120697927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGSF21,Immunoglobulin superfamily member 21,23885,117,1.08 [0.70-1.68],0.7232643374349739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGSF3,Immunoglobulin superfamily member 3,28150,131,1.39 [0.94-2.05],0.0955518088305809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGSF8,Immunoglobulin superfamily member 8,28278,131,0.79 [0.47-1.32],0.3684657463727062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGSF9,Protein turtle homolog A,24567,122,1.10 [0.90-1.35],0.344431252402262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IKBKG,NF-kappa-B essential modulator,28257,133,0.91 [0.77-1.07],0.2640438523803644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IKZF2,Zinc finger protein Helios,27585,127,0.96 [0.80-1.14],0.617753543668129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL10,Interleukin-10,27752,127,1.07 [0.89-1.28],0.496692444034491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL10RA,Interleukin-10 receptor subunit alpha,27752,127,1.13 [0.90-1.43],0.2861071563484206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL10RB,Interleukin-10 receptor subunit beta,28400,130,0.75 [0.43-1.31],0.3184966275155437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL11,Interleukin-11,27752,127,0.90 [0.68-1.18],0.4319332880978236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL12A_IL12B,Interleukin-12,28150,131,0.96 [0.78-1.19],0.7336608728449265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL12B,Interleukin-12 subunit beta,28613,132,0.95 [0.71-1.26],0.7115747827634302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL12RB1,Interleukin-12 receptor subunit beta-1,27752,127,1.18 [0.78-1.79],0.4331993289055341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL12RB2,Interleukin-12 receptor subunit beta-2,23868,118,1.04 [0.69-1.57],0.8549918847098497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL13,Interleukin-13,27752,127,0.89 [0.62-1.28],0.5416117723150373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL13RA1,Interleukin-13 receptor subunit alpha-1,27897,127,0.56 [0.32-1.00],0.0488537877236662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL13RA2,Interleukin-13 receptor subunit alpha-2,23785,114,1.01 [0.54-1.88],0.9822181794858108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL15,Interleukin-15,28257,133,1.02 [0.64-1.62],0.9336839128461992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL15RA,Interleukin-15 receptor subunit alpha,27752,127,1.06 [0.67-1.67],0.7990842412068938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL16,Pro-interleukin-16,28613,132,0.90 [0.62-1.30],0.5575572091799486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17A,Interleukin-17A,27708,127,0.79 [0.53-1.19],0.263564708490886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17C,Interleukin-17C,27752,127,1.15 [0.93-1.42],0.2104234574898721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17D,Interleukin-17D,27752,127,0.99 [0.61-1.60],0.9618295726633608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17F,Interleukin-17F,27752,127,0.99 [0.81-1.21],0.9383586023810648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17RA,Interleukin-17 receptor A,28263,129,0.75 [0.54-1.05],0.095595004485055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17RB,Interleukin-17 receptor B,27889,133,0.88 [0.66-1.17],0.3897927417137198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL18,Interleukin-18,28155,128,1.22 [0.89-1.68],0.2111797201022281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL18BP,Interleukin-18-binding protein,28359,128,0.93 [0.55-1.56],0.7740319949183109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL18R1,Interleukin-18 receptor 1,28613,132,1.66 [1.07-2.59],0.0235668213362947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL18RAP,Interleukin-18 receptor accessory protein,27900,127,0.99 [0.90-1.08],0.8005048892839026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL19,Interleukin-19,27579,127,1.01 [0.80-1.26],0.9524557158244846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1A,Interleukin-1 alpha,27752,127,0.87 [0.63-1.20],0.395853916940579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1B,Interleukin-1 beta,27612,127,0.84 [0.63-1.14],0.2639783533235558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1R1,Interleukin-1 receptor type 1,28212,129,1.91 [0.98-3.74],0.0569390993723582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1R2,Interleukin-1 receptor type 2,28208,128,1.33 [0.60-2.94],0.4767114683594394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1RAP,Interleukin-1 receptor accessory protein,28263,129,0.99 [0.69-1.42],0.9451285956936232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1RL1,Interleukin-1 receptor-like 1,28526,129,1.22 [0.87-1.71],0.2409370127163327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1RL2,Interleukin-1 receptor-like 2,27752,127,0.90 [0.61-1.33],0.5982110635954868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1RN,Interleukin-1 receptor antagonist protein,28203,130,1.02 [0.77-1.35],0.8689917439395523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL2,Interleukin-2,27752,127,0.97 [0.58-1.60],0.8973248712128965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL20,Interleukin-20,27752,127,0.79 [0.55-1.15],0.2198740714573144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL20RA,Interleukin-20 receptor subunit alpha,27752,127,0.81 [0.54-1.21],0.3013578277521908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL20RB,Interleukin-20 receptor subunit beta,23868,118,0.98 [0.65-1.48],0.9305132066384252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL21R,Interleukin-21 receptor,23868,118,1.03 [0.75-1.42],0.8419831986804074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL22,Interleukin-22,24451,121,1.09 [0.85-1.40],0.5026858111234306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL22RA1,Interleukin-22 receptor subunit alpha-1,27752,127,0.96 [0.66-1.40],0.8419413202102333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL24,Interleukin-24,27752,127,1.01 [0.73-1.41],0.9472583303786112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL25,Interleukin-25,23612,117,0.76 [0.45-1.26],0.2868311442116574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL2RA,Interleukin-2 receptor subunit alpha,28097,126,0.86 [0.58-1.28],0.4604631017939925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL2RB,Interleukin-2 receptor subunit beta,27752,127,1.16 [0.79-1.70],0.4442819058770669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL2RG,Cytokine receptor common subunit gamma,24451,121,0.84 [0.51-1.41],0.5180480684702274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL3,Interleukin-3,23697,117,1.01 [0.75-1.37],0.9260438321705786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL31,Interleukin-31,23868,118,0.80 [0.55-1.15],0.2227908941848346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL31RA,Interleukin-31 receptor subunit alpha,23783,118,1.11 [0.72-1.71],0.6310265331677507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL32,Interleukin-32,28257,133,0.66 [0.46-0.97],0.0338930551870069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL33,Interleukin-33,27752,127,0.74 [0.50-1.10],0.1404707533580715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL34,Interleukin-34,27554,125,0.94 [0.60-1.46],0.7694308646477143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL36A,Interleukin-36 alpha,23868,118,0.84 [0.59-1.19],0.3272742474550226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL36G,Interleukin-36 gamma,23788,118,0.83 [0.62-1.12],0.2248598263733067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL3RA,Interleukin-3 receptor subunit alpha,27752,127,0.85 [0.51-1.41],0.5310181550398126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL4,Interleukin-4,27752,127,0.94 [0.80-1.11],0.4831475164118427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL4R,Interleukin-4 receptor subunit alpha,28257,133,0.86 [0.56-1.34],0.5156449087885826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL5,Interleukin-5,27752,127,1.01 [0.91-1.13],0.8137886044028084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL5RA,Interleukin-5 receptor subunit alpha,28257,133,1.03 [0.78-1.36],0.8384884877224253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL6,Interleukin-6,28150,131,0.99 [0.80-1.23],0.9530242079617732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL6R,Interleukin-6 receptor subunit alpha,28086,128,0.96 [0.61-1.51],0.8470256999023125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL6ST,Interleukin-6 receptor subunit beta,28278,131,1.37 [0.58-3.26],0.4770364509945003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL7,Interleukin-7,28257,133,0.88 [0.70-1.12],0.294872562318501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL7R,Interleukin-7 receptor subunit alpha,28263,129,1.15 [0.85-1.55],0.3639611628932032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL9,Interleukin-9,24115,121,1.06 [0.79-1.42],0.7046325240846381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27565,124,0.78 [0.58-1.04],0.0962073459969794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IMMT,MICOS complex subunit MIC60,24451,121,0.98 [0.66-1.44],0.9068931382082912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IMPA1,Inositol monophosphatase 1,28081,128,1.05 [0.82-1.36],0.6796308103259944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IMPACT,Protein IMPACT,24496,120,0.96 [0.70-1.31],0.7894157861139692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IMPG1,Interphotoreceptor matrix proteoglycan 1,23785,114,1.18 [0.68-2.06],0.5601068677438277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ING1,Inhibitor of growth protein 1,27554,124,0.82 [0.56-1.20],0.3052322136594122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INHBB,Inhibin beta B chain,24019,120,1.14 [0.81-1.59],0.4627776399916439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INHBC,Inhibin beta C chain,28263,129,1.23 [0.84-1.80],0.2779636611784061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INPP1,Inositol polyphosphate 1-phosphatase,28150,131,0.78 [0.58-1.04],0.0906655174289226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23885,117,1.08 [0.80-1.47],0.603435075227024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24531,120,1.05 [0.71-1.57],0.7956647782234838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",28150,131,0.91 [0.78-1.07],0.2633507672630492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INSL3,Insulin-like 3,24496,120,0.94 [0.74-1.18],0.5743344655284084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INSL4,Early placenta insulin-like peptide,24451,121,1.09 [0.80-1.48],0.5787414505278237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INSL5,Insulin-like peptide INSL5,24472,121,1.05 [0.88-1.25],0.6231501777417456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INSR,Insulin receptor,23868,118,0.78 [0.27-2.28],0.6541213679002433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IPCEF1,Interactor protein for cytohesin exchange factors 1,28032,128,1.01 [0.85-1.20],0.9457061231992032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IQGAP2,Ras GTPase-activating-like protein IQGAP2,28150,131,1.00 [0.76-1.32],0.9947029636893944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27774,125,0.84 [0.69-1.02],0.0733478164823613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IRAK1,Interleukin-1 receptor-associated kinase 1,27752,127,0.94 [0.75-1.18],0.5869054812294738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IRAK4,Interleukin-1 receptor-associated kinase 4,28257,133,0.98 [0.85-1.13],0.7904351657002981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27187,122,1.16 [0.75-1.78],0.500886199478092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ISM1,Isthmin-1,28257,133,1.02 [0.69-1.49],0.9379266725952748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ISM2,Isthmin-2,24559,122,0.76 [0.50-1.17],0.2084320323109814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IST1,IST1 homolog,24295,121,0.97 [0.81-1.15],0.6922963551856884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGA11,Integrin alpha-11,28257,133,0.94 [0.60-1.47],0.7769189534416693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGA2,Integrin alpha-2,24019,120,0.78 [0.47-1.30],0.3413791975843462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGA5,Integrin alpha-5,28263,129,0.86 [0.46-1.61],0.6360044686426183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGA6,Integrin alpha-6,28257,133,0.84 [0.62-1.13],0.2431750666731026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGAL,Integrin alpha-L,23868,118,0.90 [0.61-1.33],0.5984097783997215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGAM,Integrin alpha-M,28263,129,1.25 [0.77-2.02],0.360861333747007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGAV,Integrin alpha-V,28529,133,0.95 [0.38-2.38],0.9169961280512964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGAX,Integrin alpha-X,24115,121,0.99 [0.71-1.38],0.951286143294662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB1,Integrin beta-1,28219,128,0.77 [0.37-1.60],0.481901452129734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB1BP1,Integrin beta-1-binding protein 1,27585,127,0.75 [0.51-1.11],0.1493232674521084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB1BP2,Integrin beta-1-binding protein 2,27774,125,0.95 [0.82-1.09],0.4418049049837401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB2,Integrin beta-2,28106,127,1.23 [0.72-2.10],0.4519606849960517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB5,Integrin beta-5,28342,129,0.72 [0.47-1.09],0.1205782784502329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB6,Integrin beta-6,27752,127,0.89 [0.53-1.52],0.675997821293856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB7,Integrin beta-7,28529,133,0.97 [0.70-1.36],0.8788170774211399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGBL1,Integrin beta-like protein 1,24559,122,0.91 [0.56-1.48],0.6904564013055039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24605,122,1.37 [0.59-3.18],0.46622299439816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28359,128,1.08 [0.72-1.61],0.7190613703293416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24605,122,0.95 [0.49-1.81],0.8659947551379196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24451,121,1.00 [0.68-1.47],0.9823763770813936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITM2A,Integral membrane protein 2A,28257,133,1.10 [0.85-1.42],0.4693497364557211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITPA,Inosine triphosphate pyrophosphatase,23789,116,1.18 [0.91-1.52],0.2072208482934465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23885,117,1.10 [0.86-1.39],0.4490564191426901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23785,114,1.06 [0.74-1.53],0.7504392936316303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27604,125,1.02 [0.73-1.41],0.921885693245271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IZUMO1,Izumo sperm-egg fusion protein 1,23697,117,1.04 [0.73-1.47],0.8384319408737388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JAM2,Junctional adhesion molecule B,28543,133,1.17 [0.64-2.13],0.6155634380283773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JAM3,Junctional adhesion molecule C,24019,120,0.71 [0.49-1.03],0.0675825272355562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JCHAIN,Immunoglobulin J chain,27752,127,1.27 [0.98-1.65],0.0653229684200481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23697,117,1.04 [0.77-1.42],0.786984231634847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JPT2,Jupiter microtubule associated homolog 2,24472,121,0.95 [0.78-1.15],0.5768707497483945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JUN,Transcription factor AP-1,27752,127,1.03 [0.76-1.39],0.8465425453635951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,28150,131,1.06 [0.75-1.51],0.7285252924551812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KAZN,Kazrin,24472,121,0.85 [0.73-1.00],0.0570887108094131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KCNC4,Potassium voltage-gated channel subfamily C member 4,23785,114,1.03 [0.75-1.42],0.8441697307462837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KCNH2,Potassium voltage-gated channel subfamily H member 2,23882,119,0.90 [0.69-1.17],0.4262481412187875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KCNIP4,Kv channel-interacting protein 4,27604,125,1.03 [0.76-1.39],0.8382408430821386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KCTD5,BTB/POZ domain-containing protein KCTD5,24022,114,0.85 [0.56-1.30],0.4515377509976818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KDM3A,Lysine-specific demethylase 3A,23868,118,1.10 [0.93-1.29],0.2525338750324357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KDR,Vascular endothelial growth factor receptor 2,28342,129,1.11 [0.60-2.03],0.7434377992230331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KEL,Kell blood group glycoprotein,27604,125,0.86 [0.55-1.33],0.4894402486444547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KHDC3L,KH domain-containing protein 3,23697,117,0.97 [0.74-1.28],0.8332170698287302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KHK,Ketohexokinase,23885,117,0.90 [0.69-1.19],0.4714099990349039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIAA0319,Dyslexia-associated protein KIAA0319,24496,120,0.99 [0.56-1.75],0.9621593584344628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIAA1549,UPF0606 protein KIAA1549,24115,121,1.14 [0.90-1.45],0.2870624551103681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIAA1549L,UPF0606 protein KIAA1549L,24115,121,1.01 [0.54-1.88],0.9864296272083262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIAA2013,Uncharacterized protein KIAA2013,24451,121,0.95 [0.69-1.31],0.746664892968945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIF1C,Kinesin-like protein KIF1C,23789,116,1.57 [1.14-2.15],0.0053541110722406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIF20B,Kinesin-like protein KIF20B,23785,114,1.05 [0.83-1.32],0.6854155429516686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIF22,Kinesin-like protein KIF22,23789,116,0.92 [0.79-1.06],0.2304921778131462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIFBP,KIF-binding protein,28150,131,0.93 [0.78-1.12],0.4549069567014792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24451,121,0.96 [0.78-1.17],0.6787707812726189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27585,127,0.86 [0.70-1.07],0.1722247656897194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24472,121,1.03 [0.94-1.14],0.5164577549422005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27585,127,1.13 [0.99-1.28],0.0675795449498926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23697,117,0.97 [0.78-1.21],0.7982602470317899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIRREL1,Kin of IRRE-like protein 1,23785,114,1.26 [1.02-1.56],0.0354236525881845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIRREL2,Kin of IRRE-like protein 2,27604,125,0.62 [0.42-0.93],0.0193564861585208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIT,Mast/stem cell growth factor receptor Kit,28324,128,0.89 [0.53-1.50],0.6578264420204828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KITLG,Kit ligand,28278,131,1.01 [0.67-1.54],0.9441132896480148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLB,Beta-klotho,27604,125,1.03 [0.83-1.27],0.8030564847515897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLF4,Krueppel-like factor 4,23785,114,0.98 [0.62-1.53],0.9129873565450136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLHL41,Kelch-like protein 41,24531,120,1.11 [0.81-1.53],0.5284075932403758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK1,Kallikrein-1,27989,129,1.11 [0.99-1.25],0.0800773668829714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK10,Kallikrein-10,28254,129,1.08 [0.73-1.59],0.6964042245485575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK11,Kallikrein-11,28066,128,1.01 [0.59-1.72],0.9691867507362768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK12,Kallikrein-12,27585,127,0.99 [0.88-1.11],0.8836961926410049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK13,Kallikrein-13,27630,130,1.07 [0.75-1.53],0.6997866714432392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK14,Kallikrein-14,28529,133,0.90 [0.65-1.25],0.5165105589223233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK15,Kallikrein-15,24413,121,1.11 [0.78-1.58],0.5598581512210207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK3,Prostate-specific antigen,24559,122,0.85 [0.68-1.06],0.1448319620863909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK4,Kallikrein-4,28529,133,1.05 [0.82-1.34],0.7013209886319729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK6,Kallikrein-6,28303,128,0.91 [0.55-1.53],0.7355616263410026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK7,Kallikrein-7,23395,120,0.71 [0.45-1.12],0.1422974627275874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK8,Kallikrein-8,27312,125,0.73 [0.46-1.15],0.1717634506660612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLKB1,Plasma kallikrein,24125,122,1.78 [0.95-3.33],0.0712717834239045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28613,132,1.10 [0.73-1.65],0.6462817005411076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23785,114,1.11 [0.86-1.45],0.423388915501434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRD1,Natural killer cells antigen CD94,28613,132,1.00 [0.72-1.39],0.987626188150455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23868,118,1.04 [0.71-1.51],0.8442886295468797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRK1,NKG2-D type II integral membrane protein,24496,120,0.93 [0.64-1.37],0.7235985482808479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT14,"Keratin, type I cytoskeletal 14",26723,123,0.90 [0.51-1.60],0.7170376646679382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT17,"Keratin, type I cytoskeletal 17",23789,116,0.89 [0.55-1.45],0.6506657099403521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT18,"Keratin, type I cytoskeletal 18",28150,131,1.07 [0.89-1.29],0.4550450702104528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT19,"Keratin, type I cytoskeletal 19",28219,133,1.03 [0.82-1.31],0.77575500909153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT5,"Keratin, type II cytoskeletal 5",27604,125,0.79 [0.56-1.10],0.1592256013440171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT6C,"Keratin, type II cytoskeletal 6C",23789,116,0.58 [0.32-1.02],0.0589810616679047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT8,"Keratin, type II cytoskeletal 8",23785,114,0.94 [0.71-1.26],0.6984468696158401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KYAT1,Kynurenine--oxoglutarate transaminase 1,28223,130,0.91 [0.69-1.19],0.4771921124122646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KYNU,Kynureninase,28613,132,0.84 [0.60-1.18],0.3195083206272679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,L1CAM,Neural cell adhesion molecule L1,28342,129,1.20 [0.70-2.04],0.5041988978376045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24567,122,0.93 [0.76-1.12],0.4328073923459182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LACRT,Extracellular glycoprotein lacritin,24406,120,0.93 [0.64-1.35],0.7032555595404244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LACTB2,Endoribonuclease LACTB2,28278,131,0.93 [0.73-1.17],0.522525264062657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAG3,Lymphocyte activation gene 3 protein,28150,131,1.43 [1.03-1.98],0.0314332658217832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,28255,128,1.02 [0.70-1.49],0.9290003714897428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,28081,128,0.94 [0.81-1.08],0.3813326490017952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMA1,Laminin subunit alpha-1,23789,116,1.19 [0.91-1.56],0.2111732285652031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMA4,Laminin subunit alpha-4,28400,130,0.73 [0.45-1.17],0.1858448926776258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMB1,Laminin subunit beta-1,23885,117,1.04 [0.58-1.87],0.8837529137789593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMP1,Lysosome-associated membrane glycoprotein 1,23894,121,1.16 [0.69-1.98],0.5735676154277893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMP2,Lysosome-associated membrane glycoprotein 2,27419,129,1.81 [0.80-4.13],0.1571870699940608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMP3,Lysosome-associated membrane glycoprotein 3,28562,132,0.75 [0.55-1.01],0.0620735316491856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMTOR5,Ragulator complex protein LAMTOR5,24451,121,0.60 [0.37-0.97],0.0381803028620777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAP3,Cytosol aminopeptidase,27752,127,0.98 [0.71-1.35],0.8975905433917807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LARP1,La-related protein 1,24451,121,1.14 [0.89-1.46],0.3114487448028701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAT,Linker for activation of T-cells family member 1,28613,132,0.91 [0.75-1.11],0.3481127765414096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAT2,Linker for activation of T-cells family member 2,28150,131,0.97 [0.86-1.10],0.6727234935894204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LATS1,Serine/threonine-protein kinase LATS1,23868,118,0.99 [0.81-1.22],0.9230511449099306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAYN,Layilin,28031,127,1.02 [0.63-1.64],0.9466798248255612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LBP,Lipopolysaccharide-binding protein,28359,128,0.95 [0.73-1.24],0.7040341774807468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LBR,Delta(14)-sterol reductase LBR,28543,133,0.90 [0.72-1.14],0.4012832624068437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LCAT,Phosphatidylcholine-sterol acyltransferase,24594,120,1.64 [0.74-3.64],0.2233546738623333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LCN15,Lipocalin-15,24531,120,1.20 [0.94-1.52],0.1398731428567562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LCN2,Neutrophil gelatinase-associated lipocalin,27381,125,0.86 [0.55-1.32],0.4847362772092433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LCP1,Plastin-2,24559,122,0.72 [0.49-1.05],0.0850889147166689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LDLR,Low-density lipoprotein receptor,28354,127,0.81 [0.60-1.09],0.156583235012314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24531,120,0.88 [0.74-1.05],0.1451057956653823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LECT2,Leukocyte cell-derived chemotaxin-2,24567,122,0.90 [0.69-1.18],0.4647163149354533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEFTY2,Left-right determination factor 2,28492,133,0.91 [0.68-1.21],0.5090217669001764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEG1,Protein LEG1 homolog,23167,114,1.24 [0.97-1.58],0.0817319818565095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LELP1,Late cornified envelope-like proline-rich protein 1,23785,114,1.08 [0.86-1.35],0.5276585835371652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEO1,RNA polymerase-associated protein LEO1,24531,120,0.95 [0.52-1.74],0.863759240777007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEP,Leptin,28278,131,0.95 [0.76-1.19],0.6592437747428816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEPR,Leptin receptor,28278,131,1.32 [0.82-2.12],0.2563782903372708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LETM1,Mitochondrial proton/calcium exchanger protein,24531,120,1.07 [0.78-1.47],0.6612734041146563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS1,Galectin-1,28278,131,0.88 [0.55-1.40],0.5840722499046902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS3,Galectin-3,28349,127,1.18 [0.70-1.98],0.5318255530922587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS3BP,Galectin-3-binding protein,24605,122,0.97 [0.55-1.70],0.9079587495535784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS4,Galectin-4,28255,128,1.36 [1.03-1.79],0.0281011979962952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS7_LGALS7B,Galectin-7,28223,132,0.66 [0.44-0.98],0.0402323701696267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS8,Galectin-8,28543,133,0.91 [0.70-1.17],0.4409399767158962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS9,Galectin-9,28257,130,1.01 [0.62-1.65],0.9528018001352748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGMN,Legumain,28400,130,1.32 [0.87-2.00],0.1969367631317992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LHB,Lutropin subunit beta,27585,127,0.94 [0.78-1.14],0.549909415694539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,28303,130,1.08 [0.84-1.40],0.5321606876820069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LIF,Leukemia inhibitory factor,27604,125,0.67 [0.47-0.96],0.030797988304465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LIFR,Leukemia inhibitory factor receptor,28257,133,1.68 [0.93-3.01],0.0836559603402163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,28263,129,0.81 [0.56-1.18],0.2666214731533758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24559,122,1.09 [0.94-1.27],0.2577734159388292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23789,116,1.01 [0.72-1.44],0.9341740539391368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,28245,131,0.86 [0.53-1.38],0.5287845985807198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24567,122,1.12 [0.89-1.41],0.3405482965487463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28628,130,0.67 [0.39-1.17],0.1576869414512352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28472,129,0.93 [0.60-1.45],0.7510256594394085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27752,127,0.85 [0.58-1.24],0.4069619017442484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28628,130,0.98 [0.79-1.22],0.8568215944344683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LIPF,Gastric triacylglycerol lipase,23885,117,1.21 [0.91-1.61],0.1838597018003425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LMNB1,Lamin-B1,24421,121,1.02 [0.77-1.35],0.9113760450474908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LMNB2,Lamin-B2,24496,120,1.22 [0.66-2.24],0.5199022500380004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LMOD1,Leiomodin-1,24531,120,1.13 [0.71-1.79],0.6177976933923306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LMOD2,Leiomodin-2,23785,114,0.98 [0.73-1.31],0.8776209952704296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LONP1,"Lon protease homolog, mitochondrial",23885,117,0.92 [0.75-1.13],0.4509781925715621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPA,Apolipoprotein(a),24003,119,0.99 [0.90-1.09],0.8547776709906012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPCAT2,Lysophosphatidylcholine acyltransferase 2,28150,131,0.84 [0.54-1.31],0.4482664454891301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPL,Lipoprotein lipase,28278,131,0.96 [0.70-1.32],0.8122029163562597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPO,Lactoperoxidase,27369,127,1.33 [1.04-1.69],0.0237542787430467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPP,Lipoma-preferred partner,23789,116,0.83 [0.64-1.09],0.1845814425339225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23789,116,0.96 [0.74-1.24],0.7439444100481959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23882,119,0.67 [0.42-1.07],0.0903164923278717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRG1,Leucine-rich alpha-2-glycoprotein,24605,122,1.88 [1.02-3.48],0.0443055211032955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28455,133,1.01 [0.65-1.57],0.9794483967342948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23782,118,1.06 [0.58-1.93],0.8534507219085786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRP1,Prolow-density lipoprotein receptor-related protein 1,28150,131,0.76 [0.42-1.38],0.3634524002638556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRP11,Low-density lipoprotein receptor-related protein 11,28278,131,1.00 [0.65-1.55],0.9952769316030669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRP2,Low-density lipoprotein receptor-related protein 2,23882,119,0.66 [0.38-1.13],0.1295896781663283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRP2BP,LRP2-binding protein,23882,119,0.79 [0.60-1.04],0.0871616072648161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28543,133,1.15 [0.90-1.47],0.2664446695556472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRC25,Leucine-rich repeat-containing protein 25,28150,131,0.91 [0.61-1.37],0.6544267608841234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24472,121,1.10 [0.74-1.66],0.6341227852862916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRC38,Leucine-rich repeat-containing protein 38,23882,119,0.93 [0.64-1.35],0.6937905841656333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRC59,Leucine-rich repeat-containing protein 59,24567,122,0.95 [0.66-1.37],0.7814149328451987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24451,121,0.76 [0.52-1.11],0.15424732485089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRN1,Leucine-rich repeat neuronal protein 1,27752,127,0.92 [0.61-1.37],0.6790373049233949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23882,119,0.98 [0.64-1.50],0.9202607805845816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24531,120,0.73 [0.37-1.46],0.3787463111729744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LSM1,U6 snRNA-associated Sm-like protein LSm1,27585,127,0.93 [0.69-1.25],0.6261575285881973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LSM8,U6 snRNA-associated Sm-like protein LSm8,24115,121,0.98 [0.80-1.20],0.8414788876878918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LSP1,Lymphocyte-specific protein 1,28257,133,1.14 [0.79-1.64],0.4957771149957202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTA,Lymphotoxin-alpha,28257,133,0.71 [0.48-1.05],0.0863292200633313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTA4H,Leukotriene A-4 hydrolase,28529,133,0.81 [0.61-1.06],0.1203237614593141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTB,Lymphotoxin-beta,24451,121,1.07 [0.65-1.75],0.7963971808565672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTBP2,Latent-transforming growth factor beta-binding protein 2,28628,130,1.01 [0.61-1.68],0.9606107215037716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTBP3,Latent-transforming growth factor beta-binding protein 3,27585,127,0.93 [0.69-1.26],0.6471378045741158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTBR,Tumor necrosis factor receptor superfamily member 3,28100,128,0.69 [0.38-1.25],0.2209506326056597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTO1,Protein LTO1 homolog,27752,127,0.98 [0.66-1.44],0.908531591749883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LUZP2,Leucine zipper protein 2,24451,121,0.92 [0.61-1.38],0.6819284886673187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LXN,Latexin,27939,126,1.21 [0.98-1.49],0.0771555895375462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LY6D,Lymphocyte antigen 6D,28104,128,0.74 [0.47-1.17],0.1963877988111146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LY75,Lymphocyte antigen 75,28257,133,0.66 [0.45-0.97],0.0351643130782245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LY9,T-lymphocyte surface antigen Ly-9,27982,130,0.92 [0.53-1.58],0.7637163929802763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LY96,Lymphocyte antigen 96,28081,128,1.03 [0.67-1.59],0.8813713216452561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYAR,Cell growth-regulating nucleolar protein,27585,127,0.92 [0.67-1.27],0.6233117326432022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYN,Tyrosine-protein kinase Lyn,28150,131,0.99 [0.82-1.18],0.8744786922122645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYPD1,Ly6/PLAUR domain-containing protein 1,27604,125,1.12 [0.90-1.39],0.3048039841958104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYPD3,Ly6/PLAUR domain-containing protein 3,28127,128,1.28 [0.82-2.00],0.2796453945263231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYPD8,Ly6/PLAUR domain-containing protein 8,27585,127,1.13 [0.86-1.49],0.3844495168092172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYPLA2,Acyl-protein thioesterase 2,23785,114,1.00 [0.84-1.18],0.9686819664430628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23882,119,0.85 [0.70-1.04],0.1124068813689788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24605,122,1.64 [0.69-3.92],0.2638804148862456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYZL2,Lysozyme-like protein 2,23697,117,0.86 [0.51-1.44],0.5625223805576969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LZTFL1,Leucine zipper transcription factor-like protein 1,24019,120,0.94 [0.73-1.20],0.6094548750351726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,M6PR,Cation-dependent mannose-6-phosphate receptor,23885,117,0.83 [0.51-1.35],0.4513056602637624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27993,127,0.99 [0.72-1.38],0.9741583745886762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAEA,E3 ubiquitin-protein transferase MAEA,27585,127,0.96 [0.64-1.43],0.8345250837276432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAG,Myelin-associated glycoprotein,23882,119,0.71 [0.49-1.02],0.0671581044304957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAGEA3,Melanoma-associated antigen 3,24115,121,0.79 [0.68-0.92],0.0027189389995497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAGED1,Melanoma-associated antigen D1,27585,127,0.85 [0.61-1.20],0.3561444977839796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAMDC2,MAM domain-containing protein 2,24567,122,1.61 [0.99-2.61],0.056304554381349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAMDC4,Apical endosomal glycoprotein,24451,121,1.16 [0.86-1.57],0.3295408336951368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23885,117,1.01 [0.51-2.02],0.9683095632325835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAN2B2,Epididymis-specific alpha-mannosidase,24567,122,1.27 [0.94-1.70],0.1177548125407131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23697,117,0.81 [0.57-1.16],0.2531131358223146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28400,130,0.95 [0.84-1.07],0.3950026438430402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MANSC1,MANSC domain-containing protein 1,28342,129,0.91 [0.52-1.59],0.7330778790025929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MANSC4,MANSC domain-containing protein 4,23789,116,1.01 [0.77-1.34],0.9216889613048448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23785,114,0.87 [0.50-1.53],0.6346430644345082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23789,116,0.95 [0.70-1.27],0.7077781793579804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP2,Microtubule-associated protein 2,24496,120,0.85 [0.57-1.25],0.4024459964488652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24472,121,0.89 [0.68-1.16],0.381185323861868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,28257,133,0.91 [0.79-1.06],0.244380173780615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27585,127,0.87 [0.73-1.03],0.0978266995615066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,28031,127,0.97 [0.85-1.12],0.7125828933768127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPK13,Mitogen-activated protein kinase 13,23697,117,0.88 [0.57-1.34],0.5415678687824257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPK9,Mitogen-activated protein kinase 9,28257,133,0.86 [0.61-1.22],0.3976411474597003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPKAPK2,MAP kinase-activated protein kinase 2,24115,121,0.86 [0.68-1.10],0.2304506144621086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPRE3,Microtubule-associated protein RP/EB family member 3,23697,117,0.83 [0.70-0.98],0.0273866321514312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPT,Microtubule-associated protein tau,27604,125,0.99 [0.73-1.34],0.9467576375252515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MARCO,Macrophage receptor MARCO,28278,131,0.76 [0.43-1.36],0.3634623757463208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MARS1,"Methionine--tRNA ligase, cytoplasmic",23967,120,0.90 [0.73-1.10],0.2892026827678916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MASP1,Mannan-binding lectin serine protease 1,28031,127,1.84 [0.95-3.56],0.0707035831415834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MATN2,Matrilin-2,28305,130,1.16 [0.69-1.95],0.5665069958222446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MATN3,Matrilin-3,28032,128,0.64 [0.41-1.02],0.0579372213205036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAVS,Mitochondrial antiviral-signaling protein,27585,127,0.87 [0.73-1.04],0.1325032076308803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAX,Protein max,27604,125,0.86 [0.74-1.00],0.0527829002770306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MB,Myoglobin,28628,130,1.01 [0.75-1.35],0.9580832805172642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MBL2,Mannose-binding protein C,24251,122,1.10 [0.94-1.29],0.2473215156574548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCAM,Cell surface glycoprotein MUC18,28359,128,1.31 [0.83-2.06],0.2475324732865081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24531,120,1.08 [0.74-1.57],0.6795283747904499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCEMP1,Mast cell-expressed membrane protein 1,23868,118,0.92 [0.75-1.12],0.3850991487696038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCFD2,Multiple coagulation factor deficiency protein 2,28156,131,0.88 [0.62-1.24],0.4603414805135688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCTS1,Malignant T-cell-amplified sequence 1,24472,121,0.77 [0.37-1.60],0.4885739008834412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,28081,128,0.97 [0.78-1.21],0.8190409535110396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MDH1,"Malate dehydrogenase, cytoplasmic",24456,120,1.07 [0.71-1.63],0.7414034159884839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MDK,Midkine,28250,129,0.93 [0.69-1.27],0.6656398638239829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MDM1,Nuclear protein MDM1,23882,119,0.50 [0.27-0.90],0.0217326592451767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23885,117,0.92 [0.76-1.12],0.4048323146054804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MED18,Mediator of RNA polymerase II transcription subunit 18,27585,127,0.89 [0.72-1.09],0.251618335100691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MED21,Mediator of RNA polymerase II transcription subunit 21,23789,116,0.74 [0.47-1.16],0.1880880861258733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEGF10,Multiple epidermal growth factor-like domains protein 10,28255,128,1.01 [0.69-1.49],0.949808533092825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEGF11,Multiple epidermal growth factor-like domains protein 11,23789,116,0.68 [0.36-1.30],0.2432599565937955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEGF9,Multiple epidermal growth factor-like domains protein 9,28526,129,0.99 [0.47-2.08],0.9771518690039762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MELTF,Melanotransferrin,24567,122,1.28 [0.72-2.29],0.3990906036693563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MENT,Protein MENT,24019,120,1.08 [0.49-2.36],0.8516874659460002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEP1A,Meprin A subunit alpha,24472,121,1.40 [1.13-1.73],0.0023672570277865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEP1B,Meprin A subunit beta,28278,131,1.03 [0.90-1.17],0.6797158520663282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEPE,Matrix extracellular phosphoglycoprotein,28255,128,0.49 [0.29-0.84],0.0088635112275864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MERTK,Tyrosine-protein kinase Mer,28613,132,0.75 [0.41-1.37],0.3417086152989833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MESD,LRP chaperone MESD,28263,129,0.94 [0.83-1.06],0.3248267193910393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MET,Hepatocyte growth factor receptor,28358,128,0.61 [0.28-1.35],0.2270503097865236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,METAP1,Methionine aminopeptidase 1,27604,125,0.71 [0.40-1.24],0.2233171000281048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",28257,133,0.97 [0.81-1.17],0.7505081647256344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,METAP2,Methionine aminopeptidase 2,28492,133,1.00 [0.77-1.30],0.996939943236454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFAP3,Microfibril-associated glycoprotein 3,27774,125,1.40 [1.10-1.78],0.005931556983707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFAP3L,Microfibrillar-associated protein 3-like,23882,119,1.14 [0.91-1.43],0.2527548642372388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFAP4,Microfibril-associated glycoprotein 4,24019,120,1.59 [0.92-2.75],0.0967008435937608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFAP5,Microfibrillar-associated protein 5,28628,130,1.13 [0.77-1.65],0.5319294486383717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFGE8,Lactadherin,28263,129,1.40 [1.00-1.96],0.0512827174740409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MGLL,Monoglyceride lipase,28357,130,0.93 [0.78-1.10],0.3956980628638084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MGMT,Methylated-DNA--protein-cysteine methyltransferase,28257,133,0.96 [0.85-1.08],0.4675277824381709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MIA,Melanoma-derived growth regulatory protein,28342,129,0.84 [0.55-1.29],0.4353657906087733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MICALL2,MICAL-like protein 2,23882,119,0.70 [0.52-0.94],0.018624642880746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,28257,133,0.99 [0.90-1.09],0.8472028967895296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MIF,Macrophage migration inhibitory factor,28214,129,0.97 [0.77-1.21],0.774142952160061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MILR1,Allergin-1,27752,127,0.82 [0.59-1.13],0.2288481209358826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24451,121,0.88 [0.75-1.03],0.1157323063624736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MINK1,Misshapen-like kinase 1,24496,120,0.90 [0.75-1.08],0.2406183300993778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MITD1,MIT domain-containing protein 1,28081,128,0.97 [0.83-1.13],0.6851484404868624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MKI67,Proliferation marker protein Ki-67,23868,118,1.02 [0.67-1.56],0.9174793641190042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MLLT1,Protein ENL,23697,117,1.04 [0.82-1.33],0.7323202977585345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MLN,Promotilin,28257,133,0.90 [0.76-1.06],0.1961875061128506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MME,Neprilysin,28150,131,1.11 [0.92-1.34],0.2620937859236993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP1,Interstitial collagenase,27272,124,1.02 [0.86-1.21],0.8224579912840225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP10,Stromelysin-2,28227,130,0.81 [0.62-1.07],0.1378627811855452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP12,Macrophage metalloelastase,28318,133,1.10 [0.81-1.48],0.549107733754088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP13,Collagenase 3,27604,125,0.80 [0.48-1.31],0.3723980683652341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP15,Matrix metalloproteinase-15,24567,122,0.90 [0.60-1.33],0.585085700935823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP3,Stromelysin-1,28263,129,1.08 [0.78-1.48],0.6446556635532448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP7,Matrilysin,27731,125,0.91 [0.66-1.25],0.5517535005298799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP8,Neutrophil collagenase,28501,133,1.00 [0.81-1.23],0.9906809432448476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP9,Matrix metalloproteinase-9,28224,129,1.11 [0.86-1.43],0.4296579272725142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23789,116,1.18 [0.84-1.64],0.3399705755821171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MN1,Transcriptional activator MN1,23882,119,0.67 [0.46-0.98],0.0369188238573481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MNAT1,CDK-activating kinase assembly factor MAT1,24115,121,0.71 [0.45-1.10],0.1266952065727495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MNDA,Myeloid cell nuclear differentiation antigen,28239,131,1.04 [0.89-1.20],0.6495869565193004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MOCS2,Molybdopterin synthase catalytic subunit,24019,120,0.85 [0.65-1.11],0.2297874858418306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MOG,Myelin-oligodendrocyte glycoprotein,28529,133,0.88 [0.55-1.42],0.604127230064119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MORC3,MORC family CW-type zinc finger protein 3,24496,120,0.62 [0.30-1.27],0.1930276147569415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MORF4L1,Mortality factor 4-like protein 1,24115,121,1.03 [0.68-1.57],0.8910010615171566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MORF4L2,Mortality factor 4-like protein 2,23697,117,0.83 [0.50-1.40],0.4893782017022235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MORN4,MORN repeat-containing protein 4,23697,117,1.05 [0.86-1.29],0.6151088197606769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPHOSPH8,M-phase phosphoprotein 8,27774,125,1.03 [0.84-1.27],0.7831602063490705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPI,Mannose-6-phosphate isomerase,28150,131,0.92 [0.77-1.10],0.3594291515369595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28357,130,0.85 [0.71-1.03],0.093821515343583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPO,Myeloperoxidase,28263,129,1.10 [0.80-1.53],0.5610768526069558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPRIP,Myosin phosphatase Rho-interacting protein,24409,120,0.87 [0.59-1.30],0.5028512291438445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRC1,Macrophage mannose receptor 1,24594,120,1.28 [0.70-2.35],0.4170524582952939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRI1,Methylthioribose-1-phosphate isomerase,23882,119,1.08 [0.83-1.40],0.5679491987152417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL24,"39S ribosomal protein L24, mitochondrial",23789,116,1.06 [0.69-1.62],0.8001243233480426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL28,"39S ribosomal protein L28, mitochondrial",24531,120,0.68 [0.36-1.32],0.2551318606728088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL46,"39S ribosomal protein L46, mitochondrial",27604,125,0.78 [0.42-1.43],0.4152564296346264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL52,"39S ribosomal protein L52, mitochondrial",23657,116,1.64 [0.88-3.05],0.1190141287828056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24531,120,0.97 [0.76-1.24],0.806650439863237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPS16,"28S ribosomal protein S16, mitochondrial",23868,118,0.93 [0.50-1.72],0.8148184572217791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSLN,Mesothelin,28113,131,0.94 [0.70-1.26],0.685270361790459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSLNL,Mesothelin-like protein,23882,119,0.80 [0.48-1.32],0.3783003599123359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSMB,Beta-microseminoprotein,28206,129,0.85 [0.68-1.07],0.1663834236472476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSR1,Macrophage scavenger receptor types I and II,28543,133,1.11 [0.79-1.54],0.553478209451453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSRA,Mitochondrial peptide methionine sulfoxide reductase,28342,129,0.91 [0.73-1.12],0.3621574324495572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MST1,Hepatocyte growth factor-like protein,24230,118,0.94 [0.74-1.21],0.6553315367220831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSTN,Growth/differentiation factor 8,27774,125,0.85 [0.63-1.15],0.2818424281654229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTDH,Protein LYRIC,23868,118,0.90 [0.74-1.09],0.2887093680767347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24496,120,1.02 [0.52-2.00],0.9630406884247028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24115,121,0.88 [0.75-1.03],0.1102077979699226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTIF3,"Translation initiation factor IF-3, mitochondrial",24472,121,0.86 [0.71-1.05],0.1409400961053634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTPN,Myotrophin,27774,125,0.93 [0.57-1.53],0.7743478259714076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTR,Methionine synthase,23789,116,1.00 [0.76-1.32],0.9928644292792904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTSS1,Protein MTSS 1,24472,121,0.89 [0.76-1.04],0.1560316894357351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTSS2,Protein MTSS 2,24451,121,0.92 [0.78-1.10],0.3703080276767341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTUS1,Microtubule-associated tumor suppressor 1,24115,121,0.94 [0.69-1.29],0.7176505905514272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MUC13,Mucin-13,27604,125,1.64 [1.22-2.20],0.0010712970990478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MUC16,Mucin-16,28150,131,0.95 [0.88-1.03],0.2012828773200329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MUC2,Mucin-2,24559,122,1.22 [1.02-1.47],0.0282865761736955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MUCL3,Mucin-like protein 3,23697,117,1.06 [0.72-1.56],0.7608030190133395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MVK,Mevalonate kinase,27752,127,1.08 [0.89-1.31],0.4366812120523883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MXRA8,Matrix remodeling-associated protein 8,24019,120,0.49 [0.28-0.86],0.0127457564187597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYBPC1,"Myosin-binding protein C, slow-type",24567,122,1.26 [1.01-1.57],0.0406388237196665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYBPC2,"Myosin-binding protein C, fast-type",23885,117,1.14 [0.95-1.37],0.157563625008366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24531,120,0.85 [0.64-1.13],0.2580285983056151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYDGF,Myeloid-derived growth factor,24567,122,0.90 [0.76-1.07],0.2213029619891021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYH4,Myosin-4,23789,116,1.09 [0.77-1.56],0.6145256349140249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYH7B,Myosin-7B,23697,117,0.95 [0.62-1.45],0.8065641026625922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYH9,Myosin-9,24559,122,0.93 [0.79-1.08],0.3165354527305309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23789,116,1.13 [0.77-1.66],0.5437988155169688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYL3,Myosin light chain 3,23885,117,1.25 [1.00-1.57],0.0519255687624865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYL4,Myosin light chain 4,23885,117,1.32 [0.99-1.74],0.0545560224760706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYL6B,Myosin light chain 6B,23882,119,0.79 [0.62-1.00],0.0520941467069566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23882,119,1.10 [0.78-1.55],0.5768618109172727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYO6,Unconventional myosin-VI,24531,120,0.76 [0.45-1.29],0.3108294256392216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYO9B,Unconventional myosin-IXb,27752,127,0.84 [0.65-1.08],0.1809465515253993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYOC,Myocilin,28263,129,0.93 [0.66-1.30],0.6564084679195696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYOM1,Myomesin-1,23785,114,0.93 [0.62-1.39],0.7242063105362168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYOM2,Myomesin-2,23789,116,1.08 [0.78-1.50],0.6457790736718023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYOM3,Myomesin-3,24019,120,1.16 [0.97-1.39],0.0977927853749475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MZB1,Marginal zone B- and B1-cell-specific protein,28348,130,0.87 [0.63-1.19],0.3817092304361948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MZT1,Mitotic-spindle organizing protein 1,27585,127,0.78 [0.57-1.08],0.1402156520557537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAA10,N-alpha-acetyltransferase 10,23789,116,0.82 [0.58-1.16],0.2621249337441805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAA80,N-alpha-acetyltransferase 80,23882,119,0.91 [0.79-1.06],0.2234728886493664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27944,128,0.98 [0.75-1.26],0.8504884410957325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NACC1,Nucleus accumbens-associated protein 1,24451,121,1.05 [0.77-1.44],0.7380672614046284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NADK,NAD kinase,28278,131,1.07 [0.82-1.39],0.6422480214762811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAGA,Alpha-N-acetylgalactosaminidase,23831,118,0.97 [0.71-1.30],0.818309239169228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAGK,N-acetyl-D-glucosamine kinase,23842,117,0.81 [0.59-1.11],0.1858540823703175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24019,120,1.87 [0.83-4.24],0.1335838589322432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAMPT,Nicotinamide phosphoribosyltransferase,27585,127,0.96 [0.70-1.30],0.7902906482639234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAP1L4,Nucleosome assembly protein 1-like 4,24432,120,1.15 [0.75-1.76],0.5177741148747532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAPRT,Nicotinate phosphoribosyltransferase,24496,120,1.13 [0.68-1.87],0.6486551034991632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24531,120,0.87 [0.60-1.24],0.4301750819373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NBL1,Neuroblastoma suppressor of tumorigenicity 1,28342,129,0.97 [0.53-1.77],0.9296871371284012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NBN,Nibrin,27752,127,0.95 [0.70-1.30],0.7528754932274524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCAM1,Neural cell adhesion molecule 1,28359,128,0.84 [0.50-1.41],0.50703506818963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCAM2,Neural cell adhesion molecule 2,28263,129,0.78 [0.44-1.40],0.4093466651557497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCAN,Neurocan core protein,28543,133,0.75 [0.50-1.13],0.1689595670890747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCF2,Neutrophil cytosol factor 2,28205,133,1.04 [0.87-1.23],0.6934922988941246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCK2,Cytoplasmic protein NCK2,28400,130,0.94 [0.82-1.09],0.4232620796244689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCLN,Nicalin,27752,127,1.00 [0.75-1.33],0.9859218045882407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCR1,Natural cytotoxicity triggering receptor 1,28219,132,0.96 [0.63-1.47],0.8487413524927874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24472,121,1.27 [0.76-2.11],0.3606225092389979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCS1,Neuronal calcium sensor 1,28529,133,1.34 [0.78-2.29],0.2886381714966377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDRG1,Protein NDRG1,27604,125,0.94 [0.73-1.20],0.5984275848725956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24451,121,1.10 [0.85-1.41],0.4651592430150814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23819,118,0.68 [0.41-1.12],0.1277922493162458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24472,121,0.83 [0.69-1.01],0.0700464793269963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27585,127,1.00 [0.83-1.22],0.9621767432328716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEB,Nebulin,23789,116,0.76 [0.44-1.30],0.3096222757909976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NECAP2,Adaptin ear-binding coat-associated protein 2,23789,116,0.89 [0.67-1.18],0.4025605739907429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NECTIN1,Nectin-1,23868,118,0.86 [0.49-1.51],0.6019690870696541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NECTIN2,Nectin-2,28245,131,0.91 [0.53-1.58],0.7483987244003422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NECTIN4,Nectin-4,28342,129,0.95 [0.55-1.62],0.8394365126473209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23868,118,1.23 [0.84-1.80],0.2927533263145057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEDD9,Enhancer of filamentation 1,23868,118,1.13 [0.70-1.81],0.6257430471962993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEFL,Neurofilament light polypeptide,27514,125,1.53 [1.11-2.11],0.0093500709234589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEK7,Serine/threonine-protein kinase Nek7,24115,121,0.86 [0.66-1.12],0.2530730674585516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NELL1,Protein kinase C-binding protein NELL1,28342,129,0.60 [0.42-0.87],0.0072775310988569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NELL2,Protein kinase C-binding protein NELL2,28400,130,0.97 [0.56-1.67],0.9170446853284652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NENF,Neudesin,24451,121,0.88 [0.73-1.06],0.1738045587324754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEO1,Neogenin,24531,120,0.73 [0.33-1.62],0.4326021888476168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEXN,Nexilin,24594,120,0.80 [0.61-1.04],0.0897505802808544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFASC,Neurofascin,28613,132,2.28 [1.35-3.84],0.0020888681469324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFAT5,Nuclear factor of activated T-cells 5,23868,118,0.80 [0.64-1.00],0.0497780685313759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",28257,133,0.93 [0.79-1.08],0.3395553221635804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27752,127,0.97 [0.74-1.27],0.8369320224689287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFE2,Transcription factor NF-E2 45 kDa subunit,23885,117,0.90 [0.71-1.14],0.383079232023208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFIC,Nuclear factor 1 C-type,24531,120,0.91 [0.58-1.43],0.6974932073826361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23789,116,0.89 [0.70-1.13],0.3301721887837482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24115,121,1.09 [0.85-1.42],0.4923797130889105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFKBIE,NF-kappa-B inhibitor epsilon,27585,127,0.92 [0.67-1.28],0.6304385782179089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24472,121,0.93 [0.79-1.10],0.3921045103286559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFX1,Transcriptional repressor NF-X1,23789,116,1.15 [0.90-1.48],0.2693511237818485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFYA,Nuclear transcription factor Y subunit alpha,23789,116,0.95 [0.59-1.52],0.8203328184326322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NGF,Beta-nerve growth factor,28081,128,0.56 [0.16-2.00],0.3695935878952298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NGFR,Tumor necrosis factor receptor superfamily member 16,24567,122,0.82 [0.44-1.55],0.5459153175380859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NGRN,Neugrin,24496,120,0.66 [0.28-1.56],0.3393124941519084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NHLRC3,NHL repeat-containing protein 3,23464,118,1.39 [0.78-2.45],0.2611291823791566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NID1,Nidogen-1,28278,128,0.85 [0.57-1.29],0.4476318123613997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NID2,Nidogen-2,28263,129,0.87 [0.70-1.07],0.1916780510972264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NINJ1,Ninjurin-1,27585,127,0.93 [0.69-1.26],0.6577296223513929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NIT1,Deaminated glutathione amidase,23885,117,0.79 [0.55-1.14],0.2146011007033215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NIT2,Omega-amidase NIT2,24473,122,0.86 [0.68-1.08],0.1834694742706277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NLGN1,Neuroligin-1,23882,119,0.91 [0.68-1.22],0.5272096995771247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NLGN2,Neuroligin-2,23785,114,1.04 [0.71-1.51],0.8501094517543869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NME1,Nucleoside diphosphate kinase A,23868,118,1.29 [0.58-2.86],0.5330530200635244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NME3,Nucleoside diphosphate kinase 3,28305,130,0.31 [0.16-0.59],0.0003529948919185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NMI,N-myc-interactor,24347,121,1.07 [0.85-1.36],0.5518668970878065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,28081,128,1.04 [0.84-1.28],0.715642876530288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NMRK2,Nicotinamide riboside kinase 2,23697,117,0.98 [0.62-1.54],0.9290918173676592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24531,120,0.93 [0.70-1.22],0.5889796737774724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOMO1,Nodal modulator 1,28263,129,1.08 [0.57-2.06],0.8098488371010749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOP56,Nucleolar protein 56,23789,116,0.95 [0.80-1.13],0.537346467540561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOS1,"Nitric oxide synthase, brain",27604,125,1.11 [0.83-1.48],0.4910931638948348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOS2,"Nitric oxide synthase, inducible",23789,116,0.73 [0.45-1.18],0.1962297075180542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOS3,"Nitric oxide synthase, endothelial",27604,125,1.03 [0.76-1.39],0.868035123753975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOTCH1,Neurogenic locus notch homolog protein 1,28628,130,0.84 [0.31-2.24],0.7214413268983949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOTCH2,Neurogenic locus notch homolog protein 2,24559,122,1.66 [0.83-3.33],0.1529412254224134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOTCH3,Neurogenic locus notch homolog protein 3,28628,130,0.90 [0.58-1.41],0.6469985681490477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPC2,NPC intracellular cholesterol transporter 2,24157,122,1.37 [0.82-2.30],0.2319192712784511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPDC1,Neural proliferation differentiation and control protein 1,28278,131,0.99 [0.59-1.66],0.963306523339826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPHS1,Nephrin,23868,118,0.52 [0.30-0.91],0.0210581069722417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPHS2,Podocin,23868,118,0.96 [0.80-1.15],0.6442960294919062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPL,N-acetylneuraminate lyase,24567,122,1.11 [0.76-1.62],0.597084192733363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPPB,Natriuretic peptides B,27774,125,1.00 [0.88-1.13],0.9994737887178872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPPC,C-type natriuretic peptide,28257,133,0.96 [0.69-1.33],0.795646935460804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPR1,Atrial natriuretic peptide receptor 1,23789,116,1.28 [0.87-1.87],0.2049624719632951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPTN,Neuroplastin,27585,127,0.84 [0.66-1.06],0.1367215458030539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPTX1,Neuronal pentraxin-1,28263,129,1.07 [0.73-1.57],0.738340737677962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPTX2,Neuronal pentraxin-2,24559,122,0.93 [0.55-1.55],0.7747473453386464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPTXR,Neuronal pentraxin receptor,28278,131,0.77 [0.49-1.23],0.276299422990788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPY,Pro-neuropeptide Y,28529,133,1.02 [0.81-1.29],0.8519826588378115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRCAM,Neuronal cell adhesion molecule,28278,131,2.11 [1.26-3.54],0.0045459661059057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRGN,Neurogranin,24594,120,0.87 [0.72-1.05],0.1499076140316609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRN1,Neuritin,24531,120,0.94 [0.57-1.56],0.8148136313036888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRP1,Neuropilin-1,28415,128,1.15 [0.66-2.01],0.6090255121670389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRP2,Neuropilin-2,28263,129,0.86 [0.50-1.48],0.5831087968254103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRTN,Neurturin,27752,127,0.75 [0.53-1.05],0.0942847191566991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRXN3,Neurexin-3,23882,119,0.58 [0.31-1.10],0.093570867592734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NSFL1C,NSFL1 cofactor p47,28543,133,1.10 [0.88-1.38],0.4133833927897271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24567,122,0.99 [0.79-1.25],0.9397140237249918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NT5C1A,Cytosolic 5'-nucleotidase 1A,24496,120,1.28 [0.80-2.05],0.2955477243183869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NT5C3A,Cytosolic 5'-nucleotidase 3A,28207,133,0.95 [0.80-1.12],0.5218568426505484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NT5E,5'-nucleotidase,28342,129,1.05 [0.80-1.37],0.7368784572613558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTF3,Neurotrophin-3,28257,133,1.21 [0.79-1.84],0.3828814488995464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTF4,Neurotrophin-4,27585,127,0.81 [0.50-1.30],0.3772334646540946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTRK2,BDNF/NT-3 growth factors receptor,28278,131,1.81 [0.99-3.29],0.0519742012904806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTRK3,NT-3 growth factor receptor,28543,133,1.13 [0.56-2.27],0.734081996963869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTproBNP,N-terminal prohormone of brain natriuretic peptide,28278,131,1.03 [0.88-1.21],0.6943649564090111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUB1,NEDD8 ultimate buster 1,28257,133,0.94 [0.79-1.13],0.5355070461557259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24451,121,0.88 [0.72-1.06],0.1826265798359991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUCB2,Nucleobindin-2,28490,133,0.93 [0.62-1.40],0.7366711451994327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDC,Nuclear migration protein nudC,28613,132,0.85 [0.68-1.07],0.1689015887326281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23885,117,0.92 [0.45-1.89],0.8271323799237389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23789,116,0.85 [0.57-1.26],0.4214770201285961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT16,U8 snoRNA-decapping enzyme,24435,121,0.90 [0.74-1.10],0.3177035587452679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],28150,131,0.75 [0.57-1.00],0.0489554659627756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT5,ADP-sugar pyrophosphatase,28263,129,1.02 [0.75-1.37],0.909771563589788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUMB,Protein numb homolog,23868,118,0.93 [0.75-1.15],0.4935726871540095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUP50,Nuclear pore complex protein Nup50,23789,116,0.96 [0.55-1.66],0.8813844145697608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NXPE4,NXPE family member 4,23789,116,0.40 [0.20-0.79],0.0080833631842228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NXPH1,Neurexophilin-1,27604,125,1.12 [0.75-1.67],0.5853501322101049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NXPH3,Neurexophilin-3,23868,118,0.82 [0.46-1.46],0.4913350392086795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OBP2B,Odorant-binding protein 2b,27982,128,0.96 [0.75-1.22],0.7340531743972721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OCLN,Occludin,24531,120,0.94 [0.63-1.41],0.7682828796420575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ODAM,Odontogenic ameloblast-associated protein,27554,125,0.94 [0.69-1.28],0.6735576366615819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OFD1,Oral-facial-digital syndrome 1 protein,24115,121,0.98 [0.75-1.28],0.8820127334137786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OGA,Protein O-GlcNAcase,24472,121,0.90 [0.70-1.15],0.3832810628151681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OGFR,Opioid growth factor receptor,28150,131,0.91 [0.56-1.45],0.6803247303124502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OGN,Mimecan,28263,129,1.28 [0.87-1.88],0.2132624934499615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24115,121,0.82 [0.59-1.12],0.2116238694262479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OLFM4,Olfactomedin-4,23129,119,1.08 [0.93-1.24],0.3320058617485131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OLR1,Oxidized low-density lipoprotein receptor 1,28005,130,1.00 [0.77-1.29],0.9754509422307386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OMD,Osteomodulin,28400,130,0.84 [0.60-1.18],0.3250792853806015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OMG,Oligodendrocyte-myelin glycoprotein,28150,131,1.05 [0.83-1.32],0.6891052965547935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OMP,Olfactory marker protein,23785,114,1.13 [0.81-1.58],0.4788430170509091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OPHN1,Oligophrenin-1,24496,120,0.90 [0.77-1.06],0.2009048524105819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OPLAH,5-oxoprolinase,23885,117,0.89 [0.69-1.15],0.3781398469096286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OPTC,Opticin,28150,131,1.05 [0.75-1.47],0.7753182741060263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ORM1,Alpha-1-acid glycoprotein 1,24521,122,1.30 [0.55-3.04],0.5470650952973507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSBPL2,Oxysterol-binding protein-related protein 2,24496,120,0.62 [0.35-1.11],0.1108472662267224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSCAR,Osteoclast-associated immunoglobulin-like receptor,28305,130,0.75 [0.48-1.18],0.2092279299524442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSM,Oncostatin-M,28113,132,1.03 [0.83-1.28],0.7587301990495993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSMR,Oncostatin-M-specific receptor subunit beta,28415,128,0.90 [0.42-1.92],0.7786323007495224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSTN,Osteocrin,23882,119,0.72 [0.43-1.20],0.2092964665298587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OTOA,Otoancorin,23785,114,0.94 [0.65-1.35],0.7324886838795007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OTUD6B,Deubiquitinase OTUD6B,24472,121,0.87 [0.65-1.18],0.3687918343780713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OTUD7B,OTU domain-containing protein 7B,24531,120,0.84 [0.64-1.10],0.2103739725699842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23885,117,0.95 [0.74-1.22],0.6967674131220851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OXT,Oxytocin-neurophysin 1,28543,133,0.99 [0.89-1.10],0.8171189323490217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,P4HB,Protein disulfide-isomerase,28122,129,0.87 [0.58-1.29],0.476094034594841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PACS2,Phosphofurin acidic cluster sorting protein 2,23789,116,1.10 [0.83-1.46],0.5018652075136558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PADI2,Protein-arginine deiminase type-2,27752,127,1.14 [0.91-1.44],0.258244278737523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PADI4,Protein-arginine deiminase type-4,27554,125,1.04 [0.84-1.28],0.7318384668609563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAEP,Glycodelin,28081,128,1.00 [0.89-1.13],0.9620469011993172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24531,120,0.92 [0.77-1.08],0.3046520937469276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24115,121,0.82 [0.57-1.18],0.2829355623153586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27774,125,0.99 [0.74-1.31],0.927961694392856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAGR1,PAXIP1-associated glutamate-rich protein 1,23885,117,1.06 [0.72-1.57],0.7608810038162059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23649,117,0.73 [0.50-1.05],0.0921586032523591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAK4,Serine/threonine-protein kinase PAK 4,27604,125,0.83 [0.63-1.09],0.1723282085990076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PALLD,Palladin,23868,118,0.94 [0.59-1.50],0.8014177349931305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PALM,Paralemmin-1,24343,120,1.28 [0.72-2.29],0.4062736517451346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PALM2,Paralemmin-2,24496,120,1.12 [0.72-1.76],0.6137483134098711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PALM3,Paralemmin-3,23789,116,0.92 [0.71-1.19],0.5297982925440319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28486,128,0.61 [0.36-1.03],0.0660044103898848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAMR1,Inactive serine protease PAMR1,28263,129,1.56 [0.89-2.74],0.1230236570752266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAPPA,Pappalysin-1,27752,127,0.94 [0.67-1.32],0.7340502415943686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PARD3,Partitioning defective 3 homolog,24115,121,1.07 [0.86-1.34],0.54860959902158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PARK7,Parkinson disease protein 7,28263,129,1.02 [0.76-1.36],0.9201251623403536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PARP1,Poly [ADP-ribose] polymerase 1,28257,133,0.98 [0.75-1.30],0.899997740440894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAXX,Protein PAXX,24019,120,0.95 [0.65-1.40],0.8084159675023119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PBK,Lymphokine-activated killer T-cell-originated protein kinase,23697,117,1.29 [0.73-2.28],0.3776618656259262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PBLD,Phenazine biosynthesis-like domain-containing protein,27604,125,0.89 [0.65-1.22],0.4651060873979581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24472,121,0.79 [0.43-1.45],0.4469606432372753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCARE,Photoreceptor cilium actin regulator,23785,114,0.99 [0.80-1.22],0.8950141851490162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23966,120,1.17 [0.83-1.67],0.3689158754902084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCBP2,Poly(rC)-binding protein 2,24531,120,0.93 [0.73-1.18],0.5278524169596501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH1,Protocadherin-1,28521,131,1.04 [0.51-2.12],0.9221543420270965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH12,Protocadherin-12,24531,120,1.16 [0.58-2.29],0.675338058716875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH17,Protocadherin-17,28278,131,1.56 [1.02-2.37],0.0391998843637528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH7,Protocadherin-7,24472,121,1.08 [0.67-1.75],0.7392165589773911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH9,Protocadherin-9,24472,121,1.10 [0.66-1.83],0.7263740637414529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDHB15,Protocadherin beta-15,24451,121,1.17 [0.77-1.78],0.4554609757003161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCNA,Proliferating cell nuclear antigen,23697,117,0.89 [0.65-1.21],0.4529301987686318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCSK7,Proprotein convertase subtilisin/kexin type 7,24451,121,1.09 [0.75-1.58],0.6664314074272368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCSK9,Proprotein convertase subtilisin/kexin type 9,28628,130,0.74 [0.50-1.09],0.1284310096905091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24472,121,0.91 [0.72-1.14],0.393337860355202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24567,122,0.95 [0.80-1.13],0.5908234491473949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCD1,Programmed cell death protein 1,28486,133,0.88 [0.60-1.29],0.4985720320231068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCD1LG2,Programmed cell death 1 ligand 2,28150,131,1.53 [0.95-2.48],0.0814913281894445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCD5,Programmed cell death protein 5,28543,133,0.99 [0.77-1.29],0.959196266245252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCD6,Programmed cell death protein 6,28278,131,1.09 [0.86-1.38],0.4901367121073096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCL2,Phosducin-like protein 2,23697,117,0.86 [0.59-1.25],0.4156646573071547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23697,117,0.91 [0.64-1.30],0.6164371381730829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23789,116,1.22 [0.97-1.53],0.0954508148654258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24019,120,0.90 [0.76-1.05],0.188609528680225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFA,Platelet-derived growth factor subunit A,28628,130,0.94 [0.76-1.16],0.5751316787410347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFB,Platelet-derived growth factor subunit B,28400,130,0.91 [0.77-1.09],0.3164373583750178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFC,Platelet-derived growth factor C,27585,127,0.88 [0.51-1.52],0.6347691562533576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFRA,Platelet-derived growth factor receptor alpha,28278,131,1.06 [0.62-1.82],0.8346719072677606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFRB,Platelet-derived growth factor receptor beta,28628,130,0.56 [0.37-0.85],0.0069006251010021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDIA2,Protein disulfide-isomerase A2,23697,117,1.09 [0.71-1.69],0.6939816682833668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDIA3,Protein disulfide-isomerase A3,24019,120,0.77 [0.37-1.60],0.4825398314852396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDIA4,Protein disulfide-isomerase A4,24559,122,0.90 [0.68-1.20],0.4758796157194186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDIA5,Protein disulfide-isomerase A5,23697,117,1.07 [0.81-1.41],0.6436619956889165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDLIM5,PDZ and LIM domain protein 5,24531,120,0.89 [0.77-1.02],0.095538783903617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDLIM7,PDZ and LIM domain protein 7,28400,130,0.92 [0.81-1.04],0.1720539636039275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27585,127,0.78 [0.55-1.11],0.1673274984226078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDRG1,p53 and DNA damage-regulated protein 1,23882,119,0.72 [0.48-1.08],0.1109036250804315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23697,117,1.10 [0.85-1.41],0.4614554201807875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDZD2,PDZ domain-containing protein 2,23789,116,0.84 [0.61-1.15],0.2812920953921505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23868,118,1.05 [0.72-1.55],0.7922373682561215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PEAR1,Platelet endothelial aggregation receptor 1,28628,130,1.09 [0.55-2.13],0.8112060007768408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PEBP1,Phosphatidylethanolamine-binding protein 1,28263,129,1.05 [0.81-1.36],0.7351582323187139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PECAM1,Platelet endothelial cell adhesion molecule,28263,129,1.03 [0.62-1.72],0.8990264384646275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23885,117,0.64 [0.32-1.26],0.1944417173746866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PENK,Proenkephalin-A,24019,120,0.89 [0.49-1.62],0.6945248212219061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PEPD,Xaa-Pro dipeptidase,24594,120,0.57 [0.30-1.11],0.0977086800920611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PER3,Period circadian protein homolog 3,23868,118,1.00 [0.86-1.17],0.9787276850833092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PF4,Platelet factor 4,24422,119,0.92 [0.77-1.10],0.3656263995638117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PFDN2,Prefoldin subunit 2,27604,125,1.02 [0.76-1.36],0.9035938066849758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PFDN4,Prefoldin subunit 4,23697,117,0.91 [0.65-1.28],0.5795761799937358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PFDN6,Prefoldin subunit 6,23882,119,0.72 [0.51-1.02],0.0640895203564049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28110,131,1.08 [0.88-1.32],0.4677915268535948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGA4,Pepsin A-4,24594,120,1.15 [0.88-1.50],0.3173677217325928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24567,122,1.25 [0.92-1.69],0.1472969441124339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGF,Placenta growth factor,28613,132,1.08 [0.59-2.00],0.801987344148842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGLYRP1,Peptidoglycan recognition protein 1,28472,129,0.76 [0.52-1.11],0.1541970587145531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24284,122,1.09 [0.62-1.91],0.7694112462927637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGLYRP4,Peptidoglycan recognition protein 4,23789,116,0.92 [0.68-1.25],0.5990428447338467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGM2,Phosphoglucomutase-2,23882,119,0.86 [0.61-1.21],0.3901369366337156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGR,Progesterone receptor,23868,118,1.03 [0.88-1.21],0.6889530805420562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHACTR2,Phosphatase and actin regulator 2,24531,120,0.89 [0.77-1.03],0.1232740874706855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHLDB1,Pleckstrin homology-like domain family B member 1,24472,121,0.94 [0.68-1.30],0.7087429588783194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHLDB2,Pleckstrin homology-like domain family B member 2,23697,117,0.91 [0.74-1.13],0.4020030751375311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,28081,128,1.69 [0.99-2.90],0.0548488462190277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24019,120,0.82 [0.54-1.25],0.3600751702581549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PI16,Peptidase inhibitor 16,24594,120,0.73 [0.36-1.47],0.3711677405977477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PI3,Elafin,27884,124,0.80 [0.58-1.10],0.1717581269037282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24531,120,0.88 [0.70-1.10],0.2495842900214663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIGR,Polymeric immunoglobulin receptor,27904,128,1.04 [0.68-1.59],0.8581501827313107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,28257,133,1.00 [0.79-1.28],0.9816860038362824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,28263,129,1.12 [0.62-2.05],0.7019358559059288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23868,118,0.79 [0.56-1.12],0.1807709535862903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PILRA,Paired immunoglobulin-like type 2 receptor alpha,28263,129,1.20 [0.82-1.74],0.347477430285568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PILRB,Paired immunoglobulin-like type 2 receptor beta,28278,131,1.09 [0.83-1.44],0.5230600373361938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24019,120,0.90 [0.70-1.15],0.3918245292590958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PITHD1,PITH domain-containing protein 1,23649,117,1.00 [0.80-1.25],0.9788023450527348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PKD1,Polycystin-1,24567,122,1.25 [0.64-2.41],0.5120965061794458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PKD2,Polycystin-2,23789,116,0.96 [0.71-1.30],0.7930949172039045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PKLR,Pyruvate kinase PKLR,28302,130,1.20 [0.97-1.50],0.0995577166732291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PKN3,Serine/threonine-protein kinase N3,24115,121,0.88 [0.69-1.12],0.2832145828039145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G10,Group 10 secretory phospholipase A2,28081,128,1.07 [0.82-1.39],0.6182476698024311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G15,Phospholipase A2 group XV,28342,129,0.91 [0.51-1.63],0.7542267969432132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G1B,Phospholipase A2,28575,130,0.56 [0.40-0.80],0.0011094901582123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G2A,"Phospholipase A2, membrane associated",28219,127,0.76 [0.55-1.05],0.0938159731568378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G4A,Cytosolic phospholipase A2,28400,130,0.91 [0.77-1.09],0.3041662689871359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G7,Platelet-activating factor acetylhydrolase,28263,129,0.57 [0.39-0.86],0.0063542705087336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLAT,Tissue-type plasminogen activator,28526,129,1.12 [0.83-1.53],0.4593476860112843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLAU,Urokinase-type plasminogen activator,28263,129,0.71 [0.41-1.22],0.216330295481445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLAUR,Urokinase plasminogen activator surface receptor,28065,128,0.89 [0.50-1.61],0.7075641865826783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLB1,"Phospholipase B1, membrane-associated",24496,120,0.76 [0.58-1.01],0.0578100207373883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23868,118,0.93 [0.62-1.39],0.7245800215536189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24496,120,0.90 [0.76-1.07],0.246611499295763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24496,120,0.94 [0.73-1.20],0.6042657069974615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLG,Plasminogen,23967,119,1.92 [1.07-3.45],0.0293112227156457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLIN1,Perilipin-1,27604,125,1.31 [0.87-1.96],0.1944626094096092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLIN3,Perilipin-3,28278,131,0.99 [0.69-1.41],0.956415726323007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLPBP,Pyridoxal phosphate homeostasis protein,28278,131,0.98 [0.79-1.23],0.8906896535942636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLSCR3,Phospholipid scramblase 3,24455,120,0.81 [0.61-1.09],0.1731977077432461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLTP,Phospholipid transfer protein,28524,129,0.93 [0.61-1.43],0.7414634384577219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXDC1,Plexin domain-containing protein 1,27585,127,1.11 [0.74-1.66],0.6297910028136144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXDC2,Plexin domain-containing protein 2,24496,120,1.32 [0.72-2.42],0.3611171389162155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXNA4,Plexin-A4,28257,133,0.94 [0.78-1.13],0.4927790912537282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXNB2,Plexin-B2,28493,129,3.20 [1.76-5.79],0.0001262661525593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXNB3,Plexin-B3,28175,130,0.94 [0.68-1.30],0.6999366112192649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,28164,131,1.03 [0.95-1.12],0.4158875374729153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PMCH,Pro-MCH,23789,116,1.17 [0.99-1.38],0.060210347299969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PMM2,Phosphomannomutase 2,23789,116,0.90 [0.67-1.22],0.5028355798014217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PMS1,PMS1 protein homolog 1,23882,119,0.86 [0.60-1.25],0.443810555202102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PMVK,Phosphomevalonate kinase,27561,125,0.90 [0.79-1.03],0.1247686439922628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNLIP,Pancreatic triacylglycerol lipase,24594,120,0.89 [0.67-1.18],0.4115778597508573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24496,120,0.92 [0.74-1.15],0.4856408705641666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNLIPRP2,Pancreatic lipase-related protein 2,28255,128,1.04 [0.98-1.10],0.1826283955274698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNMA1,Paraneoplastic antigen Ma1,23885,117,0.83 [0.60-1.14],0.2525227342708018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNMA2,Paraneoplastic antigen Ma2,23785,114,0.87 [0.56-1.34],0.518942854739344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27752,127,1.01 [0.89-1.15],0.8835156166080211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PODXL,Podocalyxin,28150,131,0.82 [0.30-2.25],0.705038860971714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PODXL2,Podocalyxin-like protein 2,28342,129,0.61 [0.35-1.06],0.0819297867130853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POF1B,Protein POF1B,23868,118,1.29 [0.92-1.81],0.1397279878696207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23868,118,1.01 [0.57-1.80],0.9666744577993368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",28150,131,1.02 [0.65-1.60],0.9169648181119756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POMC,Pro-opiomelanocortin,23885,117,0.93 [0.72-1.20],0.5799784348640371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PON1,Serum paraoxonase/arylesterase 1,24594,120,0.96 [0.50-1.82],0.8957212135229509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PON2,Serum paraoxonase/arylesterase 2,27774,125,0.80 [0.51-1.27],0.3473405622050849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PON3,Serum paraoxonase/lactonase 3,28400,130,0.76 [0.54-1.09],0.1350007274177478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POSTN,Periostin,24559,122,1.02 [0.64-1.61],0.9446484656315604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPBP,Platelet basic protein,24411,119,0.88 [0.72-1.08],0.2362240593081105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPCDC,Phosphopantothenoylcysteine decarboxylase,28543,133,0.95 [0.69-1.30],0.7532050415863487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPIB,Peptidyl-prolyl cis-trans isomerase B,28276,128,0.92 [0.79-1.08],0.3194809224643972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPIE,Peptidyl-prolyl cis-trans isomerase E,24115,121,1.09 [0.84-1.40],0.5314976557192967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24559,122,0.90 [0.68-1.20],0.4901863121710349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPL,Periplakin,23868,118,0.59 [0.33-1.06],0.0791558972486292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPM1A,Protein phosphatase 1A,27585,127,0.77 [0.45-1.32],0.3471245534265568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPM1B,Protein phosphatase 1B,23868,118,0.98 [0.74-1.29],0.8656582226759193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPM1F,Protein phosphatase 1F,24567,122,0.91 [0.66-1.26],0.5776346326486077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPME1,Protein phosphatase methylesterase 1,28150,131,1.26 [0.98-1.62],0.0734812948919048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24451,121,0.91 [0.74-1.13],0.3987227619958859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28342,129,0.91 [0.77-1.07],0.2618344010442692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24115,121,0.84 [0.63-1.11],0.2216617968284719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24531,120,0.83 [0.66-1.04],0.1082861340615542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24531,120,1.18 [0.77-1.83],0.4477121373099031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R2,Protein phosphatase inhibitor 2,28278,131,0.95 [0.79-1.15],0.6003040297169329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R9B,Neurabin-2,28613,132,0.91 [0.77-1.06],0.2326058299675404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24472,121,0.89 [0.77-1.04],0.1340283140461153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP3R1,Calcineurin subunit B type 1,28081,128,0.90 [0.62-1.31],0.5919298369317938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPT1,Palmitoyl-protein thioesterase 1,23882,119,1.07 [0.87-1.32],0.5095138107220336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPY,Pancreatic prohormone,28200,129,1.00 [0.86-1.16],0.9819182119647344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PQBP1,Polyglutamine-binding protein 1,27585,127,0.88 [0.64-1.20],0.4208591535595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRAME,Melanoma antigen preferentially expressed in tumors,23697,117,0.80 [0.39-1.63],0.5417676999546163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRAP1,Proline-rich acidic protein 1,24559,122,1.65 [1.07-2.55],0.0235285420591257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRC1,Protein regulator of cytokinesis 1,24451,121,1.13 [0.83-1.54],0.4331086191961102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRCP,Lysosomal Pro-X carboxypeptidase,28430,130,1.70 [1.08-2.66],0.0217422899314144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX1,Peroxiredoxin-1,27497,124,1.02 [0.86-1.22],0.8185131675346473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX2,Peroxiredoxin-2,24196,120,1.19 [0.92-1.56],0.1879257743459538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27752,127,1.03 [0.83-1.27],0.8148332540342575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX5,"Peroxiredoxin-5, mitochondrial",28613,132,0.90 [0.73-1.11],0.3346229884462791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX6,Peroxiredoxin-6,28529,133,1.03 [0.80-1.32],0.8101555342751953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PREB,Prolactin regulatory element-binding protein,27752,127,0.53 [0.29-0.97],0.0410807322610545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRELP,Prolargin,28255,128,1.12 [0.56-2.26],0.7408646388368322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRG2,Bone marrow proteoglycan,24559,122,1.12 [0.81-1.55],0.4846297428815229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRG3,Proteoglycan 3,24559,122,0.98 [0.71-1.36],0.9056174207524146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27752,127,0.99 [0.75-1.32],0.9539377800214848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23882,119,0.70 [0.38-1.30],0.2574116428956662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,28278,131,0.94 [0.79-1.13],0.5133337375141437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24448,120,0.87 [0.70-1.07],0.1877396600691842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKCQ,Protein kinase C theta type,27752,127,0.95 [0.66-1.38],0.7945447783795256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKD2,Serine/threonine-protein kinase D2,23789,116,0.94 [0.62-1.43],0.7757584425363425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKG1,cGMP-dependent protein kinase 1,24019,120,0.92 [0.80-1.05],0.2305004135344182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27585,127,1.11 [0.88-1.40],0.3623315192313392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRL,Prolactin,28543,133,0.94 [0.77-1.16],0.5676218410277323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRND,Prion-like protein doppel,24496,120,0.91 [0.64-1.28],0.583804593254714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PROC,Vitamin K-dependent protein C,28324,128,1.20 [0.66-2.21],0.5483562735484104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PROCR,Endothelial protein C receptor,23789,116,0.92 [0.54-1.56],0.750116879953713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PROK1,Prokineticin-1,28257,133,1.02 [0.80-1.30],0.8712569922207123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PROS1,Vitamin K-dependent protein S,24605,122,1.61 [0.86-3.02],0.1376811488677651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRR4,Proline-rich protein 4,23861,119,1.11 [0.88-1.42],0.3825498660205585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRR5,Proline-rich protein 5,23868,118,1.07 [0.75-1.52],0.7256868323544167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRRT3,Proline-rich transmembrane protein 3,23885,117,0.86 [0.53-1.38],0.5266336429127714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS2,Trypsin-2,28359,128,0.69 [0.51-0.95],0.0221302201313406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS22,Brain-specific serine protease 4,23868,118,1.04 [0.63-1.72],0.8776384264428735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS27,Serine protease 27,28176,130,1.13 [0.78-1.65],0.510722571078718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS53,Serine protease 53,24496,120,0.84 [0.55-1.30],0.4398900576075278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS8,Prostasin,28163,130,0.96 [0.66-1.41],0.8479765070003064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27604,125,0.90 [0.79-1.04],0.1485103571112032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRTG,Protogenin,28529,133,1.36 [0.74-2.48],0.3220127228210374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRTN3,Myeloblastin,27574,124,1.00 [0.72-1.40],0.9852731131783176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRUNE2,Protein prune homolog 2,24115,121,0.59 [0.30-1.16],0.1270112986579668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSAP,Prosaposin,24338,122,1.05 [0.57-1.94],0.8661690103715111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSAPL1,Proactivator polypeptide-like 1,24472,121,0.79 [0.56-1.12],0.1949038975010746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSCA,Prostate stem cell antigen,24472,121,1.03 [0.96-1.10],0.4243200020972186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSG1,Pregnancy-specific beta-1-glycoprotein 1,28081,128,1.04 [0.90-1.21],0.5728016951155159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSIP1,PC4 and SFRS1-interacting protein,28257,133,0.88 [0.68-1.14],0.3285812457301229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMA1,Proteasome subunit alpha type-1,27585,127,0.85 [0.59-1.22],0.366412993875626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMC3,26S proteasome regulatory subunit 6A,23697,117,0.68 [0.37-1.25],0.2185937553309802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24531,120,0.89 [0.62-1.27],0.5097110983111239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23882,119,0.97 [0.69-1.35],0.8489319694151509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMD9,26S proteasome non-ATPase regulatory subunit 9,28150,131,1.17 [0.90-1.52],0.2278538582584948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSME1,Proteasome activator complex subunit 1,28048,128,1.00 [0.66-1.51],0.9871851191076884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSME2,Proteasome activator complex subunit 2,27958,127,1.07 [0.70-1.63],0.7636518492631141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMG3,Proteasome assembly chaperone 3,28257,133,1.25 [0.93-1.66],0.1333646260915473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMG4,Proteasome assembly chaperone 4,23868,118,1.22 [0.91-1.62],0.1781751940967399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSPN,Persephin,28257,133,1.03 [0.88-1.21],0.6754695264032469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSRC1,Proline/serine-rich coiled-coil protein 1,27585,127,0.99 [0.76-1.29],0.9439031515694952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23139,116,0.92 [0.78-1.08],0.2926370051340178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27604,125,0.69 [0.41-1.16],0.1602835431353618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTGDS,Prostaglandin-H2 D-isomerase,28053,127,0.77 [0.44-1.36],0.3657926761905654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTGES2,Prostaglandin E synthase 2,23683,118,0.91 [0.66-1.25],0.5537770719219337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTGR1,Prostaglandin reductase 1,24567,122,1.04 [0.85-1.28],0.7049453488343858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTH,Parathyroid hormone,23882,119,0.93 [0.74-1.16],0.4938858895558543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,28257,133,1.19 [0.84-1.68],0.3386839771267692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTK7,Inactive tyrosine-protein kinase 7,27604,125,0.77 [0.51-1.16],0.2118860199618627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTN,Pleiotrophin,27774,125,0.97 [0.71-1.34],0.8686874368979716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTP4A3,Protein tyrosine phosphatase type IVA 3,23868,118,1.01 [0.72-1.42],0.9366533684910228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,28081,128,0.92 [0.75-1.12],0.4126056929971115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28357,130,0.89 [0.76-1.05],0.1614730403242674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23819,118,0.91 [0.57-1.46],0.6980380968328919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24567,122,1.87 [1.11-3.14],0.0180974561450506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRC,Receptor-type tyrosine-protein phosphatase C,24559,122,0.85 [0.39-1.82],0.6717163604487923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRF,Receptor-type tyrosine-protein phosphatase F,28628,130,0.65 [0.38-1.10],0.1050508152816177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRH,Receptor-type tyrosine-protein phosphatase H,24472,121,1.76 [1.31-2.37],0.0001539540876549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24472,121,1.27 [0.63-2.57],0.5098752484477616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRM,Receptor-type tyrosine-protein phosphatase mu,28204,133,1.18 [0.64-2.18],0.6017868119894323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27980,127,0.81 [0.49-1.33],0.4000091894394086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRR,Receptor-type tyrosine-protein phosphatase R,24496,120,0.91 [0.56-1.48],0.7122971361298596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRS,Receptor-type tyrosine-protein phosphatase S,28628,130,0.60 [0.32-1.13],0.1139129526372656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24567,122,0.97 [0.57-1.65],0.9039920054672992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24019,120,1.08 [0.81-1.44],0.6004854783664975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27479,123,1.09 [0.82-1.44],0.5633719613343553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTTG1,Securin,24115,121,1.11 [0.75-1.64],0.6066605486841994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTX3,Pentraxin-related protein PTX3,28257,133,0.93 [0.69-1.24],0.6047699016150004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PVALB,Parvalbumin alpha,28418,133,1.00 [0.87-1.13],0.9459883290087024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PVR,Poliovirus receptor,28543,133,1.17 [0.78-1.73],0.4487881570696755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PXDNL,Peroxidasin-like protein,24451,121,0.86 [0.61-1.21],0.3764097673407437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PXN,Paxillin,27604,125,0.99 [0.73-1.34],0.9471844218156376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PYDC1,Pyrin domain-containing protein 1,23885,117,0.74 [0.46-1.19],0.2163123168106161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PYY,Peptide YY,23789,116,1.15 [0.95-1.37],0.1435621839382967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PZP,Pregnancy zone protein,24605,122,1.03 [0.76-1.41],0.8335248496873007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,QDPR,Dihydropteridine reductase,28140,130,1.13 [0.79-1.60],0.5099753995742824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,QPCT,Glutaminyl-peptide cyclotransferase,28280,129,0.95 [0.54-1.65],0.8460856940738676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,QSOX1,Sulfhydryl oxidase 1,24095,121,1.31 [1.01-1.70],0.0428348218956874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB10,Ras-related protein Rab-10,24567,122,0.82 [0.59-1.13],0.2273589422293743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB11FIP3,Rab11 family-interacting protein 3,24567,122,0.91 [0.78-1.07],0.2585555249875372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB27B,Ras-related protein Rab-27B,24567,122,0.83 [0.68-1.01],0.0573242645445994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB2B,Ras-related protein Rab-2B,24451,121,0.83 [0.63-1.10],0.2014549710448175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB33A,Ras-related protein Rab-33A,23789,116,0.92 [0.71-1.21],0.5643086734811418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB37,Ras-related protein Rab-37,27752,127,0.96 [0.79-1.17],0.6850979174231683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB39B,Ras-related protein Rab-39B,23789,116,0.82 [0.63-1.06],0.1276389632594249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23785,114,0.83 [0.58-1.20],0.3208916957036151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB44,Ras-related protein Rab-44,24451,121,1.22 [0.91-1.64],0.1803687430947183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB6A,Ras-related protein Rab-6A,28257,133,0.48 [0.34-0.68],2.5354712907582863e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB6B,Ras-related protein Rab-6B,27604,125,0.78 [0.53-1.13],0.1821122647256473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RABEP1,Rab GTPase-binding effector protein 1,24019,120,0.90 [0.72-1.13],0.3723819667667356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RABEPK,Rab9 effector protein with kelch motifs,27585,127,0.99 [0.76-1.29],0.9375435118080566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RABGAP1L,Rab GTPase-activating protein 1-like,27752,127,1.07 [0.83-1.39],0.5831180487808993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAC3,Ras-related C3 botulinum toxin substrate 3,23882,119,0.89 [0.67-1.19],0.4382051074618167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAD23B,UV excision repair protein RAD23 homolog B,27585,127,0.90 [0.64-1.26],0.5377473273559532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAD51,DNA repair protein RAD51 homolog 1,24115,121,1.26 [1.01-1.57],0.0367109787114072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RALB,Ras-related protein Ral-B,23868,118,0.61 [0.33-1.10],0.1000703353325052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RALY,RNA-binding protein Raly,24451,121,0.87 [0.59-1.28],0.4778163131976635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RANBP1,Ran-specific GTPase-activating protein,23885,117,1.16 [0.83-1.61],0.3877617173186987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RANBP2,E3 SUMO-protein ligase RanBP2,23785,114,0.93 [0.54-1.61],0.8033753169275927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RANGAP1,Ran GTPase-activating protein 1,27585,127,0.76 [0.53-1.10],0.1421481977857909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAP1A,Ras-related protein Rap-1A,23868,118,0.77 [0.56-1.07],0.120598995426024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAPGEF2,Rap guanine nucleotide exchange factor 2,24115,121,0.89 [0.64-1.25],0.5032520321557664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RARRES1,Retinoic acid receptor responder protein 1,27585,127,0.73 [0.42-1.24],0.2426109388681708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RARRES2,Retinoic acid receptor responder protein 2,28415,128,0.95 [0.69-1.32],0.7755632624815365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RASA1,Ras GTPase-activating protein 1,27604,125,0.76 [0.46-1.24],0.2706100089047035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23697,117,1.18 [0.80-1.76],0.4012605256582794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RASSF2,Ras association domain-containing protein 2,27585,127,0.82 [0.60-1.13],0.2239853434449107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBFOX3,RNA binding protein fox-1 homolog 3,24531,120,1.21 [0.78-1.86],0.3887578107315996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBKS,Ribokinase,27626,127,0.95 [0.70-1.29],0.7242416085616155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBM17,Splicing factor 45,24531,120,0.91 [0.73-1.15],0.4387659697419441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBM19,Probable RNA-binding protein 19,23789,116,1.32 [0.99-1.74],0.056630568955701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBM25,RNA-binding protein 25,23697,117,0.88 [0.59-1.32],0.5465567449759019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBP1,Retinol-binding protein 1,23882,119,1.02 [0.80-1.30],0.89161943896995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBP2,Retinol-binding protein 2,28150,131,0.94 [0.76-1.15],0.5343934751110414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBP5,Retinol-binding protein 5,28150,131,1.02 [0.78-1.33],0.9052414077855584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBP7,Retinoid-binding protein 7,24472,121,1.22 [0.95-1.56],0.1134950842392196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBPMS,RNA-binding protein with multiple splicing,23868,118,0.92 [0.69-1.23],0.5804402620177997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBPMS2,RNA-binding protein with multiple splicing 2,23885,117,0.89 [0.75-1.06],0.179775523709601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RCC1,Regulator of chromosome condensation,24451,121,1.05 [0.76-1.45],0.7694681867195547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RCOR1,REST corepressor 1,27774,125,0.79 [0.51-1.22],0.2809483009534208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23885,117,1.40 [0.60-3.28],0.4411754661020918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REEP4,Receptor expression-enhancing protein 4,24531,120,0.80 [0.59-1.08],0.1398737556853292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG1A,Lithostathine-1-alpha,28108,128,0.95 [0.68-1.33],0.7797907102606738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG1B,Lithostathine-1-beta,28628,130,0.90 [0.67-1.20],0.4673052563958798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG3A,Regenerating islet-derived protein 3-alpha,28628,130,1.07 [0.83-1.38],0.6037782970351098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG3G,Regenerating islet-derived protein 3-gamma,24451,121,1.40 [0.94-2.08],0.0949554461403881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG4,Regenerating islet-derived protein 4,28305,130,1.15 [0.84-1.59],0.3772238685673337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RELB,Transcription factor RelB,23868,118,0.87 [0.59-1.28],0.474675876381384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RELT,Tumor necrosis factor receptor superfamily member 19L,28263,129,0.76 [0.42-1.39],0.3740312456615284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REN,Renin,28278,131,1.30 [1.06-1.58],0.0099008601125564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REPS1,RalBP1-associated Eps domain-containing protein 1,23868,118,0.81 [0.50-1.32],0.3910738115649254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REST,RE1-silencing transcription factor,23697,117,1.10 [0.69-1.76],0.6771729487008391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,28150,131,1.05 [0.71-1.55],0.8152866831269276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RETN,Resistin,28203,128,0.87 [0.60-1.27],0.4783399121269116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REXO2,"Oligoribonuclease, mitochondrial",23789,116,0.91 [0.61-1.35],0.6253117455445232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RFC4,Replication factor C subunit 4,24451,121,0.75 [0.32-1.72],0.4912066689819088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGCC,Regulator of cell cycle RGCC,24531,120,0.78 [0.62-0.97],0.0283727209944485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24115,121,1.05 [0.82-1.35],0.6895009175970046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGMA,Repulsive guidance molecule A,28543,133,0.81 [0.50-1.32],0.3971576206666312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGMB,RGM domain family member B,28543,133,0.83 [0.46-1.51],0.5436940048908698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGS10,Regulator of G-protein signaling 10,24531,120,0.98 [0.73-1.31],0.8789796340286249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGS8,Regulator of G-protein signaling 8,27752,127,0.80 [0.59-1.07],0.1317423005180361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RHOC,Rho-related GTP-binding protein RhoC,27912,128,0.96 [0.85-1.10],0.5767684309244576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RICTOR,Rapamycin-insensitive companion of mTOR,23868,118,0.77 [0.50-1.20],0.2565795190439649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24019,120,1.25 [0.90-1.74],0.1905693209733934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RILP,Rab-interacting lysosomal protein,28455,133,1.14 [0.89-1.46],0.2919217690159231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RILPL2,RILP-like protein 2,24567,122,0.91 [0.76-1.08],0.265360871001942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23789,116,1.19 [0.96-1.47],0.1216461290587173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RLN1,Prorelaxin H1,24531,120,0.92 [0.69-1.22],0.5537312688059648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RLN2,Prorelaxin H2,23979,120,0.95 [0.81-1.12],0.5736070905034012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE1,Ribonuclease pancreatic,24594,120,1.23 [0.60-2.53],0.5785150022857077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE10,Inactive ribonuclease-like protein 10,23885,117,0.97 [0.66-1.41],0.8628466780721001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE3,Eosinophil cationic protein,28137,130,1.06 [0.93-1.21],0.3754960022817923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE4,Ribonuclease 4,23802,114,1.83 [1.02-3.30],0.044258802773931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE6,Ribonuclease K6,24419,119,1.43 [0.86-2.40],0.1711289428314341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASEH2A,Ribonuclease H2 subunit A,24531,120,0.92 [0.64-1.33],0.66353037994347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASET2,Ribonuclease T2,28479,130,1.35 [0.76-2.39],0.3024426576217222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF149,E3 ubiquitin-protein ligase RNF149,23885,117,1.51 [0.85-2.68],0.1560906519750874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF168,E3 ubiquitin-protein ligase RNF168,23868,118,0.81 [0.51-1.29],0.380808656259634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF31,E3 ubiquitin-protein ligase RNF31,23868,118,0.69 [0.40-1.21],0.1985041574355428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF4,E3 ubiquitin-protein ligase RNF4,24115,121,0.95 [0.72-1.25],0.7145444563179724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF41,E3 ubiquitin-protein ligase NRDP1,27585,127,0.89 [0.70-1.13],0.3244934150547804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF43,E3 ubiquitin-protein ligase RNF43,24115,121,1.07 [0.81-1.42],0.6216035368803445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF5,E3 ubiquitin-protein ligase RNF5,23885,117,0.86 [0.68-1.09],0.2118960680917892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ROBO1,Roundabout homolog 1,28305,130,0.79 [0.41-1.54],0.492815375898628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ROBO2,Roundabout homolog 2,28543,133,0.86 [0.44-1.67],0.6558266892582659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ROBO4,Roundabout homolog 4,23885,117,1.09 [0.40-2.94],0.8715332877483424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,28278,131,0.79 [0.48-1.29],0.3485302760899698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RP2,Protein XRP2,28150,131,0.93 [0.65-1.34],0.7078655248822527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPA2,Replication protein A 32 kDa subunit,23868,118,0.79 [0.44-1.44],0.4446560792244957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPE,Ribulose-phosphate 3-epimerase,24115,121,0.90 [0.69-1.15],0.3956747868986361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPGR,X-linked retinitis pigmentosa GTPase regulator,23882,119,0.71 [0.43-1.15],0.162635222766147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPL14,60S ribosomal protein L14,23885,117,1.37 [0.95-1.98],0.0876263429593425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPS10,40S ribosomal protein S10,23789,116,1.06 [0.71-1.58],0.7673427780844047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RRAS,Ras-related protein R-Ras,23882,119,0.93 [0.81-1.07],0.320124286173776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27585,127,0.98 [0.71-1.35],0.914096956630888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27585,127,0.86 [0.68-1.08],0.19269044682925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RRP15,RRP15-like protein,23785,114,1.18 [0.99-1.40],0.0696112361849294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RSPO1,R-spondin-1,28081,128,0.72 [0.46-1.12],0.1478703610095141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RSPO3,R-spondin-3,28529,133,0.74 [0.41-1.31],0.2970084233584171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RTBDN,Retbindin,28150,131,1.17 [0.69-1.98],0.5713680990024625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RTKN2,Rhotekin-2,23789,116,0.85 [0.58-1.25],0.4082911985157643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24531,120,0.88 [0.73-1.06],0.1855018184772923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RTN4R,Reticulon-4 receptor,28529,133,1.03 [0.65-1.61],0.9120663541740056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RUVBL1,RuvB-like 1,27585,127,0.94 [0.79-1.11],0.447044801825163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RWDD1,RWD domain-containing protein 1,28543,133,0.98 [0.77-1.24],0.8514063412982672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RYR1,Ryanodine receptor 1,23789,116,0.91 [0.51-1.60],0.7374363811133585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A11,Protein S100-A11,28049,130,1.11 [0.82-1.51],0.4939195064951268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A12,Protein S100-A12,27884,130,1.09 [0.89-1.34],0.4060340896008287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A13,Protein S100-A13,23868,118,1.09 [0.67-1.79],0.7190639397375855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A14,Protein S100-A14,24531,120,1.13 [0.82-1.55],0.4646207111660337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A16,Protein S100-A16,27554,125,1.09 [0.86-1.39],0.4815487875478044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A3,Protein S100-A3,24451,121,0.79 [0.49-1.28],0.3415395844303144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A4,Protein S100-A4,28342,129,0.96 [0.73-1.26],0.7771962410749635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100G,Protein S100-G,24531,120,1.00 [0.68-1.47],0.991716927812174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100P,Protein S100-P,27774,125,0.85 [0.62-1.16],0.3062326632517032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAA4,Serum amyloid A-4 protein,24605,122,1.39 [1.02-1.91],0.0388487479755591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAFB2,Scaffold attachment factor B2,24531,120,0.90 [0.47-1.74],0.7577958743917435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAG,S-arrestin,23785,114,1.02 [0.72-1.43],0.9156253563759764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAMD9L,Sterile alpha motif domain-containing protein 9-like,28257,133,0.93 [0.75-1.14],0.4838166401565378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAP18,Histone deacetylase complex subunit SAP18,24115,121,1.15 [0.95-1.41],0.1570489850096779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SARG,Specifically androgen-regulated gene protein,24487,122,0.92 [0.79-1.07],0.2743267733800653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23789,116,1.06 [0.68-1.66],0.8007011723112266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAT1,Diamine acetyltransferase 1,23789,116,0.65 [0.42-1.02],0.0613624436249168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAT2,Thialysine N-epsilon-acetyltransferase,24115,121,0.79 [0.59-1.06],0.1175551315302073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SATB1,DNA-binding protein SATB1,24531,120,0.68 [0.35-1.34],0.2681917158009098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SBSN,Suprabasin,24516,122,0.70 [0.42-1.17],0.1727740338987658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCAMP3,Secretory carrier-associated membrane protein 3,28150,131,0.93 [0.78-1.12],0.4370105407524605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARA5,Scavenger receptor class A member 5,28543,133,1.24 [0.74-2.09],0.4131550896867177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARB1,Scavenger receptor class B member 1,27604,125,1.09 [0.84-1.40],0.5214242482454201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARB2,Lysosome membrane protein 2,27540,126,0.91 [0.51-1.61],0.7412753960638895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARF1,Scavenger receptor class F member 1,28628,130,0.90 [0.62-1.29],0.5521408052750603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARF2,Scavenger receptor class F member 2,28543,133,1.16 [0.67-1.99],0.5973798660897273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCG2,Secretogranin-2,28416,133,1.07 [0.66-1.74],0.7786384474689254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCG3,Secretogranin-3,28305,130,0.71 [0.45-1.14],0.157878770426505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGB1A1,Uteroglobin,28322,130,1.01 [0.77-1.34],0.9188716426570248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGB2A2,Mammaglobin-A,23789,116,0.84 [0.45-1.57],0.5907299359079718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGB3A1,Secretoglobin family 3A member 1,24019,120,1.71 [0.85-3.45],0.1355114067412353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGB3A2,Secretoglobin family 3A member 2,28357,130,1.05 [0.87-1.26],0.6344244445411862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGN,Secretagogin,27752,127,1.53 [1.10-2.13],0.0111011866089336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCIN,Adseverin,23785,114,1.09 [0.87-1.37],0.4641849776411447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCLY,Selenocysteine lyase,28455,133,0.97 [0.71-1.33],0.8651387759801581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN2A,Sodium channel protein type 2 subunit alpha,23785,114,1.29 [0.96-1.74],0.0871259117667162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN2B,Sodium channel subunit beta-2,23882,119,0.50 [0.25-1.00],0.0500819679308393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN3A,Sodium channel protein type 3 subunit alpha,23882,119,0.97 [0.60-1.55],0.8882514811747309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN3B,Sodium channel subunit beta-3,23785,114,0.47 [0.28-0.79],0.0042763747642968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN4B,Sodium channel subunit beta-4,23885,117,0.97 [0.64-1.48],0.9018910817899168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCP2,Non-specific lipid-transfer protein,27585,127,0.98 [0.79-1.20],0.81236914728529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCPEP1,Retinoid-inducible serine carboxypeptidase,23803,117,1.08 [0.76-1.52],0.6763158842773747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCRG1,Scrapie-responsive protein 1,24567,122,0.68 [0.35-1.32],0.2524225273473114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCRIB,Protein scribble homolog,23885,117,0.92 [0.74-1.13],0.410085919628083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCRN1,Secernin-1,28257,133,0.93 [0.70-1.22],0.5807678033594734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCT,Secretin,23882,119,0.78 [0.52-1.18],0.2432924293252376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDC1,Syndecan-1,28278,131,1.19 [0.81-1.74],0.3792911877127376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDC4,Syndecan-4,28278,131,0.97 [0.69-1.35],0.844741146798079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDCCAG8,Serologically defined colon cancer antigen 8,24451,121,0.87 [0.75-1.01],0.07113378988375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDHB,Succinate dehydrogenase,24472,121,0.93 [0.72-1.21],0.5836801225214419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDK2,Protein sidekick-2,24019,120,1.15 [0.73-1.82],0.5477198899048472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEC31A,Protein transport protein Sec31A,23885,117,0.91 [0.72-1.14],0.3934477841066477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEL1L,Protein sel-1 homolog 1,23885,117,1.38 [0.92-2.07],0.1144574137703452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELE,E-selectin,28628,130,1.08 [0.79-1.46],0.634430372468989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELENOP,Selenoprotein P,24605,122,1.52 [0.77-2.98],0.226567656088296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELL,L-selectin,24605,122,0.68 [0.32-1.44],0.3161687837457322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELP,P-selectin,28359,128,0.93 [0.71-1.21],0.5725833347749225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELPLG,P-selectin glycoprotein ligand 1,28257,133,1.32 [0.78-2.24],0.2945061271732245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA3F,Semaphorin-3F,28278,131,1.09 [0.61-1.97],0.7695078510988117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA3G,Semaphorin-3G,24019,120,0.79 [0.52-1.19],0.2530389835016384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA4C,Semaphorin-4C,28150,131,0.89 [0.51-1.57],0.6883293421695316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA4D,Semaphorin-4D,28543,133,0.67 [0.41-1.10],0.1140716272406351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA6C,Semaphorin-6C,23868,118,1.11 [0.59-2.09],0.7393339295055887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA7A,Semaphorin-7A,28526,129,1.46 [0.85-2.51],0.1720695208753093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEPTIN3,Neuronal-specific septin-3,24531,120,1.07 [0.86-1.34],0.5462968788381773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEPTIN7,Septin-7,24115,121,0.83 [0.56-1.23],0.3475329112841501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEPTIN8,Septin-8,24440,120,1.57 [1.00-2.47],0.0523229035465377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEPTIN9,Septin-9,28150,131,0.77 [0.44-1.37],0.3779540915422427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA1,Alpha-1-antitrypsin,24163,122,3.68 [0.61-22.25],0.1560100366647741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA11,Serpin A11,28628,130,1.23 [0.84-1.80],0.2804977448090601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA12,Serpin A12,27491,126,1.16 [1.05-1.28],0.0038249002572618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA3,Alpha-1-antichymotrypsin,24527,122,0.77 [0.23-2.57],0.6752965125670817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA4,Kallistatin,24161,122,1.08 [0.52-2.25],0.8347433867364785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA5,Plasma serine protease inhibitor,24251,121,1.24 [0.78-1.95],0.3604943801369515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA6,Corticosteroid-binding globulin,24605,122,1.38 [0.52-3.66],0.5156771710324064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA7,Thyroxine-binding globulin,24605,122,1.21 [0.48-3.02],0.6884313615473291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA9,Serpin A9,28018,131,0.94 [0.76-1.16],0.5446779984586034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB1,Leukocyte elastase inhibitor,28175,129,0.92 [0.77-1.09],0.3340621912867159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB5,Serpin B5,27774,125,1.18 [0.84-1.64],0.3426008934212534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB6,Serpin B6,28447,133,0.92 [0.72-1.19],0.5429341829653349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB8,Serpin B8,28613,132,0.93 [0.71-1.23],0.6288796950470887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB9,Serpin B9,28081,128,0.82 [0.52-1.31],0.4127149374132892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINC1,Antithrombin-III,24554,122,3.03 [0.97-9.53],0.0575173085164606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPIND1,Heparin cofactor 2,24554,122,1.68 [0.92-3.06],0.0913487866356355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINE1,Plasminogen activator inhibitor 1,28628,130,0.91 [0.73-1.14],0.4227224575768203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINE2,Glia-derived nexin,24567,122,0.86 [0.66-1.12],0.2671514472700376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINF1,Pigment epithelium-derived factor,24242,122,1.91 [1.05-3.47],0.0329971774021381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINF2,Alpha-2-antiplasmin,24150,122,4.88 [1.62-14.72],0.0048718464846492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPING1,Plasma protease C1 inhibitor,24554,122,3.60 [1.52-8.49],0.0034676137016581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINH1,Serpin H1,24115,121,0.90 [0.79-1.03],0.1273888232041851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINI1,Neuroserpin,23967,120,0.52 [0.28-0.97],0.0385463609034472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINI2,Serpin I2,24472,121,0.98 [0.73-1.32],0.9003619624425003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27604,125,0.77 [0.59-1.00],0.0459301737819698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SETMAR,Histone-lysine N-methyltransferase SETMAR,27992,127,0.71 [0.42-1.20],0.2023740711910991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEZ6,Seizure protein 6 homolog,23882,119,0.61 [0.34-1.12],0.1140966444569534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEZ6L,Seizure 6-like protein,28342,129,0.80 [0.46-1.40],0.4370408830402531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEZ6L2,Seizure 6-like protein 2,28150,131,0.55 [0.28-1.06],0.0756798640713659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SF3B4,Splicing factor 3B subunit 4,28150,131,1.11 [0.91-1.36],0.3075464681766861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFRP1,Secreted frizzled-related protein 1,27981,128,1.08 [0.75-1.54],0.6941477539559893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFRP4,Secreted frizzled-related protein 4,24019,120,0.74 [0.48-1.12],0.1548516994056935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFTPA1,Pulmonary surfactant-associated protein A1,27585,127,0.91 [0.68-1.23],0.5508209907057582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFTPA2,Pulmonary surfactant-associated protein A2,27585,127,0.67 [0.48-0.94],0.0214537894957131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFTPD,Pulmonary surfactant-associated protein D,28278,131,0.93 [0.74-1.17],0.5440159766337005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SGSH,N-sulphoglucosamine sulphohydrolase,24185,120,1.28 [0.96-1.70],0.0951419731818608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH2B3,SH2B adapter protein 3,27585,127,0.96 [0.82-1.13],0.6340465056964619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH2D1A,SH2 domain-containing protein 1A,28257,133,0.97 [0.74-1.27],0.8304895970352245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23785,114,0.90 [0.66-1.24],0.5241372970579955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH3BP1,SH3 domain-binding protein 1,24472,121,0.66 [0.43-1.01],0.0537627337273813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH3GL3,Endophilin-A3,23961,121,0.90 [0.73-1.09],0.2814403771596767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH3GLB2,Endophilin-B2,24496,120,1.14 [0.88-1.47],0.3074484307058058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHBG,Sex hormone-binding globulin,24594,120,0.73 [0.53-1.02],0.0626696541363206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHC1,SHC-transforming protein 1,23697,117,1.04 [0.89-1.21],0.6295949900315794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHD,SH2 domain-containing adapter protein D,23751,116,1.07 [0.88-1.29],0.514910962550656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHH,Sonic hedgehog protein,23868,118,0.82 [0.54-1.26],0.3673320432053875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHISA5,Protein shisa-5,24559,122,0.93 [0.45-1.92],0.8406112478369334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28357,130,0.98 [0.82-1.17],0.8160993399211138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHPK,Sedoheptulokinase,24115,121,1.05 [0.69-1.58],0.833160638212165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIAE,Sialate O-acetylesterase,28293,129,1.01 [0.73-1.40],0.9296478260406597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC1,Sialoadhesin,28400,130,0.86 [0.60-1.24],0.4301008874596245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC10,Sialic acid-binding Ig-like lectin 10,28257,133,1.01 [0.63-1.60],0.9817448322205552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27604,125,1.08 [0.89-1.30],0.4343067425887106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC5,Sialic acid-binding Ig-like lectin 5,28263,129,0.88 [0.79-0.99],0.0256388866726134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28529,133,1.39 [0.87-2.20],0.1639362445468171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC7,Sialic acid-binding Ig-like lectin 7,28278,131,1.69 [1.00-2.85],0.0512692520581388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23885,117,1.19 [0.81-1.74],0.3691742109157356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28492,133,0.78 [0.48-1.26],0.3138680243318175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIL1,Nucleotide exchange factor SIL1,23885,117,0.74 [0.39-1.39],0.3481631474153017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28341,128,0.91 [0.70-1.19],0.4826841037430355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRPB1,Signal-regulatory protein beta-1,28200,128,1.06 [0.75-1.50],0.7575256714537608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23868,118,0.97 [0.79-1.19],0.7983140982153706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRT2,NAD-dependent protein deacetylase sirtuin-2,28150,131,1.03 [0.86-1.22],0.7641341806209447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27604,125,0.91 [0.67-1.24],0.5541253600728193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIT1,Signaling threshold-regulating transmembrane adapter 1,27752,127,0.97 [0.73-1.29],0.8182437274469568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SKAP1,Src kinase-associated phosphoprotein 1,28031,127,1.08 [0.87-1.34],0.4720669907868371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SKAP2,Src kinase-associated phosphoprotein 2,28400,130,0.88 [0.76-1.02],0.0996336484903536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SKIV2L,Helicase SKI2W,23789,116,0.78 [0.48-1.29],0.3317694094017759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLA2,Src-like-adapter 2,24531,120,0.91 [0.77-1.07],0.2531380107212068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLAMF1,Signaling lymphocytic activation molecule,27752,127,0.96 [0.74-1.26],0.7909364871676886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLAMF6,SLAM family member 6,27585,127,1.02 [0.67-1.53],0.9389917393024276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLAMF7,SLAM family member 7,28257,133,1.04 [0.80-1.36],0.7577691541252373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLAMF8,SLAM family member 8,27585,127,0.95 [0.70-1.29],0.7570544877261532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC12A2,Solute carrier family 12 member 2,23789,116,0.90 [0.46-1.77],0.7661253098602196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC13A1,Solute carrier family 13 member 1,24451,121,0.98 [0.74-1.31],0.9126169796338202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC16A1,Monocarboxylate transporter 1,27604,125,0.96 [0.73-1.27],0.7868625243864589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC1A4,Neutral amino acid transporter A,23882,119,1.06 [0.77-1.46],0.7053906845015461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC27A4,Long-chain fatty acid transport protein 4,27604,125,0.75 [0.57-0.99],0.0398748131888066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC28A1,Sodium/nucleoside cotransporter 1,23697,117,0.96 [0.70-1.31],0.7971226764457324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC34A3,Sodium-dependent phosphate transport protein 2C,23697,117,1.03 [0.71-1.48],0.8921267943931377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC39A14,Zinc transporter ZIP14,27604,125,1.09 [0.68-1.76],0.714232103286951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC39A5,Zinc transporter ZIP5,28257,133,0.97 [0.73-1.29],0.8452011824491186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC44A4,Choline transporter-like protein 4,23882,119,0.89 [0.67-1.18],0.4107524582961197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC4A1,Band 3 anion transport protein,24559,122,1.21 [0.85-1.72],0.2910295549681034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC51B,Organic solute transporter subunit beta,23789,116,0.96 [0.75-1.22],0.7250991751686761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24019,120,0.91 [0.74-1.11],0.3518760243439781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24472,121,1.17 [0.89-1.55],0.2530329640152952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23697,117,0.91 [0.66-1.27],0.5861585424461433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLIT2,Slit homolog 2 protein,27604,125,1.07 [0.80-1.44],0.6459127598337372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLITRK1,SLIT and NTRK-like protein 1,23868,118,1.02 [0.59-1.75],0.9441377013718752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLITRK2,SLIT and NTRK-like protein 2,28529,133,1.15 [0.78-1.69],0.4846340803342709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLITRK6,SLIT and NTRK-like protein 6,27774,125,0.95 [0.59-1.51],0.8130107932252465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLK,STE20-like serine/threonine-protein kinase,24115,121,1.03 [0.83-1.28],0.7880267313300465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLMAP,Sarcolemmal membrane-associated protein,24472,121,0.87 [0.70-1.07],0.1895088989693041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLURP1,Secreted Ly-6/uPAR-related protein 1,24381,122,1.01 [0.65-1.58],0.9527718074818388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMAD1,Mothers against decapentaplegic homolog 1,27585,127,1.00 [0.83-1.21],0.9666538892600468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMAD2,Mothers against decapentaplegic homolog 2,24451,121,0.96 [0.75-1.23],0.741474754020659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMAD3,Mothers against decapentaplegic homolog 3,24451,121,0.68 [0.48-0.97],0.0346166399936482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMAD5,Mothers against decapentaplegic homolog 5,28150,131,1.06 [0.50-2.25],0.8794718216311891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMARCA2,Probable global transcription activator SNF2L2,27604,125,0.78 [0.61-0.99],0.0427724218744305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMC3,Structural maintenance of chromosomes protein 3,23697,117,0.77 [0.52-1.13],0.1797909316226387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMNDC1,Survival of motor neuron-related-splicing factor 30,24472,121,1.06 [0.81-1.37],0.6805718641020524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMOC1,SPARC-related modular calcium-binding protein 1,28529,133,1.64 [1.04-2.57],0.032591788062033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMOC2,SPARC-related modular calcium-binding protein 2,28400,130,0.96 [0.64-1.45],0.863752826002365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMPD1,Sphingomyelin phosphodiesterase,28403,131,1.09 [0.80-1.49],0.5805691555829098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMPD3,Sphingomyelin phosphodiesterase 3,23868,118,0.99 [0.74-1.33],0.9713583664465468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28345,130,0.92 [0.73-1.17],0.4876852122199377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24451,121,0.95 [0.75-1.21],0.6808632157177115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMS,Spermine synthase,23785,114,0.84 [0.62-1.15],0.2860721363424616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMTN,Smoothelin,24440,119,0.86 [0.71-1.04],0.1259057316553553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNAP23,Synaptosomal-associated protein 23,28278,131,0.89 [0.75-1.05],0.1667667117367535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNAP25,Synaptosomal-associated protein 25,23785,114,0.74 [0.50-1.09],0.1214422220121039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNAP29,Synaptosomal-associated protein 29,28342,129,0.93 [0.79-1.10],0.4271672553224005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNAPIN,SNARE-associated protein Snapin,24531,120,0.69 [0.51-0.95],0.0215668039861244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNCA,Alpha-synuclein,24019,120,0.99 [0.85-1.15],0.848584882613024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNCG,Gamma-synuclein,28081,128,1.06 [0.83-1.35],0.6277810432545572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23885,117,0.95 [0.55-1.65],0.8599479630874578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNRPB2,U2 small nuclear ribonucleoprotein B'',24496,120,0.91 [0.59-1.40],0.6682203860828019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNU13,NHP2-like protein 1,23789,116,0.97 [0.73-1.28],0.8150082485016139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX15,Sorting nexin-15,24019,120,1.27 [0.93-1.73],0.1328190015360591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX18,Sorting nexin-18,24472,121,1.04 [0.71-1.51],0.8545155072768104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX2,Sorting nexin-2,24451,121,1.06 [0.86-1.30],0.5930378328338533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX5,Sorting nexin-5,23885,117,0.81 [0.45-1.49],0.5015182980842174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX9,Sorting nexin-9,28278,131,0.98 [0.78-1.22],0.8426255861714786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOD1,Superoxide dismutase [Cu-Zn],27668,125,1.36 [1.00-1.84],0.0484416069972094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOD2,"Superoxide dismutase [Mn], mitochondrial",28263,129,0.84 [0.55-1.28],0.4108673977802433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOD3,Extracellular superoxide dismutase,24594,120,1.11 [0.88-1.42],0.3760631359314272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SORBS1,Sorbin and SH3 domain-containing protein 1,24531,120,0.97 [0.61-1.54],0.9056658157758254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SORCS2,VPS10 domain-containing receptor SorCS2,27585,127,0.87 [0.55-1.37],0.548562202987287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SORD,Sorbitol dehydrogenase,28402,133,1.02 [0.82-1.27],0.8680359767215903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SORT1,Sortilin,28245,131,0.94 [0.62-1.42],0.7734619297401208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOST,Sclerostin,28245,131,0.87 [0.59-1.29],0.4897552504188516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23882,119,0.65 [0.41-1.04],0.0697658515549805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOX2,Transcription factor SOX-2,24491,119,1.09 [0.52-2.26],0.8238889632085513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOX9,Transcription factor SOX-9,23882,119,0.85 [0.44-1.64],0.6250375872505989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24531,120,1.12 [0.65-1.94],0.6809249797532689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPAG1,Sperm-associated antigen 1,24531,120,0.92 [0.68-1.25],0.6000060284897519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPARC,SPARC,28342,129,0.81 [0.66-0.99],0.0367879331701531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPARCL1,SPARC-like protein 1,28267,127,1.13 [0.65-1.96],0.6770810941926584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPART,Spartin,24019,120,0.89 [0.71-1.12],0.3374021851640126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPESP1,Sperm equatorial segment protein 1,24567,122,0.90 [0.50-1.64],0.7394086759349847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK1,Serine protease inhibitor Kazal-type 1,28263,129,1.08 [0.74-1.59],0.6957096639537206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK2,Serine protease inhibitor Kazal-type 2,24019,120,1.40 [0.93-2.12],0.1066339766278893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK4,Serine protease inhibitor Kazal-type 4,28257,133,0.97 [0.76-1.24],0.8068899455827301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK5,Serine protease inhibitor Kazal-type 5,28263,129,0.69 [0.43-1.10],0.1190726663772232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK6,Serine protease inhibitor Kazal-type 6,28529,133,0.84 [0.64-1.11],0.2160129746798785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK8,Serine protease inhibitor Kazal-type 8,23789,116,0.88 [0.52-1.48],0.6335886137838953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINT1,Kunitz-type protease inhibitor 1,28163,129,0.74 [0.39-1.42],0.36653770083876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINT2,Kunitz-type protease inhibitor 2,28400,130,1.17 [0.80-1.70],0.4259815850478523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINT3,Kunitz-type protease inhibitor 3,24472,121,0.98 [0.87-1.10],0.6849575436350233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPOCK1,Testican-1,28081,128,0.70 [0.38-1.29],0.2484344961141877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPON1,Spondin-1,28305,130,1.47 [0.93-2.32],0.0989165349699824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPON2,Spondin-2,28142,130,0.80 [0.50-1.28],0.3572325166950741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPP1,Osteopontin,28574,130,0.79 [0.57-1.10],0.165694997468312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23868,118,0.85 [0.57-1.29],0.4544907014516117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRING1,SREBP regulating gene protein,23697,117,0.61 [0.40-0.93],0.0215303932621837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRR1B,Cornifin-B,24115,121,0.82 [0.64-1.06],0.1263225753559378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRR3,Small proline-rich protein 3,24496,120,1.02 [0.79-1.32],0.8936712138115649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRY2,Protein sprouty homolog 2,27752,127,0.98 [0.83-1.16],0.8193464045829275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23785,114,1.22 [0.74-2.01],0.4448638352224432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPTLC1,Serine palmitoyltransferase 1,24496,120,1.37 [0.93-2.01],0.1084420421145354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SRC,Proto-oncogene tyrosine-protein kinase Src,28298,128,0.91 [0.81-1.04],0.1603172745590243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SRP14,Signal recognition particle 14 kDa protein,28150,131,1.10 [0.86-1.40],0.4681046706168751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SRPK2,SRSF protein kinase 2,28257,133,0.91 [0.75-1.10],0.3308091119865042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SRPX,Sushi repeat-containing protein SRPX,24567,122,1.78 [1.07-2.96],0.0258620551862254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSB,Lupus La protein,27604,125,0.99 [0.76-1.31],0.9676257088414594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23868,118,0.89 [0.53-1.50],0.6635374787137285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,28245,131,1.09 [0.95-1.24],0.2139416108023277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28359,128,1.09 [0.76-1.57],0.6346805250389403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSH3,Protein phosphatase Slingshot homolog 3,23697,117,0.81 [0.43-1.51],0.4992335598565952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24472,121,1.06 [0.76-1.48],0.7274279746629007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ST13,Hsc70-interacting protein,24019,120,1.13 [0.83-1.54],0.4416720688649562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",28150,131,1.01 [0.70-1.44],0.9693177199797394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28628,130,1.22 [0.72-2.06],0.4610385746296821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23868,118,1.08 [0.77-1.50],0.656836672326481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAB2,Stabilin-2,24559,122,1.56 [0.87-2.80],0.1334618780852036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAM,Signal transducing adapter molecule 1,24451,121,0.72 [0.43-1.20],0.2120641269454288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAMBP,STAM-binding protein,28031,127,0.98 [0.77-1.25],0.8668443156157901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAT2,Signal transducer and activator of transcription 2,23868,118,0.89 [0.71-1.12],0.3102416292930453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAT5B,Signal transducer and activator of transcription 5B,28150,131,0.99 [0.89-1.11],0.8964602276810459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23697,117,1.14 [0.90-1.45],0.2677170428869077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STC1,Stanniocalcin-1,28543,133,1.20 [0.85-1.69],0.3056885593734594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STC2,Stanniocalcin-2,28223,129,1.44 [0.78-2.67],0.2428143628954763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STEAP4,Metalloreductase STEAP4,23785,114,0.93 [0.72-1.21],0.5976243641817249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STIP1,Stress-induced-phosphoprotein 1,28214,129,1.11 [0.88-1.40],0.3931675348492535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STK11,Serine/threonine-protein kinase STK11,27774,125,0.93 [0.75-1.16],0.542526943291902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STK24,Serine/threonine-protein kinase 24,27604,125,0.85 [0.66-1.10],0.2220675715337207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STK4,Serine/threonine-protein kinase 4,28278,131,0.96 [0.80-1.14],0.613087298717534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STOML2,"Stomatin-like protein 2, mitochondrial",23697,117,0.93 [0.76-1.13],0.4685389368548616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX16,Syntaxin-16,27585,127,0.72 [0.53-0.99],0.0399817362701306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX1B,Syntaxin-1B,23882,119,0.96 [0.62-1.47],0.837340778738428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX3,Syntaxin-3,24496,120,0.81 [0.48-1.36],0.4245866227461822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX4,Syntaxin-4,28150,131,0.88 [0.67-1.16],0.377014347639379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX5,Syntaxin-5,23868,118,0.89 [0.56-1.41],0.6205884963183632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX6,Syntaxin-6,27585,127,0.83 [0.64-1.07],0.1560989494816241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX7,Syntaxin-7,23868,118,1.06 [0.74-1.50],0.7615078361576663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX8,Syntaxin-8,28257,133,0.81 [0.59-1.12],0.2035254868554731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STXBP1,Syntaxin-binding protein 1,24531,120,0.83 [0.66-1.03],0.0837409154540072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STXBP3,Syntaxin-binding protein 3,27585,127,0.73 [0.49-1.07],0.1098271566214718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUGP1,SURP and G-patch domain-containing protein 1,24472,121,0.83 [0.53-1.29],0.3986128488042844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUGT1,Protein SGT1 homolog,27585,127,0.99 [0.82-1.21],0.9553340189922572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SULT1A1,Sulfotransferase 1A1,28543,133,0.92 [0.82-1.03],0.1441260223856855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SULT2A1,Bile salt sulfotransferase,28257,133,0.99 [0.75-1.29],0.9136062309534972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUMF1,Formylglycine-generating enzyme,23868,118,0.76 [0.54-1.08],0.1261853105072506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28543,133,0.86 [0.65-1.13],0.279252810664793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUOX,"Sulfite oxidase, mitochondrial",24531,120,0.92 [0.69-1.22],0.547484230907751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUSD1,Sushi domain-containing protein 1,27774,125,0.89 [0.65-1.24],0.4990929838855653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUSD2,Sushi domain-containing protein 2,28263,129,1.09 [0.63-1.87],0.7580392402744848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUSD4,Sushi domain-containing protein 4,24451,121,1.38 [0.97-1.97],0.0719570173923082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUSD5,Sushi domain-containing protein 5,23893,120,1.02 [0.61-1.70],0.932480915481966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SV2A,Synaptic vesicle glycoprotein 2A,23882,119,0.98 [0.73-1.30],0.8706588305931267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SWAP70,Switch-associated protein 70,24472,121,0.96 [0.59-1.56],0.8736719514814838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SYAP1,Synapse-associated protein 1,24019,120,0.85 [0.62-1.16],0.3046053524364193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23785,114,1.08 [0.80-1.47],0.6196346345676957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SYT1,Synaptotagmin-1,24496,120,0.92 [0.56-1.51],0.7307043023437936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SYTL4,Synaptotagmin-like protein 4,24567,122,0.84 [0.66-1.07],0.1663308269774077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24115,121,0.85 [0.72-1.00],0.0452149746606349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TACC3,Transforming acidic coiled-coil-containing protein 3,28150,131,0.92 [0.81-1.05],0.2027727980435755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TACSTD2,Tumor-associated calcium signal transducer 2,25110,116,1.29 [0.73-2.28],0.3865458219272023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TADA3,Transcriptional adapter 3,24451,121,0.83 [0.53-1.30],0.4158414544589296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAFA5,Chemokine-like protein TAFA-5,28150,131,0.89 [0.57-1.41],0.6284497094777145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAGLN3,Transgelin-3,23697,117,1.37 [1.13-1.66],0.0013271835709807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TALDO1,Transaldolase,24478,122,1.08 [0.74-1.57],0.7021177584144074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TANK,TRAF family member-associated NF-kappa-B activator,27752,127,0.96 [0.77-1.20],0.708124705156411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAP1,Antigen peptide transporter 1,24115,121,0.71 [0.48-1.04],0.0797947540381775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TARBP2,RISC-loading complex subunit TARBP2,27604,125,0.90 [0.74-1.11],0.3251400835777864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23882,119,0.95 [0.74-1.21],0.6544738328002071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24451,121,1.14 [0.72-1.80],0.5700103214976758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAX1BP1,Tax1-binding protein 1,24496,120,0.88 [0.66-1.17],0.3680494178972817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBC1D17,TBC1 domain family member 17,27604,125,1.00 [0.70-1.42],0.9796714906084152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBC1D23,TBC1 domain family member 23,28150,131,0.87 [0.73-1.03],0.1039236462120791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBC1D5,TBC1 domain family member 5,28257,133,0.84 [0.69-1.03],0.1014958032185552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBCA,Tubulin-specific chaperone A,24019,120,1.05 [0.86-1.28],0.6230356065011572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBCB,Tubulin-folding cofactor B,28081,128,0.98 [0.84-1.14],0.77514011464089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBCC,Tubulin-specific chaperone C,28081,128,0.94 [0.77-1.13],0.5057555520803423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27585,127,0.94 [0.79-1.13],0.5433472051260898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBR1,T-box brain protein 1,23882,119,0.76 [0.48-1.20],0.2395238912528726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCL1A,T-cell leukemia/lymphoma protein 1A,28028,128,0.96 [0.81-1.12],0.5737408773697812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCL1B,T-cell leukemia/lymphoma protein 1B,27774,125,1.05 [0.87-1.26],0.6176314052816767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCN1,Transcobalamin-1,24106,117,1.02 [0.61-1.72],0.9329876260588408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCN2,Transcobalamin-2,28574,130,0.96 [0.57-1.63],0.8870413793838478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCOF1,Treacle protein,24567,122,1.29 [0.78-2.12],0.3280905860331661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCP11,T-complex protein 11 homolog,24115,121,1.05 [0.79-1.39],0.7441708887252396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCTN3,Tectonic-3,24567,122,0.81 [0.45-1.45],0.4856515834405631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TDGF1,Teratocarcinoma-derived growth factor 1,27604,125,1.02 [0.91-1.14],0.7578870487932197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TDO2,"Tryptophan 2,3-dioxygenase",23882,119,1.24 [0.85-1.80],0.258065567009866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TDP1,Tyrosyl-DNA phosphodiesterase 1,24451,121,0.87 [0.66-1.15],0.3317050366951687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TDRKH,Tudor and KH domain-containing protein,27604,125,0.80 [0.65-0.98],0.0272973888456368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TEF,Thyrotroph embryonic factor,23789,116,1.14 [0.76-1.70],0.5218303493386445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TEK,Angiopoietin-1 receptor,28342,129,1.01 [0.50-2.05],0.972935287639606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TERF1,Telomeric repeat-binding factor 1,23868,118,1.00 [0.55-1.80],0.9893244358247442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TET2,Methylcytosine dioxygenase TET2,24081,121,1.04 [0.88-1.22],0.6662679824739672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TEX101,Testis-expressed protein 101,23882,119,0.79 [0.54-1.14],0.2108393414653168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TEX33,Testis-expressed protein 33,24115,121,1.13 [0.76-1.68],0.5360367649786305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TF,Serotransferrin,24605,122,0.72 [0.33-1.58],0.4150902745899636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFAP2A,Transcription factor AP-2-alpha,23785,114,0.96 [0.70-1.31],0.7785090315321839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFF1,Trefoil factor 1,28130,129,1.10 [0.91-1.33],0.3465161764020908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFF2,Trefoil factor 2,28357,130,1.32 [1.03-1.71],0.0315066974276138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFF3,Trefoil factor 3,28235,126,1.38 [1.08-1.77],0.0100760351139431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFPI,Tissue factor pathway inhibitor,28177,128,1.02 [0.62-1.65],0.9515308947273972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFPI2,Tissue factor pathway inhibitor 2,28246,129,0.98 [0.65-1.47],0.9133510979454452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFRC,Transferrin receptor protein 1,28373,128,1.66 [1.15-2.40],0.0069978491130834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TG,Thyroglobulin,24451,121,0.95 [0.81-1.11],0.5179465289188869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFA,Protransforming growth factor alpha,28257,133,1.11 [0.80-1.54],0.5383898591309311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFB1,Transforming growth factor beta-1 proprotein,28562,132,0.87 [0.59-1.30],0.506680348558822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFB2,Transforming growth factor beta-2 proprotein,24451,121,0.92 [0.66-1.28],0.6206591251828291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFBI,Transforming growth factor-beta-induced protein ig-h3,28086,128,0.56 [0.31-1.00],0.0493745253893532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFBR1,TGF-beta receptor type-1,23868,118,1.02 [0.47-2.22],0.9600739119493744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFBR2,TGF-beta receptor type-2,28342,129,1.15 [0.70-1.91],0.5800428016734533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFBR3,Transforming growth factor beta receptor type 3,28628,130,1.12 [0.69-1.82],0.6487312510744625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGM2,Protein-glutamine gamma-glutamyltransferase 2,28224,130,1.14 [0.93-1.40],0.2147926183724151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGOLN2,Trans-Golgi network integral membrane protein 2,24594,120,1.08 [0.54-2.16],0.8190949616691254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23649,117,0.84 [0.66-1.06],0.1417241817934808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THBD,Thrombomodulin,28278,131,0.96 [0.54-1.69],0.8826410061590936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THBS2,Thrombospondin-2,28263,129,0.83 [0.54-1.30],0.4195480172151292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THBS4,Thrombospondin-4,28278,128,0.92 [0.66-1.30],0.6498926289281703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THOP1,Thimet oligopeptidase,28159,130,1.06 [0.65-1.73],0.8079908916653943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THPO,Thrombopoietin,27774,125,0.71 [0.47-1.08],0.1090264490822303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THRAP3,Thyroid hormone receptor-associated protein 3,23789,116,0.98 [0.83-1.15],0.818578196075264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THSD1,Thrombospondin type-1 domain-containing protein 1,23689,117,1.32 [0.83-2.10],0.2367971425897893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THTPA,Thiamine-triphosphatase,24399,121,1.00 [0.82-1.22],0.9956401512106527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THY1,Thy-1 membrane glycoprotein,28543,133,0.78 [0.44-1.38],0.3933262808879711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIA1,Nucleolysin TIA-1 isoform p40,27469,123,0.97 [0.85-1.11],0.6491869723543436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIE1,Tyrosine-protein kinase receptor Tie-1,28628,130,0.85 [0.61-1.19],0.3373495596768682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27554,124,0.85 [0.60-1.20],0.3498774165406723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24115,121,0.64 [0.38-1.10],0.1085476501673148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28359,128,0.78 [0.55-1.12],0.179257642840198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24567,122,0.89 [0.58-1.38],0.6103850649092107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24496,120,0.86 [0.71-1.06],0.1537607527716787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMP1,Metalloproteinase inhibitor 1,27944,125,1.09 [0.62-1.90],0.7632923189260694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMP2,Metalloproteinase inhibitor 2,24567,122,0.91 [0.45-1.87],0.803675776000562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMP3,Metalloproteinase inhibitor 3,28400,130,1.02 [0.91-1.15],0.7314624471907885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMP4,Metalloproteinase inhibitor 4,28263,129,0.84 [0.57-1.26],0.4074999494529745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TINAGL1,Tubulointerstitial nephritis antigen-like,28194,131,1.50 [0.75-2.99],0.2505776375155435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TJAP1,Tight junction-associated protein 1,28342,129,0.87 [0.72-1.05],0.1464350904453366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TJP3,Tight junction protein ZO-3,23785,114,1.07 [0.71-1.62],0.7387990745560733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TK1,"Thymidine kinase, cytosolic",24115,121,0.79 [0.51-1.21],0.2789913577064376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TLR1,Toll-like receptor 1,23868,118,2.12 [1.23-3.65],0.0067979789995211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TLR2,Toll-like receptor 2,24115,121,1.29 [0.61-2.72],0.5011344509402993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TLR3,Toll-like receptor 3,28613,132,1.23 [0.94-1.59],0.130650970348398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TLR4,Toll-like receptor 4,23868,118,0.84 [0.44-1.58],0.5823375243838289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23882,119,0.80 [0.56-1.15],0.2269671408838197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMED1,Transmembrane emp24 domain-containing protein 1,24115,121,0.91 [0.65-1.28],0.593940590949668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMED10,Transmembrane emp24 domain-containing protein 10,23789,116,0.46 [0.24-0.87],0.0172292329237434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMED4,Transmembrane emp24 domain-containing protein 4,23789,116,1.10 [0.83-1.47],0.4985487175953644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMED8,Protein TMED8,24472,121,0.90 [0.76-1.06],0.1915278400917011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMEM106A,Transmembrane protein 106A,24451,121,0.89 [0.69-1.14],0.3510644287566551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMEM132A,Transmembrane protein 132A,23885,117,0.83 [0.62-1.10],0.1990940797886687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMEM25,Transmembrane protein 25,24531,120,1.27 [0.91-1.77],0.16329693320798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMOD4,Tropomodulin-4,23697,117,1.03 [0.67-1.58],0.8826139823099433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMPRSS11B,Transmembrane protease serine 11B,23785,114,0.95 [0.74-1.21],0.6620640259931863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMPRSS11D,Transmembrane protease serine 11D,24440,120,0.86 [0.53-1.38],0.5279005706898581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMPRSS15,Enteropeptidase,28150,131,1.29 [1.09-1.53],0.0035376841951458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMPRSS5,Transmembrane protease serine 5,27934,128,0.85 [0.57-1.28],0.4431174116029192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMSB10,Thymosin beta-10,28263,129,0.87 [0.71-1.07],0.1818507757151403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNC,Tenascin,28359,128,1.08 [0.78-1.50],0.6250239133661355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNF,Tumor necrosis factor,27725,124,1.26 [0.89-1.78],0.1900760649729754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24472,121,0.82 [0.56-1.19],0.2984547747062955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27752,127,1.08 [0.71-1.66],0.7184285225949263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24019,120,0.86 [0.65-1.14],0.2901388632878433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,28081,128,1.10 [0.68-1.80],0.6983287844534911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,28081,128,0.97 [0.65-1.44],0.8811913926879259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,28329,127,1.27 [0.91-1.77],0.1534595407293394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28613,132,1.10 [0.73-1.67],0.6504955076023018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,28255,128,1.15 [0.68-1.94],0.60038590337787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28342,129,1.12 [0.72-1.75],0.6088464614905706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,28305,130,1.00 [0.61-1.63],0.9962536379509292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27752,127,0.91 [0.62-1.32],0.6104548321493583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,28305,130,0.82 [0.48-1.40],0.4698358253999549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24019,120,1.01 [0.65-1.58],0.9540278811721028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28529,133,0.96 [0.57-1.60],0.8662163105513714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,28263,129,1.11 [0.63-1.93],0.7238640185942706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,28263,129,0.98 [0.62-1.55],0.938522847659614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28543,133,0.88 [0.50-1.55],0.6503721064345794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28562,132,1.08 [0.71-1.63],0.7262633884366436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,28081,128,0.98 [0.73-1.31],0.8852025709224718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28543,133,0.73 [0.51-1.06],0.0954303079577693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,28081,128,0.89 [0.59-1.36],0.5945471662424174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28613,132,0.75 [0.42-1.34],0.3234748807446932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF11,Tumor necrosis factor ligand superfamily member 11,28257,133,1.02 [0.80-1.31],0.8793025149618314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28613,132,0.63 [0.37-1.07],0.0880313097026573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28400,130,0.75 [0.42-1.37],0.3528363981168844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28573,129,0.72 [0.39-1.31],0.2831699962946916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF14,Tumor necrosis factor ligand superfamily member 14,28081,128,0.92 [0.70-1.21],0.5597052813255683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24559,122,0.90 [0.55-1.46],0.6697650418963028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNIP1,TNFAIP3-interacting protein 1,24496,120,0.84 [0.69-1.03],0.0894479925522001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNN,Tenascin-N,24559,122,0.93 [0.63-1.37],0.6991023824796243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNNI3,"Troponin I, cardiac muscle",27774,125,1.10 [0.90-1.33],0.365110887329595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNPO1,Transportin-1,24115,121,0.91 [0.55-1.49],0.6982346248298079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNR,Tenascin-R,28081,128,1.19 [0.82-1.72],0.3546091685102539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNXB,Tenascin-X,28263,129,0.74 [0.41-1.35],0.3281956664426807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24567,122,0.86 [0.68-1.08],0.2018856754325879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOP1,DNA topoisomerase 1,24472,121,1.04 [0.89-1.20],0.6446865439435743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOP1MT,"DNA topoisomerase I, mitochondrial",23697,117,0.79 [0.52-1.20],0.2730101050936663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOP2B,DNA topoisomerase 2-beta,23868,118,0.82 [0.65-1.03],0.0911434867949464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOR1AIP1,Torsin-1A-interacting protein 1,23885,117,1.03 [0.74-1.42],0.8715837127255575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP53,Cellular tumor antigen p53,27585,127,0.93 [0.64-1.33],0.6817877350742487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP53BP1,TP53-binding protein 1,23868,118,0.95 [0.77-1.16],0.6155218102590065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP53I3,Quinone oxidoreductase PIG3,23495,119,1.12 [0.81-1.55],0.5093681398795357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27774,125,0.84 [0.48-1.47],0.5366692952712797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP73,Tumor protein p73,23882,119,0.55 [0.33-0.91],0.0214292750955124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPBGL,Trophoblast glycoprotein-like,23882,119,0.58 [0.34-0.98],0.0400513912700175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPD52L2,Tumor protein D54,24019,120,0.92 [0.79-1.08],0.3057627216224072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPK1,Thiamin pyrophosphokinase 1,24567,122,0.48 [0.27-0.87],0.014958841433463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPM3,Tropomyosin alpha-3 chain,23789,116,1.06 [0.71-1.57],0.7763320650159662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPMT,Thiopurine S-methyltransferase,27585,127,0.98 [0.79-1.21],0.8272136915028796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPP1,Tripeptidyl-peptidase 1,28075,128,1.17 [0.85-1.61],0.344468735725802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPPP2,Tubulin polymerization-promoting protein family member 2,24115,121,0.93 [0.73-1.17],0.5155329804936237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPPP3,Tubulin polymerization-promoting protein family member 3,27604,125,0.76 [0.48-1.20],0.2380107884140193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPR,Nucleoprotein TPR,23789,116,0.95 [0.65-1.38],0.7883400864880109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPRKB,EKC/KEOPS complex subunit TPRKB,23697,117,0.76 [0.54-1.07],0.1179565336688278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPSAB1,Tryptase alpha/beta-1,28562,132,1.02 [0.76-1.36],0.8989677255071739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPSD1,Tryptase delta,24531,120,1.22 [0.80-1.85],0.3612097696587772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPSG1,Tryptase gamma,23868,118,1.43 [0.84-2.41],0.1875710685584458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPT1,Translationally-controlled tumor protein,27752,127,0.68 [0.49-0.94],0.0179113022634196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRAF2,TNF receptor-associated factor 2,28257,133,1.04 [0.84-1.29],0.7259755520261598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23868,118,1.25 [0.86-1.82],0.2462940892567458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23789,116,0.97 [0.66-1.43],0.8949643562445021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24115,121,0.81 [0.65-1.02],0.0754556392867364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TREH,Trehalase,24559,122,1.23 [0.98-1.55],0.0796556551967017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TREM2,Triggering receptor expressed on myeloid cells 2,28255,128,0.73 [0.54-0.98],0.0383748236378464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TREML1,Trem-like transcript 1 protein,24594,120,0.81 [0.58-1.13],0.2080402341542229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TREML2,Trem-like transcript 2 protein,28263,129,0.64 [0.40-1.03],0.0653339910148761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28529,133,0.90 [0.71-1.14],0.3908040367921586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM21,E3 ubiquitin-protein ligase TRIM21,28257,133,1.01 [0.83-1.24],0.8945315116230044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM24,Transcription intermediary factor 1-alpha,24063,121,0.94 [0.72-1.23],0.6509161689958549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24472,121,0.92 [0.78-1.08],0.2997731780972594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM26,Tripartite motif-containing protein 26,23697,117,1.04 [0.77-1.40],0.7974322552879763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM40,E3 ubiquitin ligase TRIM40,23882,119,0.86 [0.67-1.11],0.2426444996666081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM5,Tripartite motif-containing protein 5,28257,133,0.95 [0.80-1.14],0.6088554135067845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM58,E3 ubiquitin-protein ligase TRIM58,24451,121,0.98 [0.81-1.20],0.8661647895038087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRPV3,Transient receptor potential cation channel subfamily V member 3,23789,116,0.97 [0.67-1.39],0.8517432607587495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSC1,Hamartin,23868,118,0.85 [0.65-1.12],0.2580469055186251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSC22D1,TSC22 domain family protein 1,24531,120,0.87 [0.67-1.14],0.305585262199547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSHB,Thyrotropin subunit beta,28278,131,0.82 [0.68-1.01],0.0566669603306418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSLP,Thymic stromal lymphopoietin,27774,125,0.98 [0.75-1.28],0.8654278847810486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSNAX,Translin-associated protein X,23789,116,1.13 [0.73-1.75],0.5935563022086952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPAN1,Tetraspanin-1,27774,125,0.95 [0.65-1.39],0.7954042504057904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPAN15,Tetraspanin-15,23789,116,0.74 [0.48-1.13],0.1619484510923014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPAN7,Tetraspanin-7,23785,114,1.17 [0.99-1.37],0.060706397482048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPAN8,Tetraspanin-8,24472,121,1.03 [0.87-1.23],0.7140352399871241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPYL1,Testis-specific Y-encoded-like protein 1,23868,118,0.82 [0.52-1.29],0.3922624939614412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TST,Thiosulfate sulfurtransferase,27565,125,0.87 [0.71-1.08],0.2120560464887385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TTF2,Transcription termination factor 2,23882,119,0.74 [0.51-1.07],0.1113580929646421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TTN,Titin,23789,116,0.89 [0.67-1.19],0.4389133518650234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TTR,Transthyretin,24335,122,1.32 [0.67-2.61],0.4262263935687856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TUBB3,Tubulin beta-3 chain,23785,114,0.89 [0.46-1.70],0.7189439434472573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TWF2,Twinfilin-2,24559,122,0.90 [0.73-1.10],0.3011042282742869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXK,Tyrosine-protein kinase TXK,24115,121,0.98 [0.77-1.25],0.8826019370589426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXLNA,Alpha-taxilin,28081,128,0.98 [0.82-1.16],0.7802628621651602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXN,Thioredoxin,24194,118,1.04 [0.70-1.54],0.8528028880537819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNDC15,Thioredoxin domain-containing protein 15,28342,129,0.80 [0.45-1.40],0.4297128666355292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNDC5,Thioredoxin domain-containing protein 5,28543,133,1.00 [0.81-1.25],0.9760129651223828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNDC9,Thioredoxin domain-containing protein 9,24496,120,0.89 [0.64-1.25],0.5039994456954195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNL1,Thioredoxin-like protein 1,23741,114,0.89 [0.72-1.10],0.267246250864463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",28263,129,0.92 [0.66-1.29],0.624725555187403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TYMP,Thymidine phosphorylase,28103,130,0.84 [0.67-1.06],0.1507565176159373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TYRO3,Tyrosine-protein kinase receptor TYRO3,28278,131,0.79 [0.46-1.37],0.4045668015491698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23868,118,1.10 [0.82-1.47],0.5141522414978281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBAC1,Ubiquitin-associated domain-containing protein 1,28150,131,1.48 [0.96-2.28],0.0789221540273789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBE2B,Ubiquitin-conjugating enzyme E2 B,24451,121,1.14 [0.64-2.04],0.6622133869850055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24567,122,0.93 [0.71-1.23],0.6263680007564576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23868,118,0.99 [0.73-1.33],0.9254305269636998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBQLN3,Ubiquilin-3,23789,116,0.91 [0.60-1.36],0.6316934473266693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBXN1,UBX domain-containing protein 1,24019,120,1.05 [0.82-1.34],0.7169499817236573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24472,121,0.93 [0.82-1.05],0.2285324282823394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UGDH,UDP-glucose 6-dehydrogenase,23789,116,1.03 [0.88-1.22],0.6902839650858956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UHRF2,E3 ubiquitin-protein ligase UHRF2,23789,116,0.83 [0.48-1.46],0.5264645523263598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ULBP2,UL16-binding protein 2,28081,128,1.06 [0.71-1.58],0.7837374092826315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UMOD,Uromodulin,28531,130,0.70 [0.54-0.91],0.0078413976478993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UNC5D,Netrin receptor UNC5D,23868,118,0.70 [0.35-1.40],0.3183951082348197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UNC79,Protein unc-79 homolog,23697,117,0.73 [0.52-1.03],0.0764855660866988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UNG,Uracil-DNA glycosylase,24451,121,0.94 [0.57-1.56],0.8117692492815523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UPB1,Beta-ureidopropionase,24567,122,1.05 [0.87-1.26],0.616046901292364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UPK3A,Uroplakin-3a,23785,114,1.50 [1.11-2.02],0.0086256668724563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UPK3BL1,Uroplakin-3b-like protein 1,24075,120,0.71 [0.45-1.10],0.1217781271445923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UROD,Uroporphyrinogen decarboxylase,24019,120,1.07 [0.83-1.37],0.6096721198165357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UROS,Uroporphyrinogen-III synthase,23882,119,0.97 [0.75-1.26],0.8350129451506956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USO1,General vesicular transport factor p115,28150,131,0.96 [0.81-1.13],0.6134562025742618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24451,121,0.93 [0.73-1.18],0.5399418552369384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24496,120,1.01 [0.63-1.61],0.9786833644786328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23789,116,0.88 [0.70-1.10],0.2562732774993794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27774,125,1.01 [0.86-1.19],0.9164844321691727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UXS1,UDP-glucuronic acid decarboxylase 1,27585,127,1.29 [0.99-1.67],0.0620021318045978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VAMP5,Vesicle-associated membrane protein 5,27774,125,1.06 [0.80-1.42],0.6657692260649464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VAMP8,Vesicle-associated membrane protein 8,23868,118,0.91 [0.74-1.11],0.3385528588596081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VASH1,Tubulinyl-Tyr carboxypeptidase 1,28257,133,0.93 [0.77-1.12],0.4192526334294701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VASN,Vasorin,27818,126,1.37 [0.78-2.40],0.2795851762811818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VASP,Vasodilator-stimulated phosphoprotein,24594,120,0.84 [0.66-1.07],0.1649274299686355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,28150,131,0.42 [0.19-0.92],0.0309270981673602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VAV3,Guanine nucleotide exchange factor VAV3,23785,114,0.94 [0.78-1.12],0.4730711078939644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VCAM1,Vascular cell adhesion protein 1,28324,128,0.94 [0.53-1.68],0.8397973877450968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VCAN,Versican core protein,28543,133,0.95 [0.57-1.58],0.8508628099953841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VCPKMT,Protein-lysine methyltransferase METTL21D,23697,117,0.84 [0.66-1.07],0.1613760855730096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VEGFA,Vascular endothelial growth factor A,28518,132,0.91 [0.70-1.19],0.4906001231289656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VEGFB,Vascular endothelial growth factor B,23868,118,0.77 [0.42-1.43],0.4136628903492668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VEGFC,Vascular endothelial growth factor C,28342,129,0.84 [0.64-1.10],0.1984604228305337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VEGFD,Vascular endothelial growth factor D,28564,132,1.15 [0.74-1.77],0.537808198859494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VGF,Neurosecretory protein VGF,24531,120,1.07 [0.60-1.91],0.8219916887786007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VIM,Vimentin,27774,125,1.02 [0.89-1.17],0.7794660059534811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VIPR1,Vasoactive intestinal polypeptide receptor 1,23885,117,1.01 [0.51-2.00],0.96779624583966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VIT,Vitrin,24567,122,1.23 [0.78-1.94],0.3624435479130026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VMO1,Vitelline membrane outer layer protein 1 homolog,28150,131,1.15 [0.90-1.46],0.2630591565800685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VNN1,Pantetheinase,24594,120,1.22 [0.95-1.56],0.1150175057644609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VNN2,Vascular non-inflammatory molecule 2,28150,131,1.28 [0.91-1.80],0.1587647265402934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24115,121,0.87 [0.67-1.14],0.3220322995746687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VPS37A,Vacuolar protein sorting-associated protein 37A,28150,131,0.96 [0.79-1.17],0.6805471563311702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VPS4B,Vacuolar protein sorting-associated protein 4B,24451,121,0.89 [0.74-1.07],0.2242587222229644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VPS53,Vacuolar protein sorting-associated protein 53 homolog,28150,131,0.88 [0.72-1.08],0.225463220611369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIG10,V-set and immunoglobulin domain-containing protein 10,24451,121,1.50 [1.08-2.07],0.0148521779044837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23789,116,0.85 [0.49-1.48],0.5610958298305845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIG2,V-set and immunoglobulin domain-containing protein 2,24451,121,1.58 [1.22-2.06],0.0005751407047322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIG4,V-set and immunoglobulin domain-containing protein 4,28223,129,1.17 [0.79-1.75],0.4284279242030093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,28239,131,0.91 [0.70-1.17],0.4570771979871071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSNL1,Visinin-like protein 1,24496,120,0.59 [0.36-0.97],0.0356922112217084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSTM1,V-set and transmembrane domain-containing protein 1,27604,125,0.89 [0.64-1.24],0.4850604463056095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSTM2B,V-set and transmembrane domain-containing protein 2B,24115,121,1.05 [0.70-1.56],0.8249551774273821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27774,125,0.97 [0.73-1.29],0.8251914524864725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28543,133,0.95 [0.77-1.18],0.669223782441271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27585,127,0.83 [0.50-1.36],0.4609095703203238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24019,120,0.87 [0.64-1.19],0.3915177162997975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWA1,von Willebrand factor A domain-containing protein 1,28492,133,0.83 [0.58-1.20],0.3209748759016554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWA5A,von Willebrand factor A domain-containing protein 5A,23697,117,0.99 [0.80-1.24],0.959141030562513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWC2,Brorin,27982,127,0.73 [0.49-1.10],0.1345472871453862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWC2L,von Willebrand factor C domain-containing protein 2-like,24531,120,0.77 [0.48-1.21],0.2569772354144515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWF,von Willebrand factor,28628,130,1.15 [0.93-1.41],0.1994322699669764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WARS,"Tryptophan--tRNA ligase, cytoplasmic",28263,129,0.89 [0.59-1.35],0.5904358469256172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WAS,Wiskott-Aldrich syndrome protein,27752,127,0.75 [0.58-0.96],0.0213540602920055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WASF1,Wiskott-Aldrich syndrome protein family member 1,27774,125,0.97 [0.82-1.15],0.7149280961721434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WASF3,Wiskott-Aldrich syndrome protein family member 3,27604,125,0.86 [0.72-1.03],0.096720328280364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WASHC3,WASH complex subunit 3,24496,120,0.82 [0.64-1.04],0.0969978979076341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WASL,Neural Wiskott-Aldrich syndrome protein,23868,118,1.06 [0.80-1.39],0.6929554605815544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WDR46,WD repeat-containing protein 46,24451,121,1.02 [0.64-1.62],0.9313318584663112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFDC1,WAP four-disulfide core domain protein 1,23965,121,1.18 [0.89-1.56],0.2396656773164438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFDC12,WAP four-disulfide core domain protein 12,28476,133,0.88 [0.69-1.12],0.2981274264091186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFDC2,WAP four-disulfide core domain protein 2,26811,126,0.86 [0.54-1.38],0.5370546418335732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27992,127,0.97 [0.66-1.44],0.8957046787375458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",28305,130,0.94 [0.60-1.47],0.7747942733665557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WIF1,Wnt inhibitory factor 1,28529,133,0.57 [0.36-0.89],0.0136627983296295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WNT9A,Protein Wnt-9a,27752,127,1.81 [1.12-2.92],0.0154200496384396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,28081,128,0.88 [0.66-1.18],0.4020887562418223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XCL1,Lymphotactin,28529,133,0.80 [0.59-1.08],0.1477401891065927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XG,Glycoprotein Xg,28477,128,0.83 [0.51-1.35],0.4520189396956179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XIAP,E3 ubiquitin-protein ligase XIAP,23868,118,0.85 [0.62-1.16],0.3089040718825621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XPNPEP2,Xaa-Pro aminopeptidase 2,28342,129,0.92 [0.79-1.08],0.317287761522817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XRCC4,DNA repair protein XRCC4,27604,125,0.87 [0.56-1.35],0.5213067719401874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YAP1,Transcriptional coactivator YAP1,24496,120,1.15 [0.60-2.20],0.6767625880587274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24472,121,0.98 [0.87-1.10],0.7759230359285567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YES1,Tyrosine-protein kinase Yes,28150,131,0.96 [0.84-1.09],0.526158515754908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YJU2,Splicing factor YJU2,24451,121,0.99 [0.58-1.67],0.9568707095689288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YOD1,Ubiquitin thioesterase OTU1,23789,116,1.07 [0.81-1.42],0.6162656124786873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YTHDF3,YTH domain-containing family protein 3,27752,127,0.93 [0.77-1.12],0.456437817128746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YWHAQ,14-3-3 protein theta,24019,120,0.97 [0.76-1.23],0.7848523891201695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YY1,Transcriptional repressor protein YY1,23868,118,1.02 [0.54-1.92],0.9527599135571716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZBP1,Z-DNA-binding protein 1,23868,118,0.91 [0.58-1.42],0.6674425145167384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZBTB16,Zinc finger and BTB domain-containing protein 16,27585,127,0.92 [0.74-1.16],0.4987025756737699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZBTB17,Zinc finger and BTB domain-containing protein 17,27774,125,0.91 [0.61-1.35],0.6260038832463012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23789,116,0.93 [0.68-1.27],0.6509040648518414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZFYVE19,Abscission/NoCut checkpoint regulator,24472,121,1.00 [0.83-1.21],0.9945155895938176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZHX2,Zinc fingers and homeoboxes protein 2,24496,120,0.83 [0.46-1.50],0.5410774782468281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNF174,Zinc finger protein 174,23868,118,0.71 [0.40-1.27],0.2455157851181318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNF75D,Zinc finger protein 75D,24115,121,0.99 [0.74-1.32],0.9547563912123952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNF830,Zinc finger protein 830,24451,121,1.05 [0.85-1.28],0.6727837403274091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNRD2,Protein ZNRD2,24472,121,0.79 [0.60-1.03],0.0837044105686456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24451,121,0.98 [0.70-1.35],0.882730913303695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZP3,Zona pellucida sperm-binding protein 3,23885,117,1.03 [0.96-1.11],0.3654404123598274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZP4,Zona pellucida sperm-binding protein 4,23697,117,0.43 [0.20-0.91],0.0280783528413544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZPR1,Zinc finger protein ZPR1,23785,114,1.00 [0.82-1.21],0.9849017603617268
